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The metabolic processes which may be involved in damage 
to ischaemic tissue have beeh studied in a recirculating 
Langendorff perfused rat heart model.
Hearts perfused at a low-flow rate of 4 ml/min showed 
increased carbohydrate utilisation compared with high-flow 
controls. This was evidence of mild ischaemia.
In such low-flow hearts adrenaline challenge stimulated 
oxygen extraction and lipid and carbohydrate oxidation. The 
incidence of arrhythmias increased and resting tension rose. 
Tissue A T P  was lower and long chain acyl CoA and lactate 
higher than in adequately oxygenated hearts.
Hearts from rats fed a saturated fat enriched diet 
oxidised more lipid and less carbohydrate. After adrenaline 
at the low-flow they were more arrhythmic and developed 
more contracture than the normally-fed hearts; tissue long 
chain acyl CoA was higher and lactate and ATP lower. Thus 
long chain acyl CoA appeared to be more closely related to 
the process of deterioration than lactate in this model.
Tissue lactate may have been a reflection of the degree of 
carbohydrate oxidation.
Antilipolytic agents dichloroacetate and 2-bromopalmitate 
increased carbohydrate oxidation and anaerobic glycolysis 
after adrenaline in both types of heart. These effects were
accompanied by amelioration in the incidence of arrhythmias 
and in resting tension rise.
Perfusion of hearts at low flow with pyruvate as sole 
substrate caused a large increase in arrhythmic activity and 
a rise in resting tension. This is proposed to be due to 
the inability of these hearts to generate glycolytic ATP, 
since oxidative metabolism was unimpaired. The large increase 
in arrhythmias supports the proposed role for glycolytic ATP 
in maintenance of membrane function.
Thus glycolytic ATP in addition to increased carbohydrate 
oxidation produced marked ameliorations in this model.
INTRODUCTION
1.
SECTION A Structure and function of the heart
1. The circulation
The heart consists of two muscular pumps in series which 
pump the blood through a closed system of vessels. The heart
and circulation is shown schematically in Fig. 1.
The left side of the heart receives oxygenated blood from 
the lungs which is pumped through arteries and arterioles to 
the capillaries. The blood drains from the tissues into venules 
and veins and is returned to the right side of the heart. The 
right ventricle pumps the blood through the pulmonary circulation 
The reoxygenated blood returns to the left side of the heart and 
the cycle is repeated.
2. Anatomy of the heart
a ) External
The heart lies within the pericardial sac bathed in fluid.
It is a roughly conical hollow organ. The walls comprise three 
layers: the endocardium which is the innermost, the myocardium,
and the epicardium^the outermost. The blood vessels enter or 
leave at the base of the heart. The left ventricle forms the 
apex. The heart has a shallow groove running down the surface 
marking the location of the internal intraventricular septum.
In the groove lie blood vessel^ nerves and adipose tissue. The 
external anatomy is illustrated in Fig. 2.
2.
Fig. 1.
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The heart is divided into four chambers. The upper chambers, 
t h e  atria, have thin walls and are separated by a thin inter-atrial 
septum. The lower chambers, the ventricles, have much thicker 
walls and are separated by the thick muscular wall of the left 
ventricle. The atria and ventricles are divided by a fibrous 
ring from which all the muscle bundles arise. It also contains 
the valves (see Fig. 3).
The right ventricle, which is the pump for the pulmonary 
circulation, is crescent shaped in cross-section with the thick 
muscular interventricular septum bulging into its cavity. It 
does not extend as far as the apex of the heart. Only the outer 
third of the muscle wall is solid, the inner two thirds having a 
ridged appearance.
The left ventricle is conical, tapering to the apex. Much 
of the inner surface is covered by muscular ridges. The outer 
two thirds of the wall are solid muscle. The ventricular 
myocardium comprises one muscle mass with many cross branches 
between adjacent fibres.
Papillary muscles serve to open the valves of the outflow 
vessels during contraction. The anterior and posterior papillary 
muscles are attached to the leaflets of the valves by chordae 
tendinae. Isolated papillary muscles have been used in studies 
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The papillary muscles contract in concert and simultaneously 
ith the remaining ventricular muscle to maintain tension in the 
chordae tendinae. This prevents eversion of the valves into 
the atria during systole.
3. Vasculature of the hea r t .
The tissues of the heart are supplied with blood by the 
coronary arteries. The aortic wall bulges out immediately above 
the aortic semilunar valve and gives rise to the right and left 
coronary arteries (see Fig. 2).
The left coronary artery runs between the root of the pulmonary 
trunk and the left atrium. It divides into two branches, the 
anterior descending and circumflex branches. The anterior 
descending branch passes to the apex of the heart with branches 
to the interventricular septum, and thence upwards to the lower 
part of the pulmonary walls of the ventricles. The left circumflex 
branch runs to the diaphragmatic surface of the heart with branches 
to the anterior and posterior walls of the left ventricle, left 
atrium and the root of the aorta.
The right coronary artery runs in a groove adjacent to the 
right atrium, around the base of the right atrium and divides into 
t h e  anterior and posterior descending and the circumflex branches.
It also has branches to the atrioventricular node. In man the 
right coronary artery predominates in 48% of hearts, the left in 
18% and there is a roughly equal distribution in 34%. The 
dominant artery supplies almost all the muscle of the interventricular 
sep t u m .
7.
The heart has a large number of intercoronary collateral 
vessels between branches of the left anterior descending, left 
circumflex and terminal branches of the right coronary artery.
They can occur at any depth within the tissue. There is a well 
ctefined system of collaterals close to the subendocardium which 
can play a particularly important role after occlusion of a 
coronary artery by providing alternative routes for perfusion of 
the region distal to the obstruction. The venous drainage 
comprises a network which also has the major vessels located on 
the surface of the heart, running parallel to the coronary arteries. 
The majority drain into the right atrium at the coronary sinus.
There are also Thebesian veins which drain directly into the 
atria, and similar vessels draining into certain parts of the 
ventricles. The heart also has a lymphatic drainage: a deep
system under the endocardium drains into vessels of the epicardium 
and an epicardial system drains the outer regions of the walls of 
the chambers.
4. Nerve supply and the conduction system
The heart receives its nerve supply from the sympathetic 
and parasympathetic nervous systems. The sympathetic system 
accelerates the intrinsic rhythm of the heart whereas the 
parasympathetic system suppresses it.
The impulse that initiates contraction is propagated 
throughout the heart by a specialised conduction system (see Fig. 3)
The heart muscle contracts synchronously and in a highly 
coordinated manner in order to displace blood from the chambers 
efficiently. The timing is normally determined by a specialised 
node, the sinoatrial node (SA node). It is richly supplied with 
nerve fibres permitting modulation by the central nervous system 
of the rate of impulse generation. SA nodal tissue has the 
intrinsic ability to depolarise spontaneously. This occurs 
during diastole through changing ionic permeabilities of the 
cell ïnetnbtahes. When a critical threshold membrane potential 
is reached complete depolarisation occurs spontaneously, accompanied 
by Ca^^ influx which triggers contraction (see Katz, 1977).
The impulse spreads concentrically and is transmitted by 
t h e  atrial cells themselves, and by specialised conducting 
pathways to the atrioventricular (AV) node which lies in the 
floor of the right atrium. In the AV  node spontaneous 
depolarisation is absent or minimal in most regions. The 
impulse travels relatively slowly through the AV node and then 
is carried to the remainder of the heart muscle by the bundle 
of His, a bundle of conducting fibres. The right and left 
bundles terminate in a subendocardial network of Purkinje 
fibres. The cells of these fibres have a large glycogen content 
and are resistant to the effects of hypoxia. The impulse then 
travels more slowly through the ventricular muscle from the 
endocardium to the epicardial surface.
9.
Thus the muscle is stimulated sequentially so that the 
atria contract before the ventricles. The sequence of 
ventricular contraction and the arrangement of ventricular 
muscle-fibres is such that blood is ejected from the apical 
regions towards the outflow tracts, the chambers moving towards 
a spherical shape.
5. Sequence of the contraction cycle
During the period between contractions (diastole ) the 
ventricles fill under the pressure of the venous return. This 
occurs rapidly at first, then more slowly until the rate of 
filling is almost constant. At the beginning of the contractile phase 
(systole) the wave of excitation spreads from the SA node. The 
contraction of the atria displaces blood into the ventricles.
When the wave of depolarisation reaches the ventricles they 
contract isovolumically at first. When the intraventricular 
pressure exceeds the diastolic aortic pressure, the aortic valve 
opens and rapid ventricular ejection takes place, followed by a 
slowing of the ejection rate. Then intraventricular pressure 
falls, the aortic and pulmonary valves close and there is a period 
of isovolumic relaxation. When the intraventricular pressure 
falls below that of the atria the valves between these chambers 
open and ventricular filling occurs, rapidly at first but slowly 
as diastole proceeds.
10.
6. Histology of cardiac muscle
The thick muscular walls of the ventricles can be divided 
into three layers, the endocardium, myocardium and epicardium 
(Fig. 4).
a) The endocardium The chambers are lined with a layer of 
squamous epithelium comprising flattened endothelial cells over a 
layer of connective tissue. These innermost layers constitute 
the endocardium. The endocardium is thicker in the atria than 
in the ventricles. The endocardium is not vascularised^receiving 
nutrient from the chambers of the heart, whereas the overlying 
subendocardium contains arteriolar, capillary and nerve fibre 
network.
b) The myocardium This region contains the bulk of the 
muscle mass,' consisting of a branching n e t w o r k  of longitudinally and
transversely striated muscle with connective tissue. In the atria 
the muscles encircle the chambers. In the ventricles the muscle 
fibres are arranged in bundles separated by connective tissue, 
containing the capillaries and lymphatics. The fibre bundles are 
not parallel but are arranged at many different angles so that 
during contraction the blood is efficiently expelled from the 
c h a m b e r s .
c) The epicardium. This region overlies the myocardium and 
consists of an outer layer of squamous epithelium and an underlying 
layer of fibroelastic connective tissue. In the ventricles and 
around the large vessels of the ventricular surfaces the connective
11.
Fig, 4








tissue contains nerve bundles and quantities of adipose tissue..
The atrial epicardium is thinner than that of the ventricles, 
with fewer coronary vessels.
7. Ultrastructure of the myocardium (see Fig. 5)
The sarcolemma is the surface membrane of the myocardial 
cell. It invaginates the Z-line of the sarcomere surface. It 
comprises a unit plasma membrane covered with a basement membrane.
The latter is composed of glycoprotein and has a large number of 
negatively charged binding sites. (Howse et a l.,1970; Scott, 1968). 
This region may bind calcium ions and could be involved in the 
initiation of ion fluxes during the contraction cycle. The role 
of the sarcolemma and other organelles in heart function has been 
recently reviewed by Dhalla et al. (1977). The plasma membrane 
contains the ion-pumping enzyme systems and is the site of 
depolarisation which initiates contraction. Adjacent myocardial 
cells have specialised areas of sarcolemma called intercalated discs. 
They cross the fibres in the middle of the I-band. They mark the 
boundaries at each end of the myofibrils and provide anchoring 
points for the myofilaments. They also.have a region called the 
nexus or gap junction which represents a low resistance pathway 
for the transmission of impulses of excitation from cell to cell.
They consist of two closely apposed but unfused plasma membranes, 
one from each cell.
The sarcoplasmic reticulum is formed by invaginations of the 
sarcolemmal membrane. It comprises the subsarcolemmal cisternae (SC) 
and the sarcotubular network (SN). The SC is located beneath
13.
Fig. 5.
Ultrastructure of the myocardium 


















the sarcolemma and alongside the transverse tubular system 
(T-system). In cardiac muscle it has a double layered structure, 
enveloping the T-system, which may represent sites for the 
initiation of calcium release. Because it has sufficient capacity 
to provide the calcium required for the activation of troponin and 
can transport it at a rate commensurate with the observed relaxation 
rate the SN has been proposed to cause muscle relaxation by taking 
up calcium ions.
The transverse tubular system (T-system) is open to the 
extracellular space and runs alongside the Z-band in cardiac 
muscle. It also runs longitudinally and hence connects adjacent 
sarcomeres. It participates in the propagation of the action 
potential, transmitting the impulse to deep regions of the muscle.
Since cardiac muscle is predominantly aerobic rather than 
anaerobic, mitochondria are extremely abundant, comprising 30 - 50% 
of the total cell volume. They are distributed close to and 
around the contractile elements of the myofibrils. Although 
they are capable of binding and taking up calcium the rate of 
uptake is too low for them to play a significant role in 
excitation-contraction coupling. This capacity, however, may 
play an important role in ischaemia.
Heart muscle also contains glycogen granules, lipid droplets, 
lysosomes and other granules and secretions.
15
Heart muscle cells contain individual contractile fibres 
which are 10 - 20y<m in diameter and 50 - lOCy/m long. The basic unit 
of the contractile apparatus is the sarcomere. These are joined 
end to end to form the myofibrils. Adjacent sarcomeres are aligned 
across the cell to give cardiac muscle its characteristic cross- 
striated appearance under the electron microscope. The appearahce 
of the myofibrils is shown in FigsSi-6. The myofibrils appear to 
have alternate dark bands (A-band) and light bands (1-band) running 
the length of each myofilament. The A band corresponds to the 
molecules of myosin and has a fixed length of 1. 5 ^ m .  The I-bands 
correspond to actin molecules of adjacent sarcomeres. When 
contraction occurs the actin molecules (thin filaments) slide 
into the myosin molecules (thick filaments). Thus the length 
of the A band remains constant but the I band, and each sarcomere, 
is shortened.
The thin filament consists of two intertwined strands of 
F-actin. The F-actin molecule comprises a polymer of G-actin
subunits which aggregate in the presence of ATP. Within the 
grooves of the F-actin helix and bound stoichiometrically to it 
lie molecules of tropomyosin. It is involved together with 
troponin and calcium ions in modulating the actin-myosin interaction.
The thick filaments comprise bundles of myosin molecules 
arranged so that their heads protrude from the filament and are 
orientated away from the M-line in the centre of the A-band.
16.
Fig. 6
Diagram of muscle fibre as seen by electron 







They are available for interaction with the thin filament. The 
whole molecule is about 160 nm long and comprises two polypeptide 
chains which form a long supercoiled o(“belical portion, and a 
head with two globular ends. This globular head has A T P  ase 
activity. The helical portions form the rigid backbone of the 
thick filament.
8. Actin-myosin interactions (see Fig. 7)
At 40 nm intervals along the thin filament troponin complexes 
are bound to the tropomyosin. These complexes modulate the 
interaction over 7 actin monomers which is a distance of 40 nm.
Troponin-I (Tn-I) inhibits the actin-myosin interaction.
This inhibition is reversed by troponin-C (Tn-C) when calcium 
ions bind to it. The binding of calcium ions by Tn-C results in
a shift of the tropomyosin molecules towards the centre of the 
grooves on the actin filament, which facilitates interaction with 
myosin. In addition to inhibiting the onset of contraction 
when calcium ions are not bound to Tn-C the regulatory proteins 
can stimulate actin-myosin interactions once the contractile 
process has begun. The mechanism is described more fully by 
Katz (1977).
The cycle of contraction and relaxation is shown schematically 
in Fig. 8. (Troponin is excluded as its regulatory role is not 
essential to the processes of actin-myosin interaction). In the 
absence of ATP, the protruding heads of the myosin molecules
18.
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form cross-bridges with actin. This cross^bridge cannot be 
broken in the absence of ATP and is termed a rigor complex.
With the addition of ATP a myosin-ATP complex forms, which leads 
to dissociation of the cross-bridge and produces a resting state.
The ATP ase activity of the myosin hydrolyses the ATP. The products 
Pi and AD P  remain bound and the energy appears to be stored in 
a high-energy myosin-Pi bond. Subsequently actin interacts 
with the myosin cross-bridge containing the high energy bond to 
form an 'active complex'. The chemical energy is then converted 
to Mechanical energy, with movement of the cros s - b r i d g e . This 
constitutes the basic element of shortening of the muscle fibre, 
and tension development. The products ADP and Pi dissociate 
from the cross-bridge such that another rigor complex forms.
This in turn must bind another molecule of ATP to achieve the 
resting state.
The normal cytosolic concentration of ATP, which is in the 
millimolar range, (Illingworth et al. 1975) is sufficient to 
maintain the components of the myofilaments in a relaxed state 
(Katz , 1966). Under conditions of A T P  depletion the myofilaments 
may be in the form of the rigor complexes, which could partly 
explain the phenomenon of contracture in ischaemic hearts.
9. Excitation-contraction coupling
When membrane depolarisation occurs the ionic permeability of 
the sarcolemma changes so that Ca^^ is transported into the cell to 
initiate contraction. The Ca^^ fluxes are controlled by the
21
membrane systems of the sarcolemma, transverse tubular system 
and sarcoplasmic reticulum. For a review of the regulatory 
role of membrane systems in heart function see Dhalla et al (1977)
It is thought thât influx of extracellular Ca^^ triggers 
2 +release of Ca from intracellular stores and that the latter is 
primarily responsible for the process of contraction. The Ca^^ 
that enters the cell may well remain in a separate triggering or 
activating pool.
2 +To enable relaxation to occur the Ca is actively pumped
away from the myofibrils. Ca^^ is taken up by the sarcoplasmic
24-reticulum by an ATP-dependent Ca transporter. This may also be
2 +
the first step in Ca efflux from the cell. Calcium ions cross
2 -|_
the sarcolemma by a Na -Ca exchange mechanism involving Na 
influx. The Na^ is pumped from the cell by an ATP-requiring 
sodium pump (Na^, K^-ATP ase).
10. Mechanics of contraction
In cardiac muscle the force of contraction is influenced 
by two important factors; a change in the initial length of 
the muscle and a change in "contractiLL'tjj' of the muscle 
(Sonnenblick ,1962).
a ) Length-tension (L-T) relationship
The initial length can be altered by changing the degree of 
stretch of the muscle - the preload or resting tension. A change
22.
in the initial length of a muscle fibre changes the isometric 
tension development. Thus a curve representing this L-T 
relationship can be obtained in a preparation such as the 
isolated papillary muscle.
Fig. 9 shows the tension developed over a range of muscle 
lengths in cardiac and skeletal muscle. The sarcomere length 
a t  which peak tension is developed (Lq ) is approximately 2.2y^m 
in both types of muscle. Tension development declines more 
rapidly in cardiac muscle as the length deviates from L q  in either 
direction. The sliding filament theory has been proposed as an 
explanation for the observed L-T behaviour. (Huxley, 1957; 
Sonnenblick and Skelton 1974). According to this theory 
the total force on any one filament is the sum of the forces 
contributed by the individual actin-myosin cross-links. This 
is determined by the degree of overlap of the actin and myosin 
molecules (Fig. 10). In skeletal muscle such changes in overlap 
can account for the observed L-T relationship. This is not the 
case for cardiac muscle. Thus there is no plateau in the region 
2.0 - 2 .2y^m where the number of cross links should be constant. 
Between 70 and 85% of L q buckling of the myofilaments occurs which 
may account for the rapid decline in tension with decreasing length 
Possible explanations for the absence of a plateau and the decline 
of tension at lengths greater than L q  involve factors within the 
m u s c l e  fibre in addition to the contractile elements which modify 
the response. These have been termed the series elastic element 




Skeletal muscle and cardiac papillary muscle 
Length-Tension relationship
Plateau-cross-links constant









F«OM 50MNEN8UCK & SKELTON
24.
Fig. 10
The Sliding Filament theory of 
























Sonnenblick et al (1973) showed that a resting tension became 
apparent in cardiac muscle at lengths greater than 85% of L q . 
Thereafter it increases exponentially with length, accounting for 
15% of total tension at Lq. Thus the muscle becomes progressively, 
more resistant to stretching. This increased resting stiffness 
may be partly due to the greater amount of extracellular collagen 
in cardiac muscle than in skeletal muscle.
In contrast to skeletal muscle,, cardiac muscle normally operates 
on the ascending portion of the length-active tension curve, reaching 
the descending limb only if the resting tension is abnormally high 
(Fig, 11). Thus in functioning heart muscle the active tension 
a l ways increases as muscle length increases. In the intact heart 
an increase in diastolic filling of the ventricles increases the 
volume of the chambers and so increases the length of the individual 
muscle fibrés. This relationship was first described in the 
intact heart by Frank in 1895 and by Starling in 1915. The 
Frank-Starling relationship states that the ventricular stroke 
volume varies directly with changes in the end— diastolic ventricular 
volume. Thus the force of ejection always increases to accommodate 
the additional volume of blood to be displaced from the heart.
This mechanism enables beat-to-beat adjustments in cardiac output 
to be made. Small changes in diastolic fibre length are able to 
produce relatively large increases in the amount of shortening.
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Fig. 11














b ) Force-Velocity(F-V) relationship
A muscle can be subjected to a small load before contraction 
(preload) and then to a further load when contraction has begun 
(afterload). On contraction the muscle first develops force 
isoraetrically against the load, then shortens, the velocity of 
shortening being dependent upon the load. A parabolic force 
velocity curve can be derived (Fig. 12). From this relationship 
two characteristic parameters of contractile performance can be 
determined: the maximum shortening velocity (Vjjj^j^) and the
isometric force developed (Pq ). Changing the initial length 
changes the F-V relationship so that Pq and the velocity of 
shortening are affected, but V max changes little. An increased 
afterload decreases the shortening velocity and also slows and 
delays relaxation (Sonnenblick, 1967).
These observations have been summarised in the force-velocity- 
length (F-V-L) relationship of Brutsaert and Sonnenblick (1969) and 
of Henderson and Brutsaert (1973).
The description can be extended to include the time course 
of activation. However, in the cat the F-V-L relationships have 
been found to be largely independent of time, particularly early 
in contraction (Brutsaert et al. 1971).
c ) Changes in contractility
Under basal conditions only two thirds of the maximum 
contractile potential is used. Any change in w o r k  during a
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Fig. 12




F-V relationship in control hearts
F-V relationship after an increase 
in contractility
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single beat not resulting from a change in initial fibre length 
can be considered a change in contractility. Changes in 
contractility can be measured in the intact heart as a change 
in the w ork done at a constant end-diastolic volume (EDV).
Thus a heart can increase the work done by either increasing the 
EDV (moving along a Starling curve; A or B in Fig. 13) or by a 
change in contractility (moving to a new Starling curve; C or D 
in Fig. 13). Changes in contractility give more prolonged changes, 
and are caused by stimuli such as catecholamines or exercise 
(Katz 1977).
When a change in contractility occurs both Pn and v are^ max
affected with the F-V curve shifted upwards and to the right 
(Fig. 12). Thus with catecholamines for example there is an 
increase in the rate of force development, a reduced time to 
peak tension development and more rapid relaxation.
A major factor in the regulation of contractility is the 
amount of calcium released during excitation-contraction coupling 
which is available for activation of the contractile elements 
(Katz 1977).
"Contractility" itself is difficult to measure because 
there are so many other variables, but changes in contractility 
can be measured. The isolated heart or papillary muscle
preparations provide suitable models in which the other variables 
such as preload, afterload and heart rate can be controlled.
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The oxygen consumption (MV O ^ ) in the intact heart is
measured as the product of coronary blood flow x the difference
between coronary arterial and venous oxygen tension. There
a r e  a number of factors which determine M V O  in the intact heart2
a ) Basal metabolism
Metabolism not directly related to contraction^ such as 
maintenance of ion currents of prôtëiri synthesis^cari account for 
approximately 20% of the total 0^ consumption. (McKeever et al-, 
1958). Catecholamines have little effect on this component 
(Klocke et al,1965).
b ) Metabolism involving electrical activation
This accounts for 0.5% of MVO^ (Klocke et al. 1966). Also 
included are calcium uptake and release by the sarcoplasmic 
reticulum (Gibbs, 1967).
c) Intracardiac systolic tension and myocardial wall tension
Evans and Matsuoka (1915) observed that the oxygen cost of
pressure development is large compared w ith that of ejection of 
blood. Thus the development of tension in the muscle wall and 
the mass of muscle are important determinants of the oxygen cost 
of pressure development. Therefore the increased ejection of 
blood resulting from increasing the end-diastolic ventricular 
pressure (a shift along a Starling curve) occurs at the cost of 
increased energy consumption for the maintenance of higher wall 
tensions.
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d ) Fibre shortening and cardiac work
The proportion of energy required for contraction and 
ejection of blood is dependent on the afterload. In the 
normal intact heart this component may account for up to 
17% of the oxygen consumption (Burns and Covell, 1972 ).
e ) Inotropic state
Inotropic agents such as adrenaline or calcium increase 
the MVOg in proportion to the increase in muscle contraction 
(Sonnenblick et al.,1965). This has also been shown to occur 
in the empty left ventricle, when little tension is generated 
(Clancy et al., 1967).
f ) Heart rate
MVOg has been shown to increase linearly with increasing 
heart rate in the intact heart (Laurent et al.,1956). In 
addition an increase in heart rate is accompanied by a slight 
increase in inotropy which increases the MVO^/beat.
Increasing the heart rate shortens the period of diastolic 
filling so that the stroke volume is diminished. As MVO^ also 
increases with increasing heart rate, the efficiency of contraction 
is reduced. At very high rates diastole may be reduced to such 
a n  extent that coronary perfusion may be impaired.
g ) Substrate utilisation
Approximately 5% less energy is obtained from lipid than 
from the oxidation of the equivalent amount of carbohydrate 
(Opie,,1974). This is discussed further in the next section.
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SECTION B. The metabolism of the heart
The factors which determine the work done by the heart were 
outlined in the previous section. It can be seen that the heart 
requires a constant supply of energy both for maintenance of the 
heart itself and to maintain the circulation of the blood. The 
heart normally extracts the substrates to meet this demand from 
the blood. Cardiac tissue contains stores of glycogen and 
triglyceride which can also be used under certain conditions.
1. Exogenous substrates
a ) Substrates utilised
In 1907 Locke and Rosenheim observed glucose uptake in the 
isolated Langendorff rat heart preparation. Several years later 
Evans suggested that carbohydrate supplied only one third of the 
heart's energy supply (Evans 193%^. Cruickshank et al., (1936; 
1941) showed that the remainder of the energy was obtained from 
l i pid.
Lipid is supplied to the heart in vivo as free fatty acids 
(FFA) complexed with serum albumin (Solomon, 1968; Spector et al., 
1969), and as triglyceride fatty acid (TGFA).
The heart can also use lactate, pyruvate, ketone bodies 
or amino acids. However, under most conditions their 
contribution is not great (Olson, 1962 ). Free fatty acid (FFA)
uptake is not energy dependent (Evans, 1964) and is directly 
related to the extracellular fatty acid concentration in both 
intact (Ballard et al., 1960) and isolated heart (Evans et at-, 1 4 b).
34.
FFA is released from the tissue when perfusate levels are very 
low, suggesting an equilibrium between tissue and perfusate 
(Willebrands, 1964). There appears to be a threshold for FFA 
uptake of about 0.35 mM in the human heart (Carlsten et al., 1963) 
and a lower threshold in the rat with FFA as sole substrate 
( Evans et aC., The chain length of FFA appears to have an
effect on the rate of uptake in the human heart (Rothlin and 
Bing, 1961), and in the isolated perfused rat heart (Evans, 1964; 
Willebrands, 1964). Uptake of saturated fatty acids falls as 
the chain length increases and monounsaturated fatty acids of a 
given chain length are utilised more rapidly than the saturated 
or diunsaturated fatty acids. However, in the isolated rat heart 
Stein and Stein (196J) did not observe any differential selectivity 
for exogenous FFA. Exogenous fatty acids may pass through an 
intermediate triglyceride pool prior to oxidation (Crass tkcU.,(964 j 
Masters and Glaviano, 1972).
The triglyceride fatty acids (TGFA) are transported in the 
blood as components of chylomicrons or very low density lipoproteins 
(VLDL). The chylomicrons are formed in the intestinal mucosa where 
the fatty acids are assimilated directly from the diet. The VLDL are 
synthesised in the liver and are released into the blood. The 
lipid is removed from these particles by extrahepatic tissues 
including the heart, with the formation of low density lipoproteins. 
Thus the fraction of triglyceride in these particles may fall from 
60% to 10% (Fredrickson, 1974).
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It is difficult to determine the precise contribution 
made by TGFA chylomicrons and VLDL to energy generation in vivo 
since only a few percent of the circulating TGFA can account for 
the whole of the myocardial oxygen consumption (Bing et al., 1954)
In the isolated perfused heart TGFA uptake and oxidation 
have been demonstrated by several workers. Rates of uptake of 
the order of those observed with FFA were reported by Gousios 
et al., (1963) in man and Delcher et al., (1965) in the rat.
Others have observed lower rates of utilisation in the rat 
(Enser et al., 1967; Scheuer and Olson, 1967).
b ) Lipases
TGFA from chylomicrons are hydrolysed by lipoprotein 
lipase (LPL) located on the cell surface or the capillary wall 
(Korn, 1955; Fielding and Higgins, 1974). The lipase activity 
can be increased by thyroid hormone or catecholamines (Alousi 
and Mallov, 1965). It is increased in heart by alloxan diabetes 
and reduced to normal by insulin treatment (Kessler, 1963). 
Prolonged adrenaline infusion results in increased TGFA uptake 
by the heart and increased endogenous triglyceride levels, 
suggesting that uptake exceeds the capacity for oxidation (Regan 
et al., 1966; Mallov and Cerra, 1967).
There is also a non-heparin-releasable lipase which may be 
intracellular and related to endogenous lipolysis (Borensztajn 
et al., 1975; Robinson and Jennings, 1965). At least two
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triglyceride lipases have been identified in heart although 
their relationship to endogenous lipolysis and the heparin- 
releasable or non-heparin-releasable LPLs is not clear.
Catecholamine-stimulated lipase (hormone sensitive lipase 
HSL) has been reported in perfused or incubated rat heart 
(Jesmok et al., 1976; Mallov and Alousi, 1969; Shimoda, 1968)
and intact dog heart (Glaviano et al., 1975).
Analysis of individual tissue fractions has shown that 
lipase activity is present in the soluble, microsomal and 
mitochondrial fractions with high specific activity in the 
microsomal fraction which could be increased by adrenaline 
(Biale et al., 1968; George and Type, 1963). Both microsomal 
and soluble fractions appeared to have two distinct lipase 
activities, one sensitive to protamine inhibition with an 
alkaline pH optimum, the other protamine-insensitive and with a 
neutral pH optimum (Bjorntorp and Furman, 1962; Schousboe et
al., 1973). There is also high specific lipase activity
associated with the lysosomal fraction (Wang, 1977).
Triglyceride is distributed in several subcellular fractions 
and lipase may be associated with it physically rather than 
functionally (Masters and Glaviano, 1972; Mathur and Mokler, 
1975; Stein and Stein, 1968).
37.
2. Quantitative significance of substrates
a ) Exogenous substrate
Competition studies have been carried out to investigate 
the contribution of each of the exogenous substrates to energy, 
production in the heart. These have been reviewed by Opie 
(1968). It appears that any of the major substrates when 
presented to the heart in sufficiently high concentrations can 
account for most of the normal oxygen consumption. Usually 
however, the major substrates are glucose and fatty acids.
Fatty acids are utilized in preference to glucose under 
most conditions. This is particularly true in the fasting state and 
in diabetes when the supply of circulating fatty acids and ketone 
bodies is increased (Randle et al., 1964; Williamson and Krebs, 
1961). Palmitate (0.75 mM) accounts for 60% of the oxidative 
metabolism in competition with 5 mM glucose in isolated perfused 
rat hearts from starved rats (Opie, 1968). Inhibition of glucose 
oxidation by palmitate was also demonstrated by Shipp et al.,
(1961).
The major role of fatty acids has also been demonstrated 
in man. Fatty acids accounted for 70% of the oxygen consumption 
in the fasting state (Most et al., 1969). As fatty acid 
concentration increased the extraction of glucose, lactate and 
pyruvate was found to decrease (Lassers et al., 1971, 1972).
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In the fed state fatty acids are still a major substrate but 
their predominance is less marked (Shipp et al., 1961). In 
isolated perfused hearts from fed rats 8.5 mM  glucose halved the 
rate of palmitate (1 mM) oxidation whereas palmitate did not 
affect glucose utilisation (Vahouny et al., 1967).
Glucose uptake is sensitive to control by insulin levels 
(Morgan et al., 1961b) which are low relative to glucogen levels 
during fasting (Most et al., 1969),
The inter-relationship between glucose and fatty acids in 
different nutritional states has been described by Randle et al., 
(1963). Thus fatty acids or. ketone bodies are able to pre-empt 
glycolysis by increasing citrate levels which inhibits 
phosphofructokinase, and by increasing the acetyl CoA/CoA ratio 
which inhibits pyruvate dehydrogenase. After a glucose load 
net adipose tissue lipolysis is depressed and the combination 
of glucose and insulin is able to partially overcome this 
predisposition to lipid (Garland, 1964; Garland and Randle, 1964&; 
Newsholme and Randle, 1964).
Utilisation of the ketone bodies acetoacetate and 
^  -hydroxybutyrate has been demonstrated in vivo (Bing et al.,
1954) and in isolated perfused rat heart (Williamson and Krebs, 
1961). They are not a major substrate, however, accounting for 
only 2.9% of the oxygen consumption, at concentrations observed
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after an overnight fast (Bing et al., 1954), Acetoacetate was 
only able to displace 0.3 mM palmitate as substrate in the 
isolated perfused rat heart at the high concentration of 10 mM.
Pyruvate is readily metabolised by heart muscle 
(Illingworth et al., 1975; C,ar land 1964 ) . At high
concentrations it competes successfully with fatty acid as 
substrate for oxidative phosphorylation in both aerobic and 
ischaemic,hearts (Evans et al., 1961). In conditions of 
increased fatty acid or ketone body utilisation the increased 
acetyl CoA and NADH levels inhibit pyruvate dehydrogenase and 
hence pyruvate oxidation (Garland and Randle ̂ 1964^.
T  <xbl«_ I. shows the contribution of the major substrates 
to overall oxygen consumption under various conditions 
encountered in vivo
b ) Endogenous substrate
Under certain conditions endogenous t r i g l y c e r i d e C T ^  
glycogen may be used by the heart. Substrate-free perfusion 
experiments have shown that endogenous TG can play a role in 
energy generation in the heart (Crass et al., 1969; Olson 
and Hoeschen, 1967). It could account for over 50% of the 
Oxygen consumption in hearts perfused with glucose (Neely 
et al., 1972^. Since di- and mono-glyceride are present 
at only very low concentrations it is believed that they make 
only a small contribution (Denton and Randle, 1967a).
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Exogenous glucose had little effect on the degree of endogenous 
TG utilisation, but exogenous FA appeared to inhibit net endogenous 
lipolysis. However, the same workers have shown rapid incorporation 
of exogenous fatty acid and rapid turnover and utilisation of 
TGFA in the dog heart (Crass et al., 1976; Crass and Sterrett, 1975), 
Elevated endogenous FFA or long chain acyl CoA levels have been 
shown to inhibit lipolysis (Neely, et al., 1972b). Triglyceride 
levels have also been shown to be elevated in conditions where 
plasma FFA levels are raised such as in alloxan diabetes (Denton 
aid Randle, 1967b) or with fasting (Garland and Randle, 1964k). In 
alloxan diabetes there is increased turnover of a TG - FFA cycle 
(Denton and Randle, 1967b) with increased TG synthesis and increased 
lipolysis.
Rapid mobilisation of endogenous glycogen stores has also 
been demonstrated during substrate-free perfusion of the isolated 
rat heart (Shipp et al., 1964a; Neely et al,, 1967b) although most 
of the energy was derived from endogenous TG (Olson and Hoeschen, 
1967). When glucose and palmitate are present in the perfusate, 
however, net glycogen synthesis occurs (Neely et al., 1969).
Under normal conditions there is no established role for glycogen 
in energy generation (Opie, 1968).
3. Effect of adrenaline on substrate utilisation
Adrenaline increases glycerol release in Langendorff perfused 
rat hearts (Challoner and Steinberg, 1965; Christian et al.,
1969; Largis et al., 1972; Williamson, 1964) and increases
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lipase activity in heart homogenates (Bjorntorp and Furman, 1962; 
Mallov and Al.ousi, 1969). Glycerol release has been criticised 
as a measure of total lipolysis because of the presence of glycerol 
kinase which could reduce glycerol output (Kreisberg, 1966), 
However, glycerol kinase activity is low in heart (Scheuer and 
Olsen, 1967; Wieland and Suyter, 1957). Jesmok et al., (1977) 
found that glycerol release followed exactly the triglyceride 
mobilisation measured directly in isolated perfused rat hearts 
after infusion of the catecholamine analogue isoproterenol.
Increased disappearance of label from isotopically 
pre-labelled triglyceride has been demonstrated in the perfused 
rat heart by Crass et al., (1975) with adrenaline showing a 
greater lipolytic effect than noradrenaline. TG mobilisation 
was twice as extensive in hearts treated with catecholamines 
than in those not so treated. This suggests that TG may be
present in a number of pools. The adrenaline-induced endogenous
lipolysis was abolished when exogenous FFA was present.
There may be a basal lipolytic rate normally present in 
the h e a r t , a s ^ - r e c e p t o r  blockade with propanalol, and hence 
lipolytic inhibition, has been shown to increase the total TG 
level in the intact dog (Masters and Glaviano, 1972).
The role of endogenous 3 ' ;5'-cyclic AMP(cAMP) in endogenous 
lipolysis has not been conclusively proven. In the isolated 
working rat heart the cAMP analogue dibutyryl cAMP increased
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pressure development and lipolysis (Crass, 1973). It also 
increased triglyceride mobilisation in Langendorff hearts 
but this was not accompanied by an inotropic effect (Gartner 
and Vahouny, 1972). However, catecholamines have been 
shown to increase the protein kinase activity ratio in the 
heart at concentrations that increase lipolysis. The increase 
in protein kinase activity ratio also occurred before the increase 
in glycerol release (Keely et al., 1975).
The cyclic phosphodiesterase inhibitor theophylline has 
been shown to decrease endogenous triglyceride content and 
increase CO^ production from endogenous triglyceride but there 
was no accompanying inotropic or glycogenolytic effect (Crass,
1973).
Endogenous triglyceride utilisation in glucose-perfused 
guinea pig hearts was reduced by ^  -blocking agents in the presence 
or absence of adrenaline. These changes were also parallelled 
by a reduction in the force of contraction (Satchell, 1968).
4. Effect of work on substrate utilisation
The level of substrate utilisation is determined by the work 
load. Oxygen consumption increases in proportion to total wall 
tension developed in the ventricle (Braunwald, 1971). In the 
isolated working rat heart oxygen consumption was directly 
proportional to the systolic pressure and heart rate (Neely 
et al., 1967b).
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In Langendorff rat hearts glucose accounted for 40% of 
the oxygen consumed when it was the sole substrate. Under 
higher work conditions, in working hearts at 10 cm atrial 
filling pressure, it accounted for 70% (Neely et al., 1967b).
When glucose was the sole substrate glucose uptake increased 
in proportion to work (Neely et al., 1967a; Opie et al., 1971«). 
However, when both glucose and palmitate were present in the 
perfusate in a Langendorff model over a wide range of perfusion 
pressure the contribution of glucose was showh to be unchanged 
(Opie, 1965). Also, in a working heart model, fatty acids 
were oxidised in preference at both low and high levels of 
work (Randle et al., 1964; Neely et al., 1969; 1970; 1972b).
Therefore, pressure development is not a major factor in 
substrate competition in vivo, when fatty acids and glucose 
are present.
Substrate-free perfusion of isolated working rat hearts 
with radioactively pre-labelled triglycerides showed that 
triglyceride mobilisation and oxidation increased in proportion to 
increases in ventricular pressure development (Crass et al., 1971) 
Similar results were observed with increasing aortic pressure in 
the Langendorff preparation (Neely et al., 1972a).
Increased pressure development also increases endogenous 
catecholamine release and this has been suggested as the reason 
for increased lipolysis with increased work (Kjekshus and 
Mj^s, 1972*,; Lafarge et al., 1970).
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Table 1.
A summary of the balance between glucose and fatty acid oxidation 
under various conditions.

















Exercise glucose + 
lactate
0 - 5% 
10 - 30% 
10 - 30%
30%










FFA includes the contribution of triglyceride fatty acids 
and of ketone bodies. The ketone body concentration is related 
to the FFA concentration since they arise from common precursors 
in the liver.
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5. Intracellular metabolism in the heart
a ) Major pathways.
The major substrates of the myocardium under most 
circumstances are FFA and glucose, as described in the previous 
section. These substrates are metabolised aerobically when 
oxygen supplies are adequate. The large proportion of the 
myocardial cell volume (30%) occupied by mitochondria is an 
indication of the high aerobic capacity of the tissue (Sobel,
1974). The concentration of the cytochromes and the oxidative 
enzymes of the electron transport chain is also high (Penpargkul 
and Scheuer, 1970). There is also a net uptake of lactate 
across the heart in vivo (Opie, 1968). This function demonstrates 
the aerobic nature of the myocardium since lactate is produced 
anaerobically and consumed aerobically.
The pathways of energy generation in the myocardium are 
the classical pathways of carbohydrate and lipid utilisation 
(Mahler and Cordes, 1971). They are shown in outline in 
Figs. 14-16.
Glucose and glycogen are metabolised by the Embden 
Meyerhof Parnas pathway, producing pyruvate (Fig. 14). This 
enters the mitochondria by a specific carrier mechanism where 
it is the substrate for pyruvate dehydrogenase. Acetyl CoA, 
a product of the PDH catalysed reaction is further metabolised 
via the TCA cycle (Fig. 15). The reducing equivalents so 
produced are oxidised via the terminal electron transport chain.
Legend for Figure 14
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Lactate is oxidised to pyruvate by lactate dehydrogenase 
(LDH). A specific isoenzyme of lactate dehydrogenase 
is normally inhibited by high pyruvate concentrations (Everse 
and Kaplan, 1973). During hypoxia or ischaemia however, this 
inhibition is apparently overcome as there is considerable 
lactate release under these conditions.
Fatty acids, derived from endogenous triglycerides or 
from an exogenous source are activated to Coenzyme A  (CoA) 
esters and oxidised by the ̂ - o x i d a t i o n  spiral which successively 
removes 2-carbon units, generating acetyl CoA (Fig. 16). The 
acetyl CoA is oxidised via the TCA cycle. The enzymes of 
^ - o x i d a t i o n  are located within mitochondria. Fatty acids 
and their CoA esters cannot themselves cross the mitochondrial 
membrane, but enter by a carnitine-mediated transport system 
(Bremer, 1977). The mitochondrial membrane is also impermeable 
to reducing equivalents generated within the cytoplasm. They 
enter the mitochondria for oxidation primarily by the mala te 
aspartate shuttle (Fig. 17).
The oxidation of the reducing equivalents within the 
mitochondria is coupled to the generation of A T P  i.e. oxidative 
phosphorylation (Racker, 1970). The A T P  leaves the mitochondria 
by a specific transport system, ATP translocase (Shrago, 1976). 
There is evidence that creatine phosphate also plays an important 
role in energy transport from the mitochondria to the sites of 
consumption. The creatine phosphate is reconverted to ATP at the 
myofibrils and other intracellular sites (Saks et al., 1974; 1975;














b ) Minor pathways
The synthesis of glucose from lactate and pyruvate by the 
UtterOchoa pathway has been observed in heart muscle but this 
pathway is not quantitatively very important (Racker, 1954;
Stadie et al., 1947).
The pentose shunt (hexose monophosphate shunt) is thought to 
be at most only moderately active in the normal heart (Shipp et al., 
19641). Increased activity of the pathway has been shown within 
5 hours of myocardial infarction during the period of increased 
protein and lipid synthesis when increased amounts of ribose 
are required (Gudbjarnason et al., 1967).
Lipogenesis and ketogenesis occur in the myocardium but 
normally at very low rates (Evans et al., 1963a, b). Triglycerides 
are synthesised from sn-glycerol 1-phosphate and fatty acyl CoA 
(Denton and Randle, 1965). Phospholipid metabolism is believed 
to occur by classical routes (Review, Dawson, 1966).
Protein synthesis in the heart maintains the structural and 
functional proteins. Amino acids are taken up by the heart for this 
purpose. Amino acid uptake is stimulated by insulin. Protein 
synthesis is stimulated by increased cardiac work and by growth 
hormone (review Cahill, 1976).
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6. Control of metabolic pathways
The metabolic pathways already described are subject to 
control by extracellular agents and by factors operating within 
the cell.
a ) Extracellular agents
Extracellular agents include changes in the substrate supply 
or the presence of hormones. The effect on metabolism of 
competition between substrates has been outlined in the previous 
section. The role of hormones such as adrenaline and insulin on 
catabolic or anabolic pathways has also been discussed in relation 
to each substrate.
b ) Intracellular agents
(1) Respiratory control 
The most important intracellular factor for controlling 
metabolism is that of respiratory control. This mechanism serves 
to maintain the energy status of the cell. Thus an increase 
in the work done reduces the energy status of the cell which 
stimulates oxidative phosphorylation in the mitochondria.
Such stimulation consumes reducing equivalents, which are 
regenerated by stimulation of glycolysis, the TCA cycle and 
oxidation. (Neely et al., 1972a).
By this mechanism agents such as the catecholamines,
^ blockers or cardiac glycosides can affect the rate of energy 
production. Their primary effect is on the w ork done by the 
heart which in turn elicits a metabolic response. This order 
of events has been demonstrated for catecholamines by 0ye (1965)
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and Cheung and Williamson (1965), who observed that the inotropic 
event preceded the activation of glycogen phosphorylase.
The mechanisms for primary control of respiration and 
hence of energy status lie almost entirely within the mitochondria. 
Control of respiration within the mitochondria has been recently 
reviewed by Williamson (1979).
The transport into the mitochondria of certain metabolites 
such as pyruvate is also subject to regulation (review, Lanoae 
and Schoolwerth, 1979). The transport of A T P  and A D P  across 
the mitochondrial membrane is subject to tight control by adenine 
nucleotide translocase (ANT). The enzyme is located on the inner 
mitochondrial membrane and catalyses a 1:1 exchange of A T P  and ADP. 
It has a key role in controlling the energy status since it can 
affect the mitochondrial and cytoplasmic ATP/ADP ratios 
(Souvereign et al., 1970). It is also subject to reversible 
inhibition by long chain acyl CoA which may represent an important 
regulatory mechanism in ischaemia (review, Shrago, 1976).
(2) Sites of regulation
Within the framework of respiratory control the alternative 
pathways of energy generation are subject to regulation at key 
enzymatic steps. The important control points are outlined below,
Glucose uptake is limited by the rate of glucose transport 
across the cell membrane (Morgan et al., 1959). Uptake is a
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carrier-mediated process (Fisher and Zachariah, 1961). Insulin 
has been shown to accelerate the uptake process in the perfused 
heart so that the subsequent phosphorylation step becomes rate- 
limiting (Morgan et al., 1961«0 . Under conditions of increased 
w o r k  uptake has been shown to remain the limiting step in the 
perfused heart (Neely et al., 1967). Phosphorylation and hence 
glucose uptake is reduced in alloxan diabetic rats or in the 
presence of fatty acids or ketone bodies (Morgan et al., 1961&; 
Ràndlè et al., 1964). It is accelerated by anoxia or increased 
work (Morgan et al., 1965).
FFA uptake is proportional to plasma concentration (Evans, 
1964).
Phosphofructokinase (PFK) is the major control point of 
glycolysis under most conditions. It is subject to inhibition 
by citrate which provides a mechanism for restriction of glycolysis 
by FFA or ketone bodies, since citrate levels are increased when 
these substrates are oxidised. Citrate increases the K̂ j of PFK 
for fructose 6-phosphate when ATP levels are normal. The 
resulting accumulation of glucose 6-phosphate could be expected 
to inhibit hexokinase (Randle et al., 1970; review, Randle 1976).
PFK is also regulated by the energy status of the cell 
(Mansour, 1963). It is inhibited by ATP, this being opposed 
by ADP, AM P  and inorganic phosphate (Pi), and by c AMP and 
fructose 1,6-diphosphate. Inhibition of the enzyme causes the 
accumulation of fructose 6-phosphate and glucose 6-phosphate.
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The latter in turn inhibits glucose uptake and phosphorylation 
(England and Randle, 1967) and also glycogen phosphorylase. b 
(0ye, 1967). PFK inhibition can also affect glycogen synthesis 
since the resulting glucose 6-phosphate accumulation stimulates 
glucose 6-phosphate-dependent glycogen synthase.
Glyceraldehyde 3-phosphate dehydrogenase is not normally 
a control point of glycolysis. However, it can become the rate- 
limiting step in ischaemia (see below).
Pyruvate dehydrogenase (PDH) is a multienzyme complex 
which plays a key role in the integration and regulation of 
carbohydrate and lipid metabolism. Its regulation is such 
that the flow into the TCA cycle of metabolites derived from 
carbohydrate can be inhibited by FFA. The reaction sequence can 
be regulated by changes in metabolite concentrations or by a 
phosphorylation (inactivation)-dephosphorylation (activation) 
cycle. The reaction sequence can be inhibited by diabetes 
or by FFA or ketone body oxidation. It is inhibited by acetyl 
CoA in competition with CoA (Ki < 15yuM) and by NADH in competition 
with NAD^ (Ki < 50yUM). FFA and KB oxidation results in increased 
acetyl CoA and decreased CoA, explaining their inhibitory effect 
on PDH (Randle et al., 1966; Garland and Randle, 19644).
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PDH activity is also regulated by phosphorylation or
dephosphorylation, catalysed by PDH kinase and PDH phosphate
phosphatase respectively. Phosphorylation with ATP Mg^
inactivates PDH and dephosphorylation reactivates the enzyme.
Pyruvate, A D P  and pyrophosphate inhibit the kinase and activate 
2+ 2 +PDH; Mg and Ca inhibit the kinase and activate the phosphatase 
and hence also activate PDH. (Linn et al., 1969; Cooper et al., 
,1974; > Severson Whitehouse et al., 1974). In the fed
rat, 20% of cardiac PDH was found to be in the active form.
In diabetes or when perfused with FFA or ketone bodies 1-5% 
was in the active form with the total amount of enzyme unchanged. 
Perfusion with pyruvate increases the active fraction to 60 - 90%, 
this effect being greatly reduced by diabetes and moderately 
reduced by perfusion with FFA or ketone bodies. Approximately 
75% of the inhibition of PDH by diabetes or FFA appears to be 
due to the phosphorylation cycle, the remainder to acetyl CoA/CoA 
and NADH/NAD effects. (Wieland et al., 1971; Randle, 1976;
Kerby et al., 1976).
Glycogen synthesis and degradation are catalysed by glycogen 
synthase and glycogen phosphorylase respectively (see Fig. 14).
Both are separately controlled by covalent phosphorylation 
mechanisms. Such a control mechanism (1) prevents futile 
cycling and energy wasting, (2) enables only one of the enzymes 
to be active at any time and (3) enables the enzymes to respond 
to extracellular signals, such as catecholamine challenge, 




Antilipolytic agents can increase carbohydrate utilisation 
at the expense of lipid.
Nicotinic acid exhibited such an effect with a lowering of 
circulating FFA levels (Lassers et al., 1972).
In the rat heart sodium.dichloroacetate (DCA) stimulated 
glucose and pyruvate oxidation, having maximum effect when their 
utilisation was suppressed by fatty acids or ketone body oxidation. 
The rate of glycolysis was also increased (McCallister et al.,
1973; Stacpoole and Felts, 1970; 1971). Palmitate, ketone
body and acetate oxidation were inhibited. There were accompanying 
increases in acetyl CoA, acetyl carnitine and glutamate and 
decreases in pyruvate, malate and aspartate. This suggested PDH 
activation by inhibition of PDH kinase, allowing dephosphorylation 
and conversion to the active form. This activation of PDH was 
confirmed by Whitehouse et al., (1974) who showed that in hearts 
perfused with glucose and insulin DCA increased the active form 
from 20% to 69-88%. The effect was less marked in diabetic hearts 
or on perfusion with glucose, insulin and acetate. DCA was shown 
to give half-maximal activation of PDH in isolated rat heart 
mitochondria at a concentration of 4 yuM with almost complete 
activation at 10 - 5Cy<M.
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DCA is readily delivered to the intracellular site of PDH within 
the mitochondria as it is very readily transported across the 
membrane by the mitochondrial pyruvate transported (Halestrap, 
1975).
The inhibition of FFA oxidation by 2-BP has been demonstrated 
by a number of workers. 2-Bromo palmitate (2-BP)was shown by 
Burges et al., (1968) to depress palmitate oxidation by 53% in 
isolated perfused rat heart. Perfusate glucose uptake was 
increased in hearts from starved and allbxan diabetic fats bùt 
was unaffected in hearts from fed animals perfused with insulin. 
However, glucose oxidation was stimulated in all hearts. This 
effect was increased by insulin and was greatest in hearts from 
diabetic rats. 2-BP also depressed glycogen synthesis most 
markedly in hearts from starved animals.
Similarly 2-BP completely reversed the insulin resistance 
of perfused hearts from alloxan diabetic rat hearts (Randle, 1969) 
abolishing the accumulation of citrate and glycolytic 
intermediates. There were no changes in glycogen or adenine 
nucleotide concentrations. The fraction of oxygen devoted to 
glucose oxidation increased from 23% to 77%. Fatty acid oxidation 
was concomitantly reduced. Large increases in pyruvate uptake and 
oxidation by 2-BP were also reported.
Bringolf et al., (1970) demonstrated the abolition by 
2-bromostearate of depressed glucose and pyruvate oxidation in 
diaphragm from rats fed on a high-fat diet. They attributed the 
effect to reduced fatty acid oxidation.
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There is some disagreement about the site of action of
2- BP, Chase and Tubbs (1972) working with rat liver mitochondria 
proposed that 2-BP exerted its inhibitory effect as 2-bromopalmitoyl 
CoA on fatty acid oxidation by inhibiting the carnitine palmitoyl 
transferase pool on the outside of the inner mitochondrial membrane 
(carnitine acyl transferase I). The pool within the mitochondria 
(carnitine acyl transferase II) did not appear to be inhibited. 
Inhibition of the outer pool would result in inhibited oxidation 
of palmitate and palmitoyl CoA. Such an effect would be expected 
to reduce the long chain acyl CoA concentration within the 
mitochondria, as less palmitoyl carnitine would be generated for 
transport across the membrane. This could result in a greater 
fraction of the intramitochondrial coenzyme A  being available for 
pyruvate oxidation.
Mahadevan and Sauer (1971) working with rat liver cells 
proposed that 2-BP acts by competitively inhibiting fatty acid 
uptake at the cell membrane by interferring with a mechanism 
for their transport across the membrane.
Competitive inhibition of fatty acid activation by 2-BP was 
proposed by Pande et al., (1971) working with rat liver homogenates. 
The effect was reversible and was not due to a detergent effect.
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Ockner and Manning (1976) showed that 2-BP inhibited 
the binding of oleate to fatty acid binding protein (FABP) in 
rat intestine. FABP appears to be related to Z-protein 
which binds long chain fatty acids in other tissues (Ockner 
et al., 1972; Mishkin et al., 1972). Such proteins are 
postulated to facilitate desorption of fatty acids on the 
inner surface of the cell membrane and to transport them 
across the cytoplasm to the endoplasmic reticulum where . ,
activation occurs.
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SECTION C. Myocardial infarction and ischaemia 
1, Aetiology of myocardial infarction
Myocardial infarction is in the majority of cases the 
end result of the occlusion of one or more of the major coronary 
arteries (review, Flaherty and Weisfeldt 1977). Occlusion of the 
coronary arteries is caused by the development of atherosclerotic 
plaques on the intimai wall of the vessels. The lesions 
develop from the accumulation of lipid and fibrous material. - 
As the process progresses the elasticity of the vessels is also 
lost, which further impairs blood flow. The elasticity of the 
vessels is particularly important in the heart because the vessels 
normally expand during systole and contract during diastole to 
assist blood flow. (reviews Shimamoto, 1973,; Ross and Glomset 
1973).
The primary sequence of events which causes atherosclerosis 
is not well understood. However, several factors have been 
implicated. These include abnormalities of lipid metabolism, 
and genetic, hormonal^environmental and psychological factors 
(Ross, 1975).
Narrowing of the vessels produces chronic ischaemia 
(i.e. impaired blood flow to the tissues). This results in a 
reduced delivery of oxygen and substrates. In addition, washout 
of metabolic products from the tissue is impaired. Ischaemia 
should be distinguished from hypoxia or anoxia, which describe 
respectively a reduced level or total absence of oxygen in the 
blood or perfusate. Neither implies a reduction in flow rate.
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The process of chronic ischaemia proceeds slowly. The 
heart can respond by revascularisation and the development of 
anastomoses from adjacent unaffected areas. Ultimately complete 
occlusion of the lumen may occur. This can be caused by an 
accumulation of thrombin or platelets as well as cholesterol and 
fibrin on the surface of a lesion.
An acute myocardial infarction may be precipitated by one 
or more vessels becoming obstructed at a point, when a section 
of the lumen becomes narrowed or by a combination of these.
Within seconds the blood supply to the tissue is reduced. This 
causes impaired contractile performance and altered metabolism 
within the affected area.
50% of deaths from myocardial infarction occur before the 
patient can be admitted to hospital. Death may occur if the 
major coronary vessels are occluded which can lead to ventricular 
fibrillation, asystole or sudden acute heart failure. The most 
common cause of death in patients reaching hospital is pump 
failure due to loss of function of ventricular muscle. For 
many days there is a risk of arrhythmic complications, which 
may occur even with small infarctions. Approximately 9 0 %  of 
patients develop arrhythmias within 72 hours of onset of the 
infarction.
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During the period following an infarct there are large areas 
of muscle whose survival appears to depend on local factors such 
as collateral flow, coronary perfusion pressure, catecholamine 
levels or chamber dilation. Much of the large ischaemic area 
may still be perfused from the collateral circulation.
Microsphere studies have shown that superficial and mid myocardium 
can receive up to 30 - 50% of the normal flow in this manner.
The subendocardium is more severely ischaemic and may receive 
in the order of 15% of full flow (Jennings 1976). In
areas of moderate or mild ischaemia there is probably a 
mixture of aerobic and anaerobic metabolism so that some washout 
of metabolic products should occur. In severely ischaemic zones 
there is little oxygen for oxidative metabolism and little glucose 
is supplied for anaerobic glycolysis.
Acute myocardial infarction has been studied experimentally 
in several different models. Coronary artery ligation in dog 
hearts in situ has been used (Braunwald et al., 1974). The same 
technique has been applied in the rat heart (Kannengiesser et al., 
1975). An alternative approach is to employ whole heart (global) 
ischaemia by reducing the coronary flow to the whole heart.
Brownsey and Brunt (1977) have used a globally ischaemic 
Langendorff model to study the graded response to ischaemia over 
a range of flow rates. Neely has used a model performing external 
work in which coronary flow restricted but cardiac output and 
ventricular pressure development maintained. This was accomplished 
by the use of a one-way valve in the aortic outflow tract which
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prevented retrograde perfusion (Neely et al., 1973).
2. Ultrastructural changes in ischaemia and hypoxia
Reduction of oxygen supply to cardiac muscle results
in changes in the ultrastructure of the tissue. Occlusion of
the coronary artery of the dog heart initially produces reversible
injury which progresses to irreversible damage in the infarcted
tissue by 60 min. (Oliver, 1972). The rate at which injury
occurs is dependent upon the degree of collateral circulation.
Electron microscopic studies have been made on ischaemic tissue
from the coronary artery ligated dog. The irreversible damage
comprises depletion of glycogen granules, fragmentation of
sarcomeres at the I band, disruption of the sarcoplasmic
reticulum and T tubules and separation of the intercalated
2 +disc at the gap junctions. Neutral fat, Ca and iron deposits
occur in the cytoplasm. and enzyme loss from the tissue
occurs. (McCallister et a l . ,1977). Mitochondrial changes include 
swelling, an increase in matrix space, disorganisation of cristae 
and the appearance of amorphous matrix densities containing lipid. 
Granules containing Ca^^ and phosphate appear in the mitochondria. 
During the reversible phase no significant changes in mitochondrial 
structure and function were observed. The onset of irreversible 
damage coincides with the breakdown of lysosomes and the 
dissolution of gap junctions. However, a causative relationship 
between tissue damage and lysosomal damage or high energy phosphate 
depletion has not been confirmed (McCallisteretal,1̂ 77). Disruptions
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of gap junctions could affect the conduction velocity of 
the action potential, producing slowly responding fibres.
Such fibres have been implicated in the genesis of arrhythmias 
Cranefield, 1973). Thus there are areas of tissue between the 
centre of the infarct and the surrounding normally-perfused 
tissue whose fate is critically dependent upon the occurrence 
of arrhythmias and the extent to which energy generation, both 
aerobic and anaerobic, can proceed. There are many metabolic 
factors which can influence the chance of survival of a particular 
area as described below.
3. The action potential and conduction in ischaemia and hypoxia 
The myocardial muscle is more susceptible than the Purkinje 
fibres to ischaemia and anoxia. In anoxia or ischaemia the 
amplitude and duration of the action potential plateau are 
reduced. This is thought to be mainly due to a decrease in 
the slow inward Ca^^ current. Partial depolarisation of the 
cell membrane occurs. (Coraboeuf et al., 1976).
The degree of glycolytic activity has been shown to be closely
related to the shape of the action potential. A  decrease in
glycolytic rate and ATP content was accompanied by a decrease
in the action potential amplitude and duration (McDonald and
MacLeod, 1973; McDonald et al., 1971). This may be explained by
2+a special role for glycolytic A T P  to chelate subsarcolemmal Ca ,
facilitating the entry of more Ca^^ into the cell, thereby
stimulating the inward Ca current (Hyde et al., 1972;
Girardier, 1971). cAMP may also be involved in regulation of 
2+the slow inward Ca current (Watanabe and Besch, 1974) by increasing
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2 +Ca conductance.
Changes in the action potential and depolarisation occur 
more readily in ischaemia than in anoxia. Partial depolarisation 
occurs in Purkinje fibres after 20 min of coronary occlusion 
(Lazzara et al., 1974) but no change occurs for several hours in 
anoxic well perfused tissue.
Coronary artery ligation is followed by increased lactate 
production and lactate accumulation in the external medium and 
is accompanied by loss. The rate of loss is linearly 
related to the rate of lactate production. Each lactate 
molecule leaving the cell may be accompanied by a and a 
ion (Case, 1971/72). High extracellular may play a role 
in the genesis of arrhythmias (Coraboeuf tfr aL., f
Lactate has also been shown to affect the action potential 
(see below). Acute lactic acidosis can release catecholamines 
which could affect conduction (Wildenthal et al., 1969).
Acidosis produces a change in the potassium conductance 
responsible for spontaneous depolarisation (Poole-Wilson and 
Langer, 1975), which may provide a mechanism for arrhythmias 
in ischaemia. Thus the changes in the action potential observed 
in ischaemia could be caused by a number of factors.
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4. Mechanical responses to myocardial infarction and ischaemia
When ischaemia occurs the mechanical performance of the heart 
becomes rapidly depresssed. This has been demonstrated in man 
(Cohen et al., 1965). There have been similar findings in experimental 
models of ischaemia. In the perfused rat heart there have been
observed a fall in ventricular systolic pressure and tension, a 
fall in cardiac output and a rise in ventricular end-diastolic 
pressure (Opie, 1965 , Neely et al., 1973; Kannengiesser, 1975).
In the heart of the conscious dog Bishop et al- (1974) observed 
similar c h a n g e s . The anoxic and hypoxic rat heart also responded in a 
similar manner (Henderson, 1973; Henderson and Brutsaert,
1973),
The heart can maintain cardiac output when subjected to 
small flow reductions. This has been shown to occur in man 
(Hamosh and Cohn, 1971). In the anaesthetised dog heart 
Lekven et al., (1973) found that flow could fall by 20% before 
cardiac output was affected. The heart compensated for the 
loss of contractility (measured as the ratecfrise of ventricular 
pressure development, d P / ^ ^ ) by increasing ventricular diastolic 
filling. This increased the stroke volume (by Starling's Law).
However, such a manoeuvre has an energy penalty since ventricular 
dilation increases wall tension and hence the oxygen consumption.
(see Katz 1977). When the heart can no longer compensate, 
cardiac failure ensues.
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Measurements with an intraventricular balloon catheter 
have shown that there are wide pressure fluctuations in the 
left ventricle of the Langendorff preparation during the 
contraction cycle (Opie, 1965). This indicates that w ork 
is being done. The work so measured increases with
increasing coronary flow and perfusion pressure. Perfusion 
pressure is the m a j o r  determinant of such work. Neely et al. 
(1967a,b) showed that in the left ventricle without a balloon 
the peak pressure equalled the perfusion pressure .
The working heart model at a given peak systolic pressure 
has a lower diastolic perfusion pressure than the Langendorff 
model and is therefore much more susceptible to subendocardial 
ischaemia. It may be as a reflection of such susceptibility 
that Opie et al., (1971a) observed changes in adenine nucleotides 
with increased work in a working heart preparation whereas 
Neely et al., (1972a) using a Langendorff non-pumping model 
found no such c h a n g e s .
5. Metabolic responses to myocardial infarction and ischaemia
The flow rate is a very important factor in determing the 
viability of muscle which is oxygen-deficient. Liedtke et al., 
(1976) found that substrate utilization, high energy phosphate 
levels and survival of the heart were more impaired when oxygen 
supply was decreased by flow reduction (ischaemia) compared 
with reduction of oxygen tension at constant flow rate (hypoxia)
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Fig. 19
Metabolic changes in the heart in hypoxia or anoxia
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In hypoxia glucose utilization is stimulated by the Pasteur 
effect (Morgan et al., 1959; Morgan et al., 19610). In mild 
to moderate ischaemia the glycolytic rate is also enhanced.
However, glycolytic inhibition occurs subsequently. This occu-ra 
when glycogen is exhausted^ through PFK inhibition as protons 
and lactate accumulate (Kubler and Spieckermann, 1970). In 
severe global ischaemia glucose uptake is depressed (Rovetto et al., 
1973). Glycolysis is initially accelerated but this is due 
largely to the stimulation of glycogenolysis and is maintained 
only until the glycogen is exhausted. In both ischaemic and 
hypoxic hearts ATP and CrP levels are depleted and Pi elevated 
(Neely et al., 1973). In hypoxic hearts this contributes to 
the stimulation of glycolysis by activating PFK. In ischaemic 
hearts, however, lactate and protons accumulate at a rate related 
to the degree of flow restriction. The effect of the decreased energy
status in accelerating glycolysis is over-ridden and glycolytic 
inhibition is proportional to the degree of restriction of coronary 
flow (Neely et al., 1975).
The metabolic changes are accompanied by a deterioration 
of mechanical performance in ischaemic and hypoxic hearts.
Rovetto et al., (1975) showed by measurement of glycolytic 
intermediates that the site of glycolytic inhibition in the 
ischaemic isolated perfused rat heart was glyceraldehyde
3-phosphate dehydrogenase rather than PFK. This was suggested
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to be due to the inhibitory effect of accumulated A D P  and AM P  
on glyceraldehyde 3-phosphate dehydrogenase at the low intracellular 
pH of the ischaemic hearts. Under such conditions A D P  and AMP 
would act to activate PFK. In addition, inhibition of 
glyceraldehyde 3-phosphate dehydrogenase by residual A T P  and 
creatine phosphate increases as the pH falls. The accumulation 
o f  lactate and protons which occurs in ischaemia rather than hypoxia 
would intensify inhibition by this mechanism.
The NADH/NAD^ ratio is increased in ischaemic tissue and 
may contribute to inhibition of glycolysis. However, this is 
not the major cause of glyceraldehyde 3-phosphate inhibition, 
since in anoxic hearts, where the NADH/NAD^ ratio is also increased 
glycolysis is accelerated (Williamson, 1966). Low pH alone 
was insufficient to inhibit glycolysis. This was shown by the 
rate in aerobic hearts perfused with pH 6.8 buffer. However, 
the same pH value did lead to glycolytic inhibition in both 
ischaemic and hypoxic hearts. Thus glycolytic inhibition in 
ischaemic or hypoxic tissue appears to be caused by a combination 
of factors : acidosis and either high NADH, low phosphate potential
or both.
6. Role of acidosis in ischaemia
H^ could theoretically accumulate in ischaemic tissue from 
a number of sources (Opie, 1976; Gevers , 1977). These are
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summarised below.
1. Anaerobic A T P  break-down- may lead to production (Gevers
, 1977).
2. Respiratory CO^ production with reduced washout leading to 
respiratory acidosis. There could also be some CO^ from bicarbonate 
as a result of formation, i.e. metabolic acidosis.
3. Triglyceride - FFA cycling, with 6H^/mole TG synthesised and 
broken down.
4. Glycogen turnover; there may be increased production during 
the synthetic phase with nett formation of one proton per cycle of
synthesis and degradation.
2 +5. Increased mitochondrial Ca uptake could lead to ejection 
of protons (Chance and Mela, 1966).
Intracellular acidosis is likely to be more severe in 
ischaemia than in anoxia with maintained flow because washout 
is impaired at the higher flow of ischaemia. Also in anoxic 
tissue there is no respiratory CO^ generation so that the buffering 
capacity of the cell is greater. Lai and Scheuer (1975) found that 
severe hypoxia with maintained coronary flow resulted in only a mild 
intracellular acidosis.
The mechanism by which changes in contractile function occur 
in acidosis is not well understood. It appears to be effected 
through changes in intracellular pH (pHi) rather than directly from 
decreased energy levels. A combination of the consequences of 
acidosis noted below may be involved.
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Decreased pH^ has been reported to a) alter myofibrillar
2+ATPase activity, b) modify the interaction of Ca with the
2 +SR and mitochondria, c) reduce the slow Ca current and
2 +  24- total Ca influx and d) alter sarcolemmal Ca binding
(see review by Poole-Wilson^ 1978). Acidosis may also
activate lysosomes (Brachfeld, 1969),
Any accumulated protons may be compartmentalized in 
mitochondria, SR, the cell membrane or the nucleus. For this 
reason and because of technical difficulties, precise 
measurements of the degree of acidosis in ischaemia are 
difficult to obtain. The fall in pHi resulting from 
accumulation of acid metabolites is probably sufficient to 
account for the deterioration in performance in ischaemic tissue, 
b u t  not during hypoxia.
This does not exclude a role for other factors, such as changes 
in high energy phosphate compounds, compartmentalisation or a 
direct effect of oxygen lack.
7. Role of Lactate in ischaemia.
If the intracellular pH of ischaemia tissue is increased 
there is only a moderate improvement in glycolytic flux, at the 
level of PFK. In addition, lactate accumulates in ischaemic 
tissue, whereas it is washed out in hypoxic tissue. Lactate 
added to the perfusate has been shown to inhibit glycolysis in 
aerobic tissue, probably by competition with glucose as substrate 
(Williamson, 1962). It also inhibited glycolysis when added to 
the perfusate in ischaemic and anoxic hearts by a mechanism which 
was not dependent upon changes in intracellular pH (Rovetto et al
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1975). Such an effect could occur by the generation of 
intracellular lactate in ischaemic tissue. Neely et al., (1976a) 
found that the degree of glycolytic inhibition in globally ischaemic 
rat hearts was inversely related to the lactate accumulation.
There is evidence for a lactate transporting mechanism for 
removal of lactate from the cell. The time course of efflux has 
been shown not to be directly proportional to tissue lactate 
concentration. This lactate transport may be inhibited in 
ischaemia. This would contribute to the maintenance of elevated 
intracellular lactate levels (Mowbray and Ottaway, 1973;
Garfinkel, 1976). Lactate was shown to produce profound changes 
in the action potential of sheep Purkinje fibres. These 
involved a shortened action potential duration and an increased rate 
of diastolic depolarisation. These changes conformed very closely 
to those observed in ischaemic myocardium (Wissner^ 1974) (shortening 
the action potential duration and increasing the rate of diastolic 
depolarisation). Extracellular lactate (32 mM) also produced 
ultrastructural changes in mitochondria similar to those seen after 
1 hour of ischaemia (Armiger et al. 1974).
8. Ischaemia in vivo and in vitro
The flow rate observed in ischaemic tissue in the intact 
heart in experimental animals or in man has been shown by microsphere 
studies to be in the order of 10 - 40% of normal. In this range
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glycolysis is not completely inhibited and can contribute 
to energy producticn.Thus in mildly ischaemic tissue where 
glycolysis is not inhibited glycolytic ATP can contribute 
15 - 20% of the total ATP generated (Neely et al., 1975).
Neely, et al., (1975) observed a 30% reduction in oxygen 
consumption and a 20% reduction in fatty acid oxidation but a two­
fold stimulation in glycolysis at 40% of normal flow in an isolated 
rat heart model with low extracellular lactate concentration. In 
the intact heart preparation perfused with blood the arterial lactate 
is in the range of 5 - 10 mM. At this concentration some inhibition 
of washout of intracellularly generated lactate may occur. Thus 
glycolytic flux is likely to be lower at a given flow rate in the 
intact heart than in the isolated heart perfused with buffer.
9. Role of fatty acids in ischaemia
Myocardial infarction is accompanied by elevated plasma 
PFA levels (Oliver et al., 1968), glucose intolerance (Sowton, 1962) 
and increased catecholamine release (Valori et al., 1967). These 
factors have been implicated in the consequences of myocardial 
infarction such as poor recovery of ischaemic tissue and the 
occurrence of arrhythmias (Opie 1972b). These and other factors 
are considered below.
a ) Exogenous fatty acid
Plasma FFA levels have been shown to be increased in patients 
with acute myocardial infarction (AMI) (Gupta et al., 1969). 
Catecholamine secretion liberates FFA from adipose tissue and this 
has been shown to be a major causative factor (Carlson et al., 1965).
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A  number of studies in man have shown an association between the 
elevated FFA levels and the increased incidence of arrhythmias 
in the post-.myocardial infarct period (Reiroann and Schwandt 1971; 
Prakash et al., 1972). Others however, have not found such a 
relationship, (Rutenberg et al., 1969; Hagenfeldt and Wester,
1973). (These were however, exogenous fatty acids from non-cardiac 
sour c e s ).
Similar conflicting results have been obtained in experimental 
animals. Detrimental effects may be related more to the FFA/
albumin ratio than to the absolute FFA concentration. For example 
high FFA/albumin ratio produced arrhythmias even in non ischaemic 
rat hearts (Willebrands et al., 1973). Kurien et al., (1971) 
and Oliver (1972) observed arrhythmic activity in dog hearts 
w h e r e a s  Opie et al., ( 197Ü) did not at the same FFA concentration; 
the latter group used a higher albumin concentration. The FFA/albumin 
ratio has also been shown to be important in regulating FFA utilization 
(Spector, 1971). However, some workers did not observe any increase 
in arrhythmic activity at high FFA/albumin ratios (Kostis et al.,
1973). In vivo an insulin-releasing effect of FFA (Crespin et al., 
(1969) may protect against deteriorative FFA effects exp fain m g  
these negative findings. FFA has been shown to depress contractility 
in hypoxic papillary muscle (Henderson et al., 1970a) and in the 
ischaemically-perfused isolated rat heart (Henderson et al., 1970b). 
Left ventricular performance in the ischaemic dog heart was impaired 
by FFA (Kjekshus and Mjj^s 1972b). Left ventricular performance 
improved in the ligated dog heart with an antilipolytic agent 
(Kjekshus, 1974).
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FFA have been implicated in increasing infarct size. Thus 
myocardial enzyme release, an indicator of infarct size, was 
much greater in palmitate-perfused than in glucose-perfused hearts 
with ligated coronary arteries (de Leiris et al, 1975).
The sensitivity of the heart to fatty acid effects may be 
enhanced by catecholamines. S~T segment elevation,arrhythmic 
activity a n d  infarct size have each been shown to increase
when catecholamines were superimposed on elevated circulating FFA 
in dog hearts (Opie et al., 1971 Kjekshus and Mj^s, 1972b, 1973; 
Mjg(s and Kjekshus, 1971).
b ) Endogenous lipolysis
Catecholamines can stimulate endogenous lipolysis by 
activating hormone-sensitive lipase (Opie, 1968-9). This 
was suggested by Kurien and Oliver (1970) to contribute to the 
increase in cellular FFA postulated in hypoxic heart. Greater 
estérification has also been observed in ischaemic hearts 
(Scheuer and Brachfield, 1966; Wood et al., 1972) so that 
catecholamines could contribute to increased turnover of a 
triglyceride-FFA cycle. Oxygen consumption was stimulated by 
50% when endogenous lipolysis was augmented by adrenaline treatment 
in rat hearts (Challoner and Steinberg,1965). This effect could 
be partly due to enhanced futile cycling of triglycerides and FFA.
81.
Inhibition of endogenous lipolysis in coronary ligated dog 
hearts by an antilipolytic agent ̂  pyridyl carbinol reduced S-T 
segment elevation and impairment of mechanical functions. Such 
hearts also became more susceptible to detrimental effects of 
exogenous FFA. This would suggest that endogenously generated 
FFA could play a role in the mechanism of deterioration 
(Kjekshus 1974).
c ) Proposed detrimental actions of FFA
Arrhythmic effects of FFA have been suggested to be caused
by detergent effects on cell membranes leading to K^ loss from
the cell (Kurien and Oliver, 1970). Uncoupling of mitochondrial
2 +iBspiration (Opie, 1970a) or the loss of cytoplasmic Ca as a 
result of mitochondrial accumulation have also been suggested 
as mechanisms for impaired performance (Henderson,1970). Oxygen- 
wasting effects of FFA in excess of that predicted on the basis 
of differences in P/0 ratio (2.85 for carbohydrate, 3.15 for 
lipid, 11% difference) have been reported. A  40% increase was 
found by Challoner and Steinberg (1966) with FFA as sole substrate. 
Consumption of 0^ for non-phosphorylating reactions would be an 
explanation for this. Challoner (1966) found in the rat heart 
that FFA stimulates oxygen consumption, some of which was oligomycin- 
insensitive and therefore not subject to respiratory control. 
(Challoner and Steinberg, 1965).
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FFA haS" been particularly implicated in the oxygen-wasting 
effects of catecholamines (Mj^s et al., 1972; Mj^s, 1971;
MJ0S et a l . , 1971).
In heart mitochondria adenine nucleotide translocase (ANT) 
has been shown to be reversibly inhibited by low concentrations 
of long chain acyl CoA esters (Shug and Shrago, 1973; Harris et al., 
1972; Pande and Blanchaer,1971). Long chain acyl CoA is a normal 
intermediate of fatty acid and accumulates in the tissue in 
conditions of oxygen limitation and reduced washout such as in 
ischaemia (Shug et al., 1975).
Such accumulation has been shown to inhibit myocardial ANT 
in vitro in isolated mitochondrial preparations. It has also 
been found in mitochondria isolated from ischaemic tissue after 
coronary artery occlusion in the dog (Shug et al., 1975). The 
inhibition is reversible and can be relieved by carnitine through 
enzymatic conversion to long chain acyl carnitine, which is not 
inhibitory (Pande and Blanchaer,1971 ; Shug et al. 1971).
The inhibition of ANT by long chain acyl CoA can explain 
many of the toxic effects reported for FFA in ischaemic myocardium 
(Shrago et al., 1976). Depressed A N T  activity would impair 
respiration by preventing entry of A D P  into the mitochondria and 
would impair translocation of mitochondrial A T P  to the cytoplasm
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for contraction or maintenance of membrane function. The 
cytoplasmic and mitochondrial ATP/ADP ratios would be affected 
(McLean et aL, 1971). The creatine phosphokinase located on the 
outer side of the inner mitochondrial membrane and which converts 
ATP leaving the mitochondria to creatine phosphate would also be 
affected. Thus the creatine phosphate supply to the cytoplasm 
would decrease (Jacobus and Lehninger, 1973).
Long chain acyl CoA could accumulate because of increased 
catecholamine-stimulated lipolysis, or by inhibition by long 
chain acyl CoA itself of the carnitine acyl transferase which 
effectively translocates long chain acyl CoA into the mitochondria 
(Bremer and Norum, 1967). Chronic ischaemia also reduces the 
activity of carnitine acyl transferase (Wood et al., 1973).
10. Catecholamines in ischaemia and myocardial infarction
The metabolic effects of catecholamines of stimulating 
glycogenolysis and lipolysis generate intermediates such as 
long chain acyl CoA + which require oxygen for removal. The 
oxygen supply is limited in ischaemia so that the oxygen supply/ 
demand ratio is reduced. Oxygen demand can be increased by 
inotropic or chronotropic effects of catecholamine, decreased 
efficiency of oxidative phosphorylation or catecholamine-stimulated 
calcium accumulation (Shen and Jennings, 1972 ). The catecholamines 
could be exogenous or endogenous ( Wollenberger et a l , 1966).
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Catecholamine secretion is greatest during the first hour 
after myocardial infarction (Vetter, 1974) and is greatly 
increased during the first 24 hours of chest pain (Valori et al., 
1967). Both adrenaline and noradrenaline have been suggested 
to play a role in the regulation of circulatory FFA levels 
(Taggart et-al.,1^72; Gupta et al., 1969). Catecholamine infusion 
at the rates found in dog hearts with large infarcts produced 
significant and phosphate loss and S-T segment elevation 
similar to that observed after coronary artery ligation (Opie, 
1972a). Such effects of catecholamine infusion were decreased 
by treatment with theyg-blocker propanolol (Maroko et al., 1971; 
Sommers and Jennings, 1972).
Larger doses of catecholamines can induce necrosis (Rona 
et al., 1959) when tissue perfusion is normal (Sobel, 1966).
They have also been shown to cause mitochondrial uncoupling 
and oxygen wasting (Raab, 1963). The necrosis was reduced by 
antilipolytic treatment (Kjekshus, 1973), suggesting a role for 
FFA in the mechanism of necrosis.
The effect of catecholamines of increasing the heart rate 
may also contribute to deterioration. Tachycardia has been shown 
to have detrimental effects in the coronary artery ligated dog 
heart (Redwood et al., 1972; Shell and Sobel, 1973). blockade,
which reduces S-T segment elevation, is also accompanied by a 
decrease in heart rate ( P a n t r i d g e M 7 4 ) .
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11. Arrhythmias
Catecholamines may induce arrhythmias by stimulating
lipolysis (Kurien and Oliver, 1970) increasing K^ loss, slowing
conduction following catecholamine-induced depolarisations
2 +caused by the slow inward Ca current (Surawicz, 1974).
Peak plasma noradrenaline and adrenaline values associated 
with peak FFA levels were related to the onset of arrhythmias in 
m a n  (Valori et al., 1971) and peak adrenaline were associated with 
\entricular ectopic beats in the study (Siggers et al., 1971).
The rate of secretion of catecholamines has also been related 
to early arrhythmias in dog heart (Ceremuzynski et al., 1969). 
Catecholamine administration has been shown to produce ectopic 
activity up to 4 days after experimental myocardial infarction 
in the dog.
Impairment of anaerobic glycolysis by utilization of exogenous 
FFA rather than glucose would result in reduced glycolytic ATP 
production. Such ATP constitutes only a small percentage of the 
total A T P  produced in the cell but it has been suggested that it 
has a specific role in maintaining action potential duration 
(Cheneval et al., 1972; Prasad and McLeod, 1969). Such an effect 
could lead to the genesis of airhythmias.
Other factors reported to predispose to arrhythmias in 
ischaemia are K^ loss and high extracellular K^ (Regan et al., 1967), 
changes in K^, Ca^^ and Mg^^ levels in the plasma (Surawicz 1971),
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the size and location of the infarct (Thomas et al., 1970), 
inhomogeheity of blood flow (Lubbeet al., 1974) catecholamines and 
intracellular acidosis.
There is evidence that high extracellular glucose content 
and in particular glycolytic ATP may protect against arrhythmias.
12. Glycolytic ATP
Glycolytic ATP has been functionally associated with
transmembrane electrical activity (McDonald et al., 1971) and
ion pumps (Fossel and Solomor^ 1977). ATP has been found to be
bound firmly to proteins of the cell membrane in heart and nerve
tissue (Abood and Matsubara, 1968). Glycolytic enzymes such as
phosphoglycerate kinase have also been shown to be membrane bound
(MargrethçtoLJ9é3i Parker and Hoffman, 1967) and could participate
in the maintenance of a submembrane A T P  pool. SR is impermeable
to ATP, has glycogenolytic enzymes associated with it and A T P  so
2+generated could have a role in regulation of Ca concentration in 
SR ( Entman ctaL, Glycolytic AT P  may also contribute to the
maintenance of membrane integrity by providing energy for the 
phosphatidic acid cycle which removes membrane-disrupting 
lysophospholipids.
The maintenance of membrane ionic currents by cytoplasmic 
A T P  may act to prevent arrhythmias. Thus glucose had a protective 
effect Oh the development of ventricular tachycardia and
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fibrillation after coronary artery occlusion in dogs (Serur et al.,
1976). A reduction in ventricular arrhythmias during and after 
oxygen restriction was found with glucose but not with pyruvate in 
isolated rat hearts (Willebrands In a coronary artery ligated
dog heart, partially ischaemic areas receiving collateral flow 
showed a greater decrease in FFA than in glucose utilization,with 
l^ycolytic flux remaining the major energy source (Opie eë at.,1473- 
Owen et al., 1969). Although GIK may not further increase 
carbohydrate utilization it may spare glycogen utilization.
In vivo elevated glucose levels may inhibit adipose tissue 
lipolysis and lower circulating FFA levels (Gupta, 1969).
Increased glycolysis could also increase intracellular 
rd(."ëlycerophosphate levels^ facilitating removal of FFA 
or long chain acyl CoA by re-esterification ( Wood et al., 1972;
Brachf e l d , 1969). G I K  may also act through membrane effects 
(Oliver, 1972) and decreasing lysosomal activity (Wildenthal^ 1973).
The rates of anaerobic glycolysis observed during sustained 
anoxia in rat and dog hearts are sufficient to provide 1/10 to 1/3 
of the energy needs of the mammalian heart. This could provide 
sufficient energy for normal function of the dog heart in partial 
but not total anoxia and could accelerate recovery on reoxygenation 
(Winbury, 1956). The maximum activities of the glycolytic enzymes are 
sufficient to be able to produce anaerobic A T P  at a rate just 
sufficient to generate the amounts normally produced aerobically 
(Opie, 1968).
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Glucose in conjunction with insulin and potassium (GIK) has 
been reported to produce beneficial effects in ischaemic tissue.
The inclusion of potassium is thought to return lost potassium 
to ischaemic cells thereby"repolarising'* them and reducing the 
likelihood of arrhythmias (Regan eVat.,K)67). Exogenous glucose 
has been suggested as beneficial for salvaging ischaemic myocardium 
via residual collateral circulation (Opie, 1970b ; Maroko and 
Braunwald, 1973). Glucose insulin potassium therapy was first 
actively proposed by Sodi-Pollares et al., (1962). A  beneficial 
effect of GI K  on infarct size has been found in baboon and dog 
hearts, with improved tissue high energy phosphate levels (Opie,
1975). Glucose alone was found to be almost as effective in 
a similar model (Maroko 19%). Glucose may exert a beneficial
effect by providing more energy anaerobically (Weissler /Q6î)
with glucose utilization being stimulated in hypoxia or mild 
ischaemia. In severe ischaemia, however, glycolysis becomes 
inhibited when accumulates (Rovetto et al., 1973).
Liedtke et al., (1976) used an intact globally ischaemic 
working swine heart model and reduced coronary flow to 50% of 
normal. Under these conditions a 26 mM glucose + insulin supplement 
did not improve performance orener^ levels in ischaemic hearts. 
However, glucose utilization in this ischaemic model was reduced 
to 44% of the high flow level indicating that glycolysis was 
inhibited. Thus any beneficial effects of glycolytic A T P  were 
not fully expressed.
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Thus the mechanism of deterioration in ischaemia has been 
shown to involve the accumulation in the tissue of the metabolic 
products intermediates of carbohydrate and lipid.
Catecholamines appear to act synergistically with fatty 
acid metabolites to enhance the deterioration.
In severe ischaemia the metabolic products of glycolysis 
are detrimental to the tissue. In mild ischaemia however, 
stimulation of glycolysis can generate ATP which may have beneficial 
e f f e c t s .
These factors which can influence the survival of tissue 
in the infarcted heart in vivo have been investigated in this 
work in the rat heart. Lipid and carbohydrate metabolism and 
mechanical performance were studied in a globally ischaemic 
recirculating Langendorff model.
Substrate utilization was shifted towards lipid by feeding 
rats on a diet rich in saturated fat prior to perfusion.
Carbohydrate oxidation and anaerobic glycolysis was 
stimulated with antilipolytic agents in normally-fed and fat-fed 
hearts. The contribution of glycolytic A T P  was investigated by 
substituting pyruvate for glucose as sole exogenous substrate.
The effect of adrenaline challenge on each of these metabolic 
conditions was examined. In each case any accompanying changes in 
mechanical performance were r e c o r d e d .
MATERIALS AND METHODS
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SECTION A. Animal diet.
Male albino Wistar rats (Anglia Laboratory Animals Ltd.) 
weighing 100 - 120 gram were divided into two groups. One 
group was fed ad libitum for three weeks on modified 41B laboratory 
diet (Oxoid Ltd., London). The other group was fed for the same 
time on a fat-enriched diet containing (g/kg): casein (270),
potato starch (30), beef dripping (250), microcrystalline cellulose, 
"Avicel” (EMC Corporation Philadelphia Pa. USA) (416), vitamin mixture 
(ICN Pharmaceuticals Inc., Cleveland Ohio, USA) (5), and salt mixture 
(29).
The vitamin mixture was composed of (g/kg): vitamin A
200 000 units/g (4.5) ; vitamin D 400 000 units/g (0.25); o<.-tocopherol
(5.0); ascorbic acid (45.0); inositol (5.0); choline chloride
(75.0); menadione (2.25); p-aminobenzoic acid (5.0); niacin 
(4.5); riboflavin (1.0); pyridoxine hydrochloride (1.0); 
thiamine hydrochloride (1.0); calcium pantothenate (3.0); it
also contained (mg/kg); biotin (20); folic acid (90); vitamin B^^ 
(1.85). This mixture was then diluted with glucose to 1 kg, 5 g of 
this mixture being added to 1 kg of the diet.
-2The salt mixture was composed of (mol/kg; g/kg) CaCO^ (9.4 x 10 ;
15.12); CuS0^,5H^0 (7.05 x lo“ ^; 0.0173); KIO^ (9.34 x lo"^; 
0.000236); MgCl^,6H^0(7.73 x 1 0 ~ ^ ; 1.57); FeS0^,7H20 (4.54 x lo"^;
0.124); MgS0^,7H^0 (8.24 x lo"^; 0.203); KH^PO^ (4.61 x lo” ^;
6.27); ^aHgP0^,2H^0 (2.22 x 10 3.46); ZnS0^,7H20 (1.76 x lo"^;
0.0505); total = 29.015 g.
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The powdered components were thoroughly mixed together and 
the melted dripping stirred into the powder until a fine free- 
running mixture was obtained, care being taken to break up any 
small lumps of unmixed dripping. The diet was prepared in batches 
of at least 2 kg and stored at 4°C until required. The rats were 
used for heart perfusion after three weeks, when their weights were 
in the range 200 - 280 g.
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SECTION B Heart perfusion.
1. Preparation of perfusate
The perfusate was bicarbonate buffer (Krebs and Henseleit, 1932) 
pH 7.4, containing defatted bovine serum albumin (2 g/100 ml), and 
either glucose (5.55 mM, 1 g/1) or sodium pyruvate (11 mM, 1.21 g/1) 
qs substrate. The components of the buffer were sodium chloride 
(118.4 mM, 6.92 g/1), sodium hydrogen carbonate (24.9 mM, 2.1 g/1), 
potassium chloride (4.6 mM, 0.354 g/1), magnesium sulphate heptahydrate 
(1.1 mM, 0.294 g/1), sodium dihydrogen orthophosphate (1.0 mM, 0.162 g/1) 
and calcium chloride dihydrate (2.54 mM, 0.374 g/1).
To prevent the precipitation of calcium phosphate, all the salts 
except calcium chloride were dissolved in double glass-distilled water 
and the solution gassed for 20 min. with O^/CO^ (95 : 5, v/v) gas 
mixture. The calcium chloride, dissolved in distilled water, was 
then added to the buffer.
Bovine serum albumin, Fraction V (Armour Pharmaceutical Co. Ltd.,
Eastbourne, Sussex), was defatted according to the method of Chen (1967).
50 g albumin was dissolved in 500 ml water at 2°. 25 g activated
charcoal was added, the pH adjusted to 3.0 with 1 M  hydrochloric
acid and the mixture stirred for 1 hr. at 4°. The charcoal was
removed by centrifugation at 20,000 g for 20 min. at 4°. The
charcoal pellet was washed with 100 ml acidified water, pH 3.0, 4°
and the supernatant fractions were pooled. The supernatant was
filtered through a 50 mm diameter 0.45y^m pore size membrane filter
to remove the remaining charcoal, the pH adjusted to 7.0 with 2 M
sodium hydroxide, and freeze dried. The defatted albumin was stored 
oat 4 C.
93.
Albumin was dissolved in the buffer at 2 g/100 ml, and dialysed 
against a further 1 litre of buffer for each gram of albumin at 4° 
for 60 hr. to allow equilibration of calcium with binding sites on 
the albumin. After the dialysis and immediately before use the 
albumin solution was filtered again through a 0 . 4 ^  pore size 
membrane filter.
2. Perfusion a p p a r a t u s .
The perfusion system was a modified Langendorff apparatus 
shown in Fig. 21 and was constructed from standard water-jacketed 
glassware connected by polythene tubing (i.d. 0.86 mm, o.d. 1.52 mm). 
Joints between the glassware and polythene tubing were made with silicone 
rubber tubing. As can be seen the perfusate recirculated in this 
system which was completely closed except for a small opening in the 
top of the heart perfusion vessel (A). This arrangement allowed 
oxygen consumption to be monitored continuously by means of an 
oxygen electrode (B) situated immediately after the perfusion 
vessel. The perfusate was pumped by a variable speed peristaltic 
flow inducer (C), (Watson Marlow M H R E  22, Falmouth, Cornwall). The 
silicone pump tubing dimensions were 3.2 mm i.d., 6.4 mm o.d. To 
calibrate the flow rate of the pump the apparatus was set up for 
non-recirculating perfusion. The perfusate leaving the cannula 
was collected in a measuring cylinder and the volume emerging was 
recorded over two minute intervals.
Air bubbles and pump-induced pressure pulses were removed from 
the system by the bubble trap (D). A thermostated recirculating 






Components of the perfusion apparatus
The identifying letters are those used 
in the text.
A heart perfusion vessel 
B oxygen electrode
C variable speed peristaltic flow inducer 
D bubble trap
E temperature equilibration coil 
F 3y^m pore size membrane filter and housing 
G cannula
H perfusate aerator column 
I strain gauge 
J 3-way tap
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glass vessels. The perfusate also passed through a thickly-jacketed 
temperature equilibration coil (E) shortly before entering the heart 
on each circuit. The thermostat was adjusted so that the 
temperature of perfusate in the perfusion chamber was 37°. The 
perfusate was filtered on each circuit by a 25 mm diameter prefilter 
and a 3 ^  m pore size membrane filter (F). Bacterial growth in the 
apparatus was inhibited by filling overnight with an antibiotic 
mixture of penicillin (300 U/ml) streptomycin (1 mg/ml) and 
neomycin (1 mg/ml).
After 8 - 1 0  perfusions or following a prolonged period when not 
in use the circuit and joint tubing were replaced and the glassware soaked 
in Decon 400 detergent (Decon Ltd,Hove, England), followed by 
repeated rinsing in tap water and double distilled water.
3. Perfusion.
Rats were anaesthetised by intraperitoneal injection of a 
mixture of pentobarbitone sodium ("Sagatal", May and Baker,
Dagenham, Essex), 80 mg/kg, and heparin (sodium salt, freeze-dried,
Evans Medical, Speke, Liverpool), 2400 U/kg. The heart was rapidly 
excised and contraction completely arrested by immersion in ice-cold 
Krebs-Henseleit buffer containing glucose (5.5 mM). The aorta was 
transected at the apex of the aortic arch, a vinyl cannula (G) 
inserted and held in place with an artery clip. (The cannula was 
made from an intravenous cannula set cut obliquely at the end, 
inserted into the aorta and notched 3 - 5 mm from the same end).
The heart was rapidly mounted in the perfusion apparatus via the 
cannula and non-recirculating washout perfusion at a flow rate of
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7 ml/min. was started. The perfusate comprised Krebs-Henseleit 
buffer with 2% fat-free albumin and 5.5 mM glucose. It was 
maintained at 37° and gassed with O^/CO^ (95 : 5 v/v). Gas 
exchange was facilitated by the aerator column (H), gas passing 
up the column and perfusate running down the inner walls. During 
washout perfusion the aorta was tied to the cannula with silk suture. 
The notch in the cannula prevented the heart from slipping off when 
the artery clip was removed. Connective tissue and adipose tissue 
was dissected away from the atria and aorta and a thread was attached 
to the apex of the heart with a small nickel hook. The thread 
passed through the opening in the perfusion vessel.
After 7 minutes of washout perfusion the heart was inverted 
and positioned in the perfusion vessel, the rubber bung to which 
the cannula was attached forming the base of the vessel.
Recirculating perfusion at 9 or 4 ml/min. was then started.
The heart was suspended from the thread attached in turn to the 
Dynamometer UF2 strain gauge (I). Thus, when the chamber was 
filled with perfusate the heart was supported by both the surrounding 
perfusate and by the thread. Vertical movement of the strain gauge 
enabled adjustments of the resting tension to be made. When the
chamber had filled with perfusate this was set at 2 g . When the
perfusate volume was approximately 33 ml, inflow was shut off at
the 3-way tap (J), giving a closed recirculating system. An initial
1 ml sample of perfusate was taken from the 3-way tap and subsequently 
at 10 minute intervals throughout the perfusion.The volume of perfusate 
was maintained by adding 1 ml of fresh buffer at the top of the
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aerator column. Perfusate samples were stored sealed at -20° 
until estimations were carried out.
At the end of the perfusion the rubber bung with cannula and 
heart attached was rapidly removed from perfusion vessel and the 
heart was freeze clamped with aluminium (Wollenberger) tongs cooled 
in liquid nitrogen. The atria, adipose and connective tissue were 
rapidly removed from the frozen disc of heart tissue and the 
remaining ventricular tissue was wrapped in aluminium foil and 
stored in liquid nitrogen until extraction and assay of metabolites 
were performed.
4. Measurement of mechanical performance and oxygen consumption
Developed tension and resting tension were recorded continuously 
by means of the strain gauge which was connected to a Devices MX2 
chart recorder (Devices Instruments Ltd., Welwyn Garden City, Herts).
Heart rate was measured with a stopwatch by counting the 
recorder pen deflections or when at the Pfizer Laboratories with 
an instantaneous ratemeter. The two methods agreed to within
+ 5 beat/min.
Coronary perfusion pressure was measured with a mercury 
manometer. Heart rate and perfusion pressure were noted at 
10 minute intervals, or more frequently immediately after 
adrenaline infusion.
It was found possible to detect ventricular arrhythmias from 
irregularities in the developed tension trace.
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Oxygen consumption was recorded continuously with a modified 
Clark electrode (Chappell, 1961) with a PTFE membrane, 0 . 0 0 0 5 ” 
thickness. It was calibrated at 37° in an aqueous solution of 
sodium dithionite and N^/CO^ (95 : 5, v/v) to set zero and in 
Krebs Henseleit buffer gassed with O^/CO^ (95 : 5, v/v) to 
measure oxygen saturation. The calibration was checked periodically 
throughout the day with the gas mixtures. Initial experiments 
showed that the oxygen tension of the oxygenated perfusate measured 
atspoint immediately before the perfusion chamber was constant. 
Therefore the "pre-heart” or "arterial” electrode was not used 
subsequently and oxygen consumption was determined by an electrode 
located immediately after the heart perfusion c h a m b e r .
5. Drug protocol
The time sequence for perfusion with a) adrenaline alone,
b) dichloroacetate or 2-bromopalmitate and adrenaline, and
c) pacing and adrenaline, are shown in F i g s . 22 a, b and c 
respectively. All drug additions were made to the perfusate 
at the top of the aerator column since this point was close to 
the venous side of the heart. Thus maximum mixing and dilution 
of the drug occurred in the perfusate before reaching the heart. 
Mechanical performance oxygen consumption and perfusion pressure 
were recorded as before.
a ) Adrenaline
To investigate the effects of adrenaline on performance 
and metabolism a freshly prepared aqueous solution of adrenaline 
hydrogen tartrate was infused as a bolus after 30 min. recirculating 
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in 100 ml Krebs Henseleit buffer and then diluted tenfold in the 
same buffer, 0.5 ml of this solution was mixed with 0.5 ml buffer 
containing 2% defatted albumin. When infused the 1 ml solution 
so prepared gave a final perfusate concentration of l ^ M .
1 ml perfusate samples were taken at 10 min intervals throughout, 
with replacement by 1 ml fresh perfusate except at the time the 
adrenaline bolus was infused. The hearts were freeze-clamped 
after 60 min. recirculating perfusion.
b ) Dichloroacetate and 2-Bromopalmitate
These compounds were infused after 20 min. recirculating 
perfusion. After a further 20 min. the adrenaline ( l ^ M )  was 
infused. After another 30 min. the hearts were freeze clamped.
The perfusate was sampled at 10 min. intervals throughout with 
volume replacement.
5 5 ^ 1  dichloroacetic acid (DCA) was neutralised with a 
stoichiometric amount of NaOH in 5 ml 0.155 M  NaCl. This was 
mixed with 5 ml Krebs-albumin buffer, giving a solution 66 m M  
with respect to DCA. 1 ml was added to the perfusate, giving a 
final perfusate DCA concentration of 2 mM.
Immediately before infusion^2-bromopalmitic acid (8.4 mg) 
was dissolved with heating in 0.5 ml 0.155 M NaCl containing a 
stoichiometric amount of NaOH. When dissolved the pH was checked 
a n d  the solution was added to 0.5 ml Krebs-albumin buffer. This 
solution was then added to the recirculating perfusate, giving a 
final perfusate 2-BP concentration of 0.8 mM.
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6. Pacing.
Hearts were paced at 350 bt/min. using two platinum wires as 
electrodes. One electrode entered the perfusion chamber through 
the bung at the bottom of the chamber and was in contact with the 
atria. The second electrode was passed through the opening at 
the top of the chamber and was in close proximity to the apex of 
the heart. This arrangement enabled the hearts to be stimulated 
without affecting the tension recording, the apex of the heart 
remaining free to move laterally. A  C.F.P. model 4048 stimulator 
provided a square-wave pulse of 2msec duration at a voltage slightly 
above threshold, which was approximately 10 V. When adrenaline 
infusion caused performance to deteriorate it was often necessary 
to increase the voltage to maintain the heart rate at 350 bt/min.
Hearts were set up for recirculating perfusion as described 
above and performance was allowed to stabilize for 10 min, during 
which time the position of the electrodes was adjusted. Pacing 
was then initiated and adrenaline infused after a further 20 minutes
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SECTION C . Perfusate and tissue analysis
1. Perfusate analysis
Rates of perfusate glucose uptake and perfusate lactate and 
glycerol output were calculated from measurements made on the 
samples taken at 10 min. intervals throughout the perfusions.
It was shown that stored samples gave identical rates of glucose 
uptake, lactate output and glycerol release to fresh samples.
Initially the 1 ml perfusate samples were deproteinised with
0.6 ml ice cold 6% perchloric acid and the pH of the supernatant
adjusted to 7 - 8 with 1 5 0 ^ 1  saturated potassium hydrogen carbonate.
After removing the potassium perchlorate by further centrifugation 
oat 4 the supernatant was assayed for glucose, lactate and glycerol. 
However, with this procedure the rates of uptake and output were 
not linear, particularly with the glucose determination. Nevertheless 
the variabilfty between duplicates prepared in this matter was 
better than 5%. These observations suggested that significant 
dilution errors were occurring during the deproteinisation procedure. 
Assay of un-deproteinised perfusate gave linear rates of glucose 
uptake. Subsequently the deproteinisation step was discarded 
and the perfusate assayed directly. All assays were performed 
in duplicate. The variability of a method was calculated as the 
difference between duplicates x 100/mean of duplicates.
a) Glucose uptake
Glucose was determined with glucose oxidase (EC 1.1.3.4) and 
peroxidase (EC 1.11.1.7) by the method of Werner et al. (1970), using 
the Boehringer Mannheim test kit (Cat. No. 124028). The principle
of the method is
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glucose oxidase
glucose + Og + HgO ------------------^gluconic acid + H^O^
peroxidase
HgOg + ABTS .... ■■■... ^  coloured complex + H^O
2 ml of reagent was added to 1 0 perfusate, incubated at room 
temperature for 30 min. and the absorbance measured at 610 nm.
The buffer/enzyme/chromogen reagent comprised 0.1 M phosphate buffer 
pH 7.0, glucose oxidase (10 U/ml), peroxidase (0.8 U/ml) and 
di-ammonium 2,2'-azino-bis(3-ethylbenzothiazolazine-6-sulphonate) 
(ABTS) (1.0 mg/ml). Variability between duplicates was better 
than 2%. The method was linear over the range of glucose 
concentrations encountered, i.e. 0 - 6 mM.
b) Lactate production
Lactate was determined by the method of Hohorst (1963). The
principle of-the method is
pH 10
Lactate + NAD ------- ^ pyruvate + NADH + H
2 ml buffer/NAD^/lactate dehydrogenase (LDH) was added to lO^wl 
perfusate, the mixture incubated at room temperature for 45 min. 
and the absorbance read on a spectrophotometer at 240 nm 
(F.S.D. = 0.2 absorbance units). The buffer/NAD^/LDH reagent 
comprised 0.1 M (7.51 g/l)glycine buffer pH 10.0, 0.9 mM  NAD 
(0.6 mg/ml), and 1 . 5 ^  1/ml of a 5 m g / m l (550 U/mg) suspension of 
rabbit muscle LDH (EC 1.1.1.27). The assay was linear over a 
perfusate lactate concentration range of 15 - 300(^M and the 
variability between duplicates was 2%.
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c ) Glycerol production
Glycerol was determined according to the method of 
Eggstein (1966) using the Boehringer Mannheim triglyceride 
test kit (Cat. No. 125032). The principle of the method is
glycerokinase
glycerol + A T P  -------------— ^  glycerol-3-phosphate + ADP
pyruvate kinase 
ADP + p h o s p h o e n o l p y r u v a t e ------------------^ p y r u v a t e  + A T P
LDH
pyruvate + NADH + H ■ ^ lactate + NAD
1 ml buffer/enzyme mixture was added to 200^1 perfusate 
and the initial absorbance read at 340 nm on a spectrophotometer 
(F.S.D. = 0.2 absorbance units). 5 0 ^ 1  of a 150U/ml suspension 
of glycerokinase (EC 2.7.1.30) was added, the tubes incubated 
for 10 min. at room temperature and the decrease in absorbance 
determined. ,
The buffer/enzyme mixture was prepared as described below 
from the reagents provided in the kit. These were stated to 
be of the following compositions when reconstituted.
20 ml of (i) 0.1 M  triethanolamine buffer pH 7.6 containing
4 mM MgSO^.
2 7 ^ 1  of (ii) a solution containing 6 mM NADH, 33 mM ATP, and 
11 mM PEP.
1 0 0 ^ 1  of (iii) a 800 U/ml solution of LDH (EC 1.1.1.27) and 
130 U/ml solution of pyruvate kinase (EC 2.7.1.40).
The method was sensitive to a minimum perfusate glyerol 
concentration of O.l^M and was linear over the range 0 - 1 . 2 5 ^  M. 
Variability between duplicates was 8%.
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2. Tissue analysis
Heart tissue was stored in liquid nitrogen until extraction 
and estimations were performed.
a ) Tissue pulverisation
The disc of heart tissue was broken into small fragments 
in a stainless steel percussion mortar cooled in liquid nitrogen 
It was further reduced to a fine powder in a stainless steel pestle 
and mortar, also cooled in liquid nitrogen This powder could be 
stored in stoppered tubes in liquid nitrogen
The powdered tissue was extracted as described below.
b ) Tissue extraction
An accurately weighed quantity of frozen tissue (approx. 0.4 g) 
was carefully'added to the surface of 1 ml 6%  perchloric acid 
(PCA) previously frozen in a plastic centrifuge tube by brief 
immersion in liquid nitrogen. The tissue was mixed thoroughly 
with the thawing PCA and placed on ice so that the mixture of 
tissue and PCA reached 0°C over a period of 10 - 15 min. When 
thawed the contents of the tube were mixed again and centrifuged 
at 3000 g for 10 min. at 4°C.
The pellet was washed with 0.6 ml ice-cold PCA and the 
supernatants pooled in a plastic stoppered tube. The pH of the 
supernatant was adjusted to 7 - 8 with 0.4 ml ice cold saturated 
potassium hydrogen carbonate and the precipitate removed by 
centrifugation. The resulting supernatant was kept on ice
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and assayed within a few hours for AT P  and creatine phosphate, the 
remainder being frozen for the determination of lactate + carnitine 
the following day. Carnitine is stable for several days in the 
neutralized extract at -25° (Pearson et al. 1974).
The perchloric acid pellet was washed twice more with 0.5ml 
ice-cold 6% PCA. The inside walls of the tube were dried as 
thoroughly as possible by inversion and careful wiping. The 
tubes containing the pellets were frozen at -20°C and assayed within 
48 hr. for both long chain fatty acyl CoA and long chain carnitine. 
Both compounds are stable under these conditions for this period of 
time (Garland^1974 ; Pearson et al. 197 4).
On the day of the assays the frozen pellet was divided into two 
approximately equal portions and each was accurately weighed (see 
sections f and g ) .
Tissue glycogen was determined on a separate fraction of tissue 
powder (see section h) .
c ) Tissue lactate.
1 5 0 ^ 1  of the neutralised PCA extract was assayed in duplicate 
with 1 ml buffer/NAD^/lactate dehydrogenase reagent by the method 
described in l.b above. The recovery of lactate was measured as the 
proportion of a known amount of lactate, added in aqueous solution to 
thawing tissue in the PCA, which was detected in the enzymatic lactate 
assay after extraction. The recovery was found to be almost complete 
Variability between duplicates was 4%.
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d ) Tissue adenosine triphosphate (ATP) and creatine phosphate 
The ATP concentration of the neutralised PCA extract was 
determined in duplicate by the method of Bilcher (1947) using the 
Boehringer Mannheim test kit (Cat. No. 123897). Creatine 
phosphate (CrP) was measured in the same cuvette by the subsequent 
addition of ADP and creatine kinase (EC 2.7.3.2) by the method of 
Fawaz et al.(1962).
The reaction sequence was:
creatine kinase 
Creatine phosphate + ADP ■ - — ^  Creatine + A T P
(CK)
phosphoglycerate
A T P  + glycerate-3-phosphate--------------------1,3-phosphoglycerate + ADP
kinase (PGK)
glyceraldehyde-3-phosphate
1, 3-diphosphoglycerate + ------------------- ^ g l y c e r a l d e h y d e - 3 - p h o s p h a t e +
NADH + H+ ^ ^ NAD+ + Pidehydrogenase (GAPDH)
triose phosphate
glyceraldeh'yde-G-phosphate —  ~ — ~ ^  dihydroxyacetone phosphate
isomerase (TIM)
glycerol phosphate
dihydroxyacetone phosphate — — ^  glycerol-l-phosphate + NAD
+ NADH + H+ d̂ ehydrogenase (GDH)
5Cyt1 neutralized extract was mixed with 1 ml buffer/glycerate-3- 
phosphate and lOCy^1 2.5 ml NADH, and the absorbance recorded at 340nm. 
7 . 5 ^ 1  of enzyme mixture containing GAPDH, PGK, GDH and TIM was added 
and the absorbance read again after 15 min., the reaction having 
reached completion. The change in absorbance was due to ATP. To 
measure the creatine phosphate concentration, 1 0 ^ 1  10 mM ADP and 
lOyx.1 creatine kinase (90 U/ml) were added to the cuvette and the 
additional decrease in absorbance determined after 15 min.
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The buffer mixture was 0.5 M triethanolamine buffer pH 7.6,
4 mM MgSO^ and 6 mM glycerate-3-phosphate. The enzyme mixture 
comprised GAPDH (EC 1.2.1.12) (560 U/ml), PGK (EC 2.7.2.3) (450 U/ml), 
GDH (EC 1.1.1.8) (80 U/ml) and TIM (EC 5 . 3 . 1 1 )  (1000 U/ml).
The recovery of ATP was 95 + 1% and of creatine phosphate 
90 + 2% (three experiments in each case). Variability between 
duplicates was better than 5%.
e ) Tissue carnitine
Tissue (-) carnitine was measured in duplicate by the 
5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) method of Pearson et al. 
(1974). The principle of the method is
carnitine




COASH + , "-21 »  ^ _  + 8^  _  .COO‘ +








The 5-thio-2-nitrobenzoate anion absorbs strongly at 412 nm.
The pH must not exceed 8.5 since carnitine acetyltransferase is 
rapidly inactivated (Fritz et al. 1963). At a pH value lower 
than 7 insufficient dissociation of the dye leads to low results.
The following solutions were pipetted into a 1 ml cuvette:
15Cy^l deproteinized neutralised sample
200y>cl 1 M (121 g/1) Tris buffer, pH 7.8
1 2 . 5 ^ 1  10 mM DTNB, pH 7-8 (40 mg dissolved in approximately 5 ml
2% KHCO^, pH adjusted to 7-8, made up 
to 10 ml).
10 1 15 mM (13.2 mg/ml) acetyl CoA
2 5 y ^  1 50 mM  EDTA (0.46 g disodium salt, pH adjusted to 8 ,
made up to 25 ml).
Water to 1 ml.
The absorbance was determined at 412 nm, 5yt1 of a suspension 
of carnitine acetyltransferase (80 U/ml) was added and after 3-5 min. 
the absorbance was read again several times. The absorbance due 
to carnitine was determined by extrapolation to the time of addition 
of carnitine acetyltransferase.
The method is sensitive to carnitine in the cuvette in the 
range 2 - 3 0 ^  M. Recovery was 94 ± 2% (four experiments). Variability 
between duplicates was better than 5% .
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( f ) Tissue long chain acyl carnitine
Long chain acyl carnitines were determined as free carnitine 
after alkaline hydrolysis of the acid-insoluble fraction. An 
accurately weighed fraction of the frozen PCA-insoluble pellet was 
suspended in 0.6 ml 0.2 M KOH. The pH was adjusted to 12.5 - 13.0 
by the addition of a known volume of 2 M  KOH if necessary. The 
extract was then hydrolysed at 55° for 2 hr, cooled, acidified with 
70% (w/v) PCA (glass electrode) and the protein precipitate removed 
by centrifugation at 4° (3000 g, 10 min.). The supernatant was 
buffered with 2 drops 0.5 M phosphate buffer pH 7.5 and the pH 
adjusted to 7 - 8 with 2 M KOH (glass electrode). 3 0 0 ^ 1  of the 
neutralised hydrolysate was assayed in duplicate as described for 
free carnitine with adjustment of the quantity of water used to give 
a total cuvette volume of 1 ml.
(g) Tissue long chain acyl CoA
The tissue concentration of long chain acyl CoA was determined 
fluorimetrically as free CoA after hydrolysis with alkali and 
mercaptoethanol according to the method of G a r l a n d , (1974)
(see below).
An accurately weighed fraction of the PCA-insoluble pellet was 
resuspended in 0.6 ml distilled water, 1 2 ^ 1  0.15 M  2-mercaptoethanol 
was added and the pH adjusted to 12.5-13.0 (glass electrode) with a 
m eas u r e d  quantity of 2 M KOH. The tissue was thoroughly agitated 
until dissolved, giving a gelatinous solution. After leaving at 
room temperature for 30 min. the solution was cooled to 0° , acidified
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to pH 2 - 3 (glass electrode) with 70% (w/v) PCA and the protein 
precipitate removed by centrifugation at 4° (3000 g, 10 min.).
The supernatant fluid was decanted, 1 0 0 ^ 1  0.5 M ice cold arsenate buffer 
pH 12.3 was added and the pH adjusted to 6.5 - 7.0 with ice cold 
saturated potassium hydrogen carbonate. The perchlorate-free 
supernatant was assayed immediately for CoASH.
The CoASH liberated by hydrolysis was measured fluorimetrically
in duplicate by the method of Garland^ (1974), using the reaction
2-oxoglutarate
CoASH + 2-oxoglutarate + NAD —---- ^  succinyl CoA + CO^ +dehydrogenase 2
NADH + H+
The preparation of the enzyme 2-oxoglutarate dehydrogenase 
(EC 1.2.4.2) is described at the end of this section. All reagents
for the assay were prepared with double glass-distilled water and
glassware was acid-washed.
Assay system;
A  reagent mixture was prepared freshly each day, comprising 
10 ml 0.1 M arsenate buffer, pH 7.2 (9 g KH^AsO^ in 450 ml water,
to pH 7.2 with solid KOH)
0.2 ml 10 mM NAD (70 mg made up to 10 ml, adjusted to pH 6 - 7
with 1 M  tris)
0.4 ml 0.1 M -2 oxoglutarate (73 mg and 121 m g  tris in 5 ml
distilled water)
and EDTA, 7.5 mg.
1.060 ml reagent mixture, 4Cyz 1 50 mM  cysteine, 0.4 ml neutralised 
hydrolysate and 500^1 water were pipetted into a fluorimeter cuvette.
The initial fluorescence was recorded using an Aminco spectrophoto- 
fluorimeter, excitation wavelength 340 nm, emission wavelength 457 nm.
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3ye 1 2 oxoglutarate dehydrogenase suspension (2 U/ml) was 
added with mixing and the fluorescence noted again after exactly 
1 minute, when the reaction was complete (A,E^). A  further 3 jil 
enzyme was added and the increase in fluorescence caused by the 
enzyme itself was recorded E^ ). 10 ̂ 1  of approximately 0.2 mM
NADH in 0.1 M arsenate buffer, pH 7.2 was then added and the increase 
in fluorescence was recorded E ^ ).
The concentration of the NADH solution was accurately determined 
spectrophotometrically (F.S.D. 0.2 absorbance units) from the molar
3
absorption coefficient of NADH at 340 nm, which is 6.22 x 10 .
Linear calibration curves were obtained in the fluorimeter with NADH 
and CoASH. Variability between duplicates was 5%.
2-Oxoglutarate dehydrogenase (EC 1.2.4.2) was prepared by the 
method of Sanadi et al. (1952). Four fresh pig hearts (ca. 600 g) 
were cut into 1 cm cubes and homogenised on ice with 4 1 ice cold 
30 mM potassium phosphate buffer, pH 7.4 (KH^PO^ 4.08 g/1; 1 mM
(372 mg/1) EDTA) for 30 sec. in a Waring Commercial Blender. The 
pH was adjusted to 7.4 with 10 M KOH and the extract homogenised for 
a further 30 sec. The pH was adjusted to 7.4 and the extract 
centrifuged at 1000 g for 15 min. at 2° and filtered through gauze. 
The filtrate was adjusted to pH 5.4 with 10% (w/v) acetic acid and 
centrifuged for 20 min at 10,000 g. The supernatant was discarded, 
and the mitochondrial precipitate resuspended in 1.5 1 water and 
centrifuged again at 10,000g for 20 rain, at 2°. The precipitate 
was suspended in 500 ml distilled water, the pH adjusted to 7.2 with
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10 M  KOH, frozen with liquid nitrogen and stored at -20° overnight.
The mitochondria were thawed, then frozen and thawed twice more, 
and centrifuged for 30 min. at 18,000 g . The supernatant contains 
the e n z y m e .
38.5 g ammonium acetate was added to each 100 ml supernatant.
The solution was maintained at pH 7.4 on ice for 30 min. The 
solution was centrifuged at 18,000 g and the precipitate discarded,
45 g ammonium acetate was added to each 100 ml supernatant, adjusting 
the pH to 7.4 with 10 M  KOH. After 30 min. on ice the fluid was 
centrifuged for 30 min. at 18,000 g . The yellow precipitate was 
dissolved in 6 ml of 30 mM potassium phosphate buffer (pH 7.4;
1 mM EDTA).
The ammonium acetate was removed by overnight dialysis against
2 changes of 1,000 ml buffer. The enzyme was stored frozen at -20° 
in portions of 0.25 ml in capped tubes. It is slowly inactivated by 
repeated freezing and thawing.
The enzyme was assayed spectrophotometrically using the reagent 
system described with 0.5 ml 1 mg/ml (approx. ImM) CoASH as substrate
h) Tissue glycogen
Tissue glycogen content of the heart tissue was determined by 
a modification of the methods of Chan and Exton (1976) and Selling and 
Esmann (1975) involving precipitation on filter paper, enzymatic 
hydrolysis of the glycogen. The glucose so liberated was measured 
by the glucose oxidase method of Werner et al. (1970) as already 
described. The enzyme amyloglucosidase (EC 3.2.1.3) hydrolyses
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o <-D” (l— > 4 )  and D - ( 1 — ^  6 ) linkages (Pazur and Audo, 1960) at
pH 4 - 5:
amyloglucosidase
Glycogen + (H^O)  4  (glucose)
2 pH 4.75 '
An accurately weighed (150 - 200 mg) portion of powdered frozen 
tissue was transferred to a glass homogeniser on ice containing 2 ml 
ice-cold 0.03 M  HCl. The tissue was homogenized with a teflon 
pestle until a uniform suspension free from tissue pieces was 
obtained. The suspension was transferred to a tall test tube and 
placed in a boiling water bath for 5 min. with a glass marble on 
each t u b e .
The resulting extract was whirlimixed to obtain a uniform 
opalescent suspension and 7 5 ^ 1  was applied in duplicate to 2 x 2 cm 
squares of Whatman 3 M M  chromatography paper. The paper squares 
were dropped immediately into ice-cold 66%  ethanol (10 ml/square) 
and stirred for 10 min.,the papers being protected from the revolving 
stirring bar by a wire gauze. The ethanol was discarded and the 
papers washed with the same volume of 66%  ethanol at room temperature 
for 10 min. The wash was repeated three times more and the papers 
rinsed in acetone for 5 min. and dried in a stream of warm air.
The dried papers are stable for several weeks if stored desiccated 
(Selling and Esmann, 1975). However, hydrolysis and measurement of 
the glucose were usually performed within 24 hours.
Each paper square was cut into quarters and dropped into a test 
tube containing 3 0 0 ^ 1  0.1 M  acetate buffer pH 4.75 well mixed with 
3 0 ^ 1  amyloglucosidase (140 U/ml) from Aspergillus niger 
(1,4-ol-D-glucan glucohydrolase, EC 3.2.1.3). It was important to 
ensure that the paper was thoroughly soaked with enzyme.
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The tubes were incubated at room temperature for 10 min. 2 ml of 
glucose reagent was added and the tubes mixed very gently at intervals 
during the 30 min, incubation to prevent fibres breaking away from the 
papers. The glucose was determined as described in section 1 a.
The absorbance obtained with blank filter papers was subtracted from 
that of the tests ( < 5 %  of absorbance of tests). Variability 
between duplicates was 5%. The standard curve was linear over the 
range O - 100 n mol g l y c o g e n / 7 5 ^  1 extract. The recovery of glycogen 
was 83 + 1% (three determinations). When performed in parallel with 
an acid hydrolysis method ( I N  HCl, 3 hr. 100°C) the results obtained 
from the two techniques were not significantly different. The 
filter paper technique with enzymatic hydrolysis has the advantage 
that determinations can be made more rapidly.
i ) Tissue triglyceride glycerol
Tissue triglyceride levels were measured as total glyceride 
glycerol by a modification of the method of Denton and Randle, (l967a)*
An accurately weighed portion of the frozen powdered tissue 
(approx. 0.4 g) was homogenised in 8 ml chloroform : methanol, 2 : 1 
(v/v) for 30 sec. in a Waring blender. The extract was shaken for 
1 hr. 1.7 ml methanol was added, the mixture centrifuged at 
3000 g for 10 min. The supernatant was aspirated from the tissue 
pellet. 3.4 ml chloroform and 2.87 ml 0.05 M  NaCl were added and 
the mixture shaken to produce a milky emulsion. The mixture was 
centrifuged at 3000 g for 10 min. to separate the layers. The 
upper phase was discarded.
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The tissue pellet was washed with 5 ml chloroform : 
methanol, 2 : 1 (v/v) centrifuged, and the supernatant added 
to the lower layer from the first extraction. The combined 
extract was evaporated to dryness under nitrogen on a rotary 
evaporator.
The residue was redissolved in 8 ml redistilled chloroform
1 g silicic acid (100 mesh, Mallinckrodt Chemical Works,
oSt. Louis, Mo.), previously heated for 18 hr at 110 , was added 
to remove phospholipids. The mixture was shaken, left to 
stand for 5 min. and centrifuged at 3000 g for 10 min.
1 ml fractions of the supernatant were taken in duplicate 
for hydrolysis and assay of glyceride glycerol as follows.
The 1 ml fraction was evaporated to dryness. To the 
residue was added 0.8 ml 95% ethanol, and 0.2 ml KOH (3.6 M). 
The capped tubes were incubated at 60° for 30 min.
The hydrolysate was acidified with 0.4 ml perchloric 
acid (2.5 M) and neutralised with 0 3 ml saturated potassium 
hydrogen carbonate.
0.1 ml of neutralised extract was assayed for glycerol 
using the Boehringer Mannheim test kit (Cat. No. 125032).
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The principle of the method is
glycerol kinase (GK) 
glycerol + A T P— ( 2 7 1  30)------- ^  glycerol 3-phosphate + AD P
pyruvate kinase(PK)
AD P  + phosphoenol p y r u v a t e  ^  pyruvate + ATP
(2.7.1.40
Lactate dehydrogenase(LDH) 
pyruvate + NADH + H ---— -—  ..-----------^ lactate + NAD^
The assay mixture comprised
1 ml buffer/enzyme reagent.
0.1 ml neutralised hydrolysate.
10 fil GK (150 U/ml) was added and the increase in absorbance 
at 340 nm was measured after 15 min (spectrophotometer FSD 0.2 
absorbance units).
The buffer enzyme reagent was prepared from
a) 20 ml triethanolamine buffer, O.IM, pH 7.6, 
magnesium sulphate 4 mM.
b) 250 ^1 of a mixture of NADH (6 mM), ATP 33 mM and 
phosphoenol pyruvate (11 mM)
c) 100 ^1 of a mixture of PE (130 U/ml) and LDH 
800 U/ml.
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SECTION P . Calculations and analysis of results
1) Rates of perfusate uptake or output
The effect of adding b a c k  a fresh 1 ml of perfusate each time 
a 1 ml sample was taken has been taken into account in the 
calculation of rates of perfusate glucose uptake or lactate and 
glycerol output. The fresh perfusate reduces the apparent 
glucose uptake and the lactate and glycerol output. The rates were 
corrected with the following equation:
True glucose uptake = (g^-g^)V + (g^-gg) + (S^-gg)
where g^ = initial glucose concentration (mM) (i.e. that of the
first perfusate sample) and
g^(gg, g^) = glucose concentration (mM) of the fourth (third, 
second) perfusate samples.
V = total volume of recirculating perfusate.
Similarly for lactate or glycerol output, where for example 4 samples 
are taken
True output rate = (C^-C^)V + (C^-C^) + (C^-C^)
where 0^(0^, C^, C^) are the concentrations (mM) of the metabolite 
in the fourth (third, second, first) samples 
V = total volume of recirculating perfusate.
2) Myocardial oxygen consumption
The oxygen consumption, MVO^ ^  mol oxygen/min./g wet weight
tissue) was calculated from the equation
MVOg = (arterial 0^ content - venous 0^ content) x coronary flow rate
( ^ m o l / m l )  ( mol/ml ) (ml/min/g wet
' weight)
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To obtain the oxygen content of the perfusate the oxygen 
tension (PO^) from the oxygen electrodes was multiplied by the 
Bunsen coefficient and corrected for temperature and the solute 
content of the perfusate (Umbreit et al., 1964).
The "arterial" 0^ tension was measured in initial experiments 
and found to be constant. Thus only the "venous" oxygen tension 
was measured routinely. The "arterial" tension was 550 mm Hg 
at the point of entry into the heart. This represents a perfusate 
oxygen content of 15.9 y / 1 O^/ml, or 0 . 7 1 ( ^  m o l / m l .
(The solubility of 0^ in water at 37° = 0.0003 ml/ml w ater/mm Hg)
Thus the oxygen supply to the heart at a flow rate of 9 ml/min 
was 6 , 3 9 ^  mol 0^/min and at 4 ml/min it was 2 . 8 ^ ^  mol 0 ^ / m i n .
3) Glucose,+ glycogen appearing as lactate
The fraction of perfusate glucose and endogenous glycogen 
appearing as perfusate lactate was calculated from the equation
%  glucose + glycogen appearing as lactate =
0.5 X perfusate lactate output ( ^ m o l / g  wet wt/unit time) ^ 
perfusate glucose uptake glycogen mobilised
^  mol/g wet wt/unit time) (y^ mol glucose equivalents/g wet wt/
unit time)
4) Analysis of results
Statistical analyses were performed according to the usual 
formulae for S t u d e n t ’s t-test and least squares linear regression 
analysis as described by Campbell (1974). The significance of drug 
effects within a group of hearts was tested with a paired t-test.
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Differences between groups were tested for significance with an 
unpaired t-test. All values presented as m e a n  value + S.E.M.
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SECTION E. Materials
The sources of items not already specified were as follows:
1. Perfusion equipment
0 . 4 5 ^ membrane filters were obtained from Sartorius GmbH, 
Gottingen, West Germany (Cat. No. 11306) or from Millipore, London 
(Cat. No. HAWP04700). The 25 mm diameter prefilters were 
Millipore Cat. No. AP25025000; the 3 ^  pore size filters were
Millipore Cat. No. SSWP02500. The housing was a Millipore
Swinnex 25.
Silicone tubing for (a) the pump and (b) glass-to-polythene 
tubing connections were from Watson Marlow, Falmouth, Cornwall.
The dimensions were (a) 3.2 mm i.d., 6.4 mm o.d.; (b) 1.6 mm i.d.,
4.8 mm o.d.
Polythene transmission tubing was supplied by Portex Ltd. 
(Hythe, Kent) Cat. No. 800/100/280. Three-way stopcocks were 
from Baxter Laboratories, Thetford, Norfolk; Cat. No. BR-625.
Silk suture was "Abrasilk", black braided. No. 2 metric.
Perfusion glassware was obtained from Jencons Ltd., Hemel 
Hempstead, Herts.
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2. Chemicals and biochemicals
Laboratory chemicals (AnalaR grade) were from BDH Ltd., Poole, 
Dorset, except potassium dihydrogen arsenate from Sigma Chemical 
Co., Kingston-upon-Thames, Surrey. All enzymatic test kits were 
from Boehringer Corp. Lewes, East Sussex. All individual enzymes 
and cofactors were also from Boehringer Corp. except 2-oxoglutaric 
acid, CoASH, and L-cystine hydrochloride which were from Sigma Co. 
Adrenaline hydrogen tartrate and DCA were from BDH. 2 -BP was a gift 
from Pfizer Ltd., Sandwich, Kent.
RESULTS
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SECTION A  Effect of flow rate and adrenaline challenge In normally- 
fed hearts
1. General
The data in this section compare the behaviour of hearts from 
normally-fed rats (hereafter referred to as normally-fed hearts) 
perfused at a flow rate of 9 ml/min (high-flow) with hearts perfused 
at a relatively more ischaemic flow rate of 4 ml/min (low-flow). 
These flow rates were chosen empirically since at coronary flow 
rates greater than 9 ml/min there was a gradual deterioration in 
developed tension in our model system and at flow rates below 
4 ml/min there was a steady rise in resting tension.
After 30 min of recirculating perfusion both high-flow and 
low-flow hearts were challenged with adrenaline, which was 
infused to give a final perfusate concentration of ^ M .  The 
mechanical and metabolic consequences were observed during the 
subsequent 30 min. period in order to determine the effects 
of reduced flow upon the response to adrenaline.
2. Effect of flow rate on performance and metabolism
a ) Mechanical responses
In hearts perfused at either 9 ml/min or 4 ml/min mechanical 
performance had stabilized after 10 min recirculating perfusion 
and did not change markedly when perfusion was continued without 
drug ' interventions for a further 70 min. The mechanical 
performance observed between 10 and 30 min after the start 
of recirculating perfusion is shown in Table 2.
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Table 2.
Performance of isolated perfused rat hearts perfused at 
high-flow (9 ml/min) and low-flow (4 m l / m i n ).
High-flow (n = 5) Low-flow (n = 9)
Perfusion pressure (mm Hg) 85.8 + 4.3 32.6 + 1.3
Heart rate 
(bt/min)
217 + 6 215 + 7
Developed tension 
(g)
11.0 + 1.2 5.09 + 0.37 **
Heart rate x 
developed tension 
(g. bt/min)
2331 + 213 1097 + 93 **
Resting tension 
(g)
1.54 + 0.05 1.90 + 0.04
Arrhythmias 
(% time)
0 2.2 + 2.2
Values are mean + S.E.M.
Significant differences between high and low-flow hearts 
are indicated as follows;
* P < 0.01
** P <  0.001
125.
Hearts perfused at 4 ml/min showed a perfusion pressure 
of 32 mm Hg. At 9 ml/min this pressure was 84 mm Hg.
Perfusion at the lower flow rate did not affect the heart rate 
but there was a significant reduction in developed tension. The 
increase in the incidence of arrhythmias was not statistically 
significant. The resting tension fell below 2 g in the high-flow 
hearts during 30 min perfusion but did not change in the low-flow 
group. This accounts for the statistically significant difference 
in resting tension between the two groups after this period.
b ) Metabolic responses
The metabolic responses to perfusion at the lower flow rate 
are shown in Table 3. Hearts perfused at 4 ml/min showed a more 
glycolytic mode than hearts perfused at 9 ml/min, the perfusate 
glucose uptake being stimulated by 80%. Despite this stimulation, 
glycogen mobilisation at t he lower flow rate still only contributed 
less than 10%  of the total carbohydrate substrate.
Perfusate lactate output increased 12 fold. This resulted 
in a highly significant increase in the proportion of glucose 
appearing as lactate from 7.3 + 1.8% in the high-flow hearts to 
54.4 ± 6.3% in the low-flow group.
Perfusion at 4 ml/min increased the %  perfusate oxygen 
extraction by 11%  but the MVO^ (the oxygen consumed per gram of 
heart per min) fell to 48% of its high-flow value. Since the 
heart rate did not differ significantly from that observed at 9 ml/min 
the MVOg/beat decreased in proportion to the fall in MVO^.
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Table 3.
Metabolism of isolated perfused rat hearts perfused at bigb-flow 
(9 ml/min) and low-flow (4 m l / min).
High-flow (n = 5) Low-flow (n = 9)
**
Perfusate glucose uptake 37.3 + 6.1 67.2 + 7.1
(y^mol/g/hr)
**Perfusate lactate output 4.45 + 1.56 57.0 + 7.4
(yz mol/g/hr )
Glycogen mobilization - 4.8 + 3.3
(«. mol/g/hr )
/ **
%  glucose + glycogen 7.3 + 1.8 5 4 . 4 + 6 . 3
metabolised to lactate
*% oxygen extraction 76.4 + 3.0 85.0 + 2.3
MVOg (yi m o l / g / m i n ) 5.85 + 0.23 2.94 + 0.08
MVO^/beat 27.0 + 1.0 13.0 + 0.62 -  -
( nmol/g/beat)
**
Glycogen mobilisation was not measured in the high-flow group. 
/ indicates that glycogen contribution was not included. 
Values are mean + S.E.M. using tissue wet weight values 
Significant differences between high and low-flow hearts 
are indicated as follows:
* P < 0 . 0 5
** P ( 0.001
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Heart rate is known to be a more important determinant of MVO^ 
than developed tension (Sonnenblick and Skelton, 1971). The fall 
observed here would suggest a reduction in the oxygen cost of work 
at low-flow. Such an effect could be explained by an increase in the 
proportion of energy derived from glycolysis at the lower flow rate.
3. Effect of adrenaline infusion on performance and metabolism
Adrenaline was infused after 30 min recirculating perfusion 
and the responses observed for a further 30 min as shown in Fig. 23.
Hearts perfused at either flow rate showed a biphasic response 
to adrenaline infusion. During the 10 minute interval immediately 
after adrenaline infusion (first phase) there was firstly a rapid 
increase in both heart rate and developed tension (positive 
chronotropic and inotropic responses respectively). Secondly there 
was a decline towards a new stable level. During the following 
20 minutes (second phase), heart rate and developed tension did not 
show any further significant changes.
a ) Effect of flow on the mechanical response to adrenaline 
The heart rate (Table 4.) was markedly stimulated by adrenaline 
in both groups in the first phase. During the second phase the 
heart rate in the high-flow group was maintained at a level 20 + 10%  
higher than before adrenaline. In the low-flow group however, the 
heart rate was significantly reduced, falling to 85 ± 7% of its pre­
adrenaline level.
At both flow rates the developed tension (Table 5) was stimulated 
significantly during the first phase. The second phase response 
showed deterioration to 55 ± 5% of the pre-adrenaline value in the 
high-flow hearts and to 81 + 7% in the low-flow hearts.
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Fig. 23
Time course of perfusion with adrenaline challenge at 30 min
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Effect of flow rate on the response of heart rate to adrenaline
Pre-adrenaline Peak-adrenaline Post-adrenaline
phase phase phase




High-flow (n = 5)  + 6 296 + 12* 260 + 25
Low  9) 215 + 7 282 + 9* 196 + 32
Values are mean + S.E.M.
* indicates value is significantly different from 
pre-adrenaline phase ( P <  0.001)
Table 5




High-flow (n = 5) 11.0 + 1.19 12.6 + 1.4 5.93 + 0.70**
(9 ml/min)
Low-flow (n = 9) 5.09 + 0.37 7.47 + 0.68* 4.17 + 0.53*
(4 ml/min)
Values are mean + S.E.M.
Significant differences from the pre-adrenaline phase are 
indicates as follows:
* P < 0.05
** P < 0.01
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Thus in the high-flow hearts deterioration was expressed 
as a decline in developed tension whereas in the low-flow hearts 
it was the heart rate that showed the greater decline.
The resting tension (Table 6) was unaffected by adrenaline in 
the high-flow hearts, remaining unchanged to the end of the perfusion. 
In the low-flow group the resting tension rose significantly by 
2.92 + 0.22 g . This rise occurred almost entirely during the 
f i r s t  phase.
The incidence of arrhythmias (measured as the percentage of 
the time when irregular contractions were observed on the developed 
tension trace) was increased significantly by adrenaline in hearts 
perfused at either flow rate (Table 7). However, there was no 
significant difference between the high-flow and low-flow hearts 
in the incidence of arrhythmias during the 30 min period after 
a d r e n a l i n e .
b ) Effect of flow on the metabolic response to adrenaline
Metabolite measurements were calculated as average rates 
over the whole period of the 1st and 2nd phases. This was so that 
comparison could be made between lactate production and the 
utilization of glucose and glycogen. Glucose uptake measurements 
were not sufficiently accurate to make useful estimates for a 
shorter time span. Tissue glycogen levels were measured immediately 
before adrenaline challenge or at the end of the second post­
adrenaline phase so that it was not possible to calculate separate 
rates of glycogen degradation for each of the post-adrenaline 
p h a s e s .
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Table 6.
Effect of flow rate on the rise in resting tension after adrenaline
High-flow (n = 5) Low flow (n = 12)
Rise in resting tension 0.05 + 0.04 2.92 + 0.22*
(g)
Final resting tension 1.59 + 0.07 4.74 + 0.22
(g)
Values are mean + S.E.M.
* indicates that the rise in resting tension was statistically 
significant (P < 0.001)
Table 7 .
Effect of flow rate on the incidence of arrhythmias after adrenaline
Pre-adrenaline Post-adrenaline
High-flow (n = 5) O 4 1 . 6 + 1 2 . 3
Low-flow (n = 9) 2.2 + 2.2 30.9 + 8.8*
Values are mean + S.E.M. Units afe %  time of post-adrenaline
p e r i o d .
* indicates that the pre-adrenaline and post-adrenaline incidence 
of arrhythmias were significantly different (P ^ 0.01)
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Glycogen mobilisation was stimulated significantly by 
adrenaline. The same rate of breakdown was observed in both groups.
Adrenaline infusion resulted in a 2.5 fold stimulation of 
perfusate glucose uptake (Table 8) in the high-flow hearts and 
a 78% increase in the low-flow group. In both cases the stimulation 
oc curred in the first phase and was maintained throughout the 
second phase. Despite the greater stimulation in the high-flow 
hearts, their absolute post-adrenaline rate of glucose uptake 
remained significantly lower than in the low-flow group.
Thus the sum of glucose and glycogen utilization after adrenaline 
showed a marked trend towards greater utlization in the high-flow 
hearts and a statistically significant increase in the low-flow 
h e a r t s .
Perfusate lactate output (Table 9) was stimulated in both 
groups, reaching a peak during the first phase, and declined steadily 
from the peak value throughout the second phase. It returned to 
the pre-adrenaline rate of output by the end of the perfusion.
Adrenaline stimulated the perfusate lactate output 12-fold in the 
high-flow hearts and by 93 + 34% in the low-flow hearts. Even so the 
absolute post-adrenaline rate of lactate output remained significantly 
higher in the low-flow groups. The fraction of glucose + glycogen 
appearing as lactate (Table 9) was increased 3-fold in the high-flow 
hearts but declined to 58.8 + 7.6% of its pre-adrenaline value in the 
low-flow hearts. However, the absolute post-adrenaline value still 
showed a trend towards a higher value for the low-flow hearts than
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Table 8 .
Effect of flow on post-adrenaline substrate utilisation
Higb-flow (n = 5) Low-flow (n = 9)
30
(y^mol/g wet wt/br)
1) Glycogen mobilisation 20.2 + 2.4* 20.8 + 2.8*
2) Perfusate glucose uptake 83.2 + 3.4 115 + 9**
( mol/g wet wt/br)
%  of pre-adrenaline value 256 + 51^ 178 + 18^^
*3) Glucose + glycogen utilisation 104 + 6 137 + 11
(y ^ m o l / g  wet wt/br)
%  of pre-adrenaline value 267 + 41^ 219 + 33^
Values are mean + S.E.M. for tbe 30 min post-adrenaline period. 
Significant differences between bigb-flow and low-flow values 
are indicated as follows:
* P <  0.05 
** P < 0.01
Significant differences between pre-adrenaline and post-adrenaline 
values are indicated as follows:
/  P < 0.01 
// P <  0.001
* Glycogen mobilisation was significantly greater after 
adrenaline in bigb-flow and low-flow hearts.
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Table 9.
Effect of flow on post-adrenaline lactate output
1) Perfusate lactate output 
mol/g wet wt/br)
Higb-flow (n = 5) Low-flow (n = 9)
*56.0 + 7.7 91.1 + 9.6
%  of pre-adrenaline value 2488 + 1121// 193 + 54/
2 ) %  glucose + glycogen 
metabolised to lactate
27.3 + 3.8 38.7 + 4.5
Values are mean + S.E.M. for tbe 30 min post-adrenaline period
* indicates a significant difference between bigb-flow and 
low-flow values (P<^ 0 .02)
Significant differences between preradrenaline values and 
post-adrenaline values are indicated as follows:
/  P <  0.05 
/ / P < 0 . 0 1
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for tbe bigb-flow group. Tbe smaller fraction of glucose and 
glycogen appearing as lactate after adrenaline in tbe low-flow 
hearts suggests tbat tbere was a significant increase in tbe 
fraction oxidised.
Tbe %  oxygen extraction (Table 10) and MVO^ were stimulated 
by adrenaline in bigb-flow and low-flow hearts and maintained at 
significantly elevated levels throughout tbe 30 minutes after 
adrenaline challenge. Tbe %  oxygen extraction reached 94% in 
both groups although MVO^ was greater in tbe bigb-flow hearts 
because of tbe higher flow rate. MVO^/beat did not change 
significantly in tbe bigb-flow hearts but was raised significantly 
in tbe low-flow group indicating tbat in tbe latter group adrenaline 
induced an apparent decrease in tbe mechanical work done for a 
given oxygen consumption, i.e. an increase in tbe oxygen cost 
of work.
c ) Tissue metabolite levels
Tbe final tissue metabolite levels obtained from tissue 
freeze-clamped 30 min. after adrenaline infusion are shown in 
Table 11. Tbe tissue levels of lactate, long chain acyl CoA and 
long chain carnitine were significantly higher in tbe hearts 
perfused at low—flow, indicating a greater accumulation of these 
metabolites in tbe tissue at 4 m l / m i n . Free carnitine, A T P  and
creatine phosphate were significantly lower in tbe low-flow hearts. 
Thus tissue high energy stores were depleted further in tbe low- 
flow hearts than in tbe bigb-flow hearts.
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Table 10.
Effect of flow on post-adrenaline oxygen utilization
Higb-flow (n = 5) Low-flow (n = 9)
%  oxygen extraction 93.7 + 1 . 1  94.0 + 0.8
MVO2 (yLtmol/g/min) 7.16 + 0.09 3.26 + 0.03 **
MVOg/beat ( n m o l / g / b e a t ) 2 8 . 5 + 2 . 4  18.8 + 3.4*
MVOi /beat as %  of 105 + 8 143 + 22^2
pre-adrenaline value
Values are mean j. S.E.M. for tbe 30 min post-adrenaline period 
Significant differences between bigb-flow and low-flow values 
are indicated as follows:
* P < 0.05 
** P < 0.001
/ indicates a significant difference between pre-adrenaline 
and post-adrenaline values (P < 0.05)
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Table 11
Final tissue metabolite levels in bigb-flow (9 ml/min) and 
low-flow (4 ml/min) hearts.
Higb-flow (n = 5) Low-flow (n = 9)
Lactate 0.92 + 0.03 2.44 + 0.13***
mol/g wet wt)
***Long cbain acyl CoA 6 . 7 2 + 1 . 4 1  1 4 . 5 + 0 . 8
(n mol/g wet w t )
*Long cbain acyl carnitine 147 + 18 242 + 34
(n mol/g wet w t )
Carnitine 790 + 40 660 + 70
(n mol/g wet w t )
AT P  2.44 + 0.27 1.58 + 0.11**
mol/g wet wt)
Creatine pbospbate 2 . 6 5 + 0 . 1 3  1 . 7 1 + 0 . 0 9
(y/mol/g wet wt )
Values are mean + S.E.M.
Significant differences between bigb-flow and low-flow values 
are indicated as follows:
* P <  0.05 
** P < 0 . 0 2
*** P <  0.001
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SECTION B Perfusion of hearts from fat-fed rats
1. General
Having established some of the effects of reduced flow rate on 
performance and metabolism in normal hearts an investigation was 
made of the effect of low-flow and of adrenaline challenge in fat- 
fed rats. These animals were fed for the 3 weeks prior to perfusion 
on a diet rich in saturated animal fat (beef dripping) ("fat-fed 
rats"). It can be seen from Table 12 that the hearts from these 
animals had an elevated tissue triglyceride level.
The hearts from fat-fed rats ("fat-fed hearts") were perfused 
at 4 ml/min for 60 min with adrenaline infusion at 30 min, as 
described for the normally-fed hearts in the previous section.
2. Effect of fat-feeding on performance and metabolism at 4 ml/min
a ) Mechanical responses 
The heart rate of the fat-fed hearts (Table 13) did not differ 
from that of the normally-fed hearts either before or after 
adrenaline challenge.
There was no significant difference between normally-fed and 
fat-fed hearts in the developed tension before adrenaline or in 
the peak response to adrenaline (Table 14). In the subsequent 
second phase there was a tendency towards a more rapid decline 
in the fat-fed group.
Resting tension during the pre-adrenaline phase was unaffected 
by fat-feeding (Table 15). There was, however, a major difference 
between the groups in the resting tension response to adrenaline.
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Table 12
Tissue triglyceride level before perfusion
Tissue triglyceride concentration
Normally-fed hearts
(n = 7) 4.7 + 0.7
Fat-fed hearts
( n = 5 )  6 . 8 + 0 . 5
Values are mean + S.E.M.
Units a r e ^ m o l  triglyceride glycerol/g wet weight 
The values are significantly different ( P <  0.05)
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Table 13.
Effect of fat-feeding on heart rate during perfusion with
adrenaline at 4 ml/min
Normally-fed (n = 9) Fat-fed (n = 7)
Pre-adrenaline phase 215 + 7 212 + 8
Peak adrenaline response 282 + 9 295 + 18
(First phase)
Second post-adrenaline phase 196 + 32 183 + 19
Values are mean + S.E.M. beats/min
Table 14
Effect of Fat-feeding on developed tension during perfusion 
with adrenaline at 4 ml/min
Normally-fed (n = 9) Fat-fed (n = 7)
Pre-adrenaline phase 5.09 + 0.37 5.16 + 0.41
Peak adrenaline response 7 . 4 7 + 0 . 6 8  7 . 4 6 + 0 . 8 9
(First phase)
Second post-adrenaline phase 4 . 1 7 + 0 . 5 3  3 . 6 2 + 0 . 4 4
Values are mean S.E.M. gram.
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Table 15.
Effect of fat-feeding on tbe rise in resting tension after
adrenaline infusion.
Normally-fed (n = 9) Fat-fed (n = 7)
*
Rise in resting tension 2.92 + 0.22 4.52 + 0.37
(g)
Final resting tension (g) 4.74 + 0.22 6.96 + 0.47
Values are mean + S.E.M. Hearts were perfused at 4 ml/min 
* indicates that normally-fed and fat-fed values are 
significantly different (P < 0.01)
Table 16.
Effect of fat-feeding on the incidence of arrhythmias during 
low-flow perfusion after adrenaline challenge.
Normally-fed (n = 9) Fat-fed (n = 7) 
Pre-adrenaline 2.2 + 2.2 8.7 + 4.5
Post-adrenaline 30.9 + 8.8 56.3 + 8.1
Values are mean + S.E.M.
* indicates that normally-fed and fat-fed values are 
significantly different (P (, 0.05)
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The resting tension rise in the fat-fed group (4.52 + 0.37 g) was 
significantly greater than in the normally-fed hearts (2.92 + 0.22 g) 
and occurred more rapidly. The maximum rate of rise in the fat-fed 
(2.30 + 0.38 g /min) was twice that observed in the normally=fed hearts 
(1.15 + 0.25 g / m i n ).
There was little difference between normally-fed and fat- 
fed hearts in the incidence of arrhythmias during the pre-adrenaline 
phase (Table 16). After adrenaline, however, there was a greater 
increase in the incidence of arrhythmias in the fat-fed hearts so 
that the %  time arrhythmic in the fat-fed (56.3 + 8 .1%) was 
significantly greater than in the normally-fed hearts (30.9 + 8 .8%).
b) Metabolic responses
There was a marked trend towards an impaired glucose uptake 
(Table 1 7 ) in the fat-fed hearts before adrenaline which was not 
offset by an increase in glycogen mobilization (Table 17) over 
this period. Adrenaline infusion caused a significant stimulation 
of glucose uptake in both groups of hearts but the post­
adrenaline rate was significantly lower in the fat-fed group.
Glycogen mobilization (Table 17) was stimulated further by 
adrenaline in the fat-fed hearts but despite this the total 
glucose + glycogen utilization (Table 17) after adrenaline was 
significantly lower in the fat-fed hearts (100 + 7 m o l / g / h r ) 
than in the normally-fed hearts (137 ± 1 1 ^ m o l / g / h r ).
The fat-fed hearts showed a marked trend towards a lower 
rate of perfusate lactate output before adrenaline (Table 18).
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Table 17
Effect of fat-feeding on carbohydrate utilisation during low-flow
perfusion after adrenaline challenge.
Normally-fed
mol/g w e t  wt/hr)
Fat-fed
(n 3 9) (n = 7)
4.8 + 3.3 4.6 + 3.0
20.8 + 2.8 29.8 + 2.8
2) Perfusate glucose Pre-adrenaline 67.2 + 7.1
uptake
(yymol/g wet wt/hr) Post-adrenaline 115 + 9
Post-adrenaline uptake as 
% of pre-adrenaline rate 178 + 18//





glucose + glycogen 
utilisation 
^ m o l / g  wet wt/hr)
137 + 11 100 + 7
Values are mean + S.E.M.
Differences between normally-fed and fat-fed hearts are 
indicated as follows:
* P < 0.05 
** P <  0.01
Differences between pre-adrenaline and post-adrenaline 
values are indicated as follows:
/  P < 0.01
// P < 0.001
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The stimulation in output following adrenaline challenge was also 
smaller in the fat-fed group. The pattern of lactate output in 
these hearts followed that observed in the normally-fed group, 
being greatest during the first phase and decreasing throughout 
the second phase towards the pre-adrenaline level. The mean 
post-adrenaline rate of output showed a marked trend towards 
a lower value in the fat-fed hearts.
There was no difference between normally-fed and fat-fed 
hearts in the proportion of glucose + glycogen appearing as 
lactate (Table 18) either before or after adrenaline challenge 
despite the lower rate of glucose utilization in the fat-fed 
animals. The smaller fraction of glucose + glycogen appearing 
as lactate after adrenaline suggests that there was an increase 
in the fraction oxidised, as was also observed in the normally- 
fed group perfused at 4 ml/min.
There were no significant differences between normally-fed 
and fat-fed hearts before or after adrenaline challenge in the 
%  oxygen extraction MVO^ or MVO^/beat (Table 19).
Thus the fat-fed hearts appeared to be deriving less energy 
than the normally-fed hearts from carbohydrate, although there 
were no significant differences in oxygen consumption or mechanical 
performance. The apparent energy deficiency in these hearts 
could be anticipated to be derived from the endogenous lipid store. 
Measurement of perfusate glycerol release did not show a 
significant difference between the two groups in the rates of 
glycerol production. However, the difference in output required 
to account for the energy deficit is less than the limits of
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Table 18
Effect of fat-feeding on perfusate lactate output during low- 
flow perfusion after adrenaline challenge.
mol/g wet wt/hr)
Post-adrenaline lactate 
output as % of pre-adrenaline 
rate
2) %  glucose + glycogen 
metabolised to lactate 
(yt/mol/g wet wt/hr)
Post-adrenaline rate as % 
of pre-adrenaline rate
/
(n = 9) (n = 7)
57.0 ± 7.4 43.1 + 4.8
91.1 + 9.6 64.6 + 9.6
193 *+ 54 142 + 13**
54.4 + 6.3 50.3 + 9.5
38.7 + 4.5 33.7 + 6.9
58.8 + 7.6* 66.8 + 2.4**
Values are mean + S.E.M.
/ Glycogen contribution not included in pre-adrenaline values. 
Differences between pre-adrenaline and post-adrenaline values 
are indicated as follows:
* P <  0.05
** P <  0.02
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Table 19.
Effect of fat-feeding on oxygen utilisation in hearts perfused 
at 4 ml/min.
Normally-fed Fat-fed
(n = 9) (n = 7)
85.0 + 2.3 83.4 + 1.7
94.0 + 0.8 94.2 + 0.7
Post-adrenaline extraction * * *as %  of pre-adrenaline value 111 + 3 112 + 2
2) M V O  Pre-adrenaline 2.94 + 0.08 2.94 + 0.102 -  -
(yizmol O^/g/min) Post-adrenaline 3.26 + 0.03 3.28 + 0.03
3) MVO^/bt Pre-adrenaline 1 3 . 0 + 0 . 6  1 3 . 0 + 0 . 42 -  -
(n mol/Og/g/beat) Post-adrenaline 1 8 . 8 + 3 . 4  1 6 . 5 + 2 . 0
Post-adrenaline MVO^/bt ^ ^
as %  of pre-adrenaline value 143 + 22 127 + 16
Values are mean + S.E.M.
Differences between pre-adrenaline and post-adrenaline values 
are indicated as follows:
* P <  0.05
** P <  0.01
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precision of the glycerol method.
c ) Tissue metabolite levels
The final tissue metabolite levels obtained from tissue 
freeze-clamped 30 min after adrenaline infusion are shown in 
Table 20.
The final tissue lactate concentration was significantly 
lower in the fat-fed hearts (1.82 + O . l O ^ m o l / g )  than in the 
normally fed group (2.44 + 0.13/^m o l / g ) . By contrast the 
tissue long chain CoA level was significantly higher (19.7 +
1.7 n mol/g) than in the normals (14.5 ± 0.8 n mol/g). Long 
chain carnitine levels did not differ but free carnitine showed 
a trend towards a lower level in the fat-fed hearts. Tissue 
ATP and creatine phosphate levels were both significantly 
lower in the fat-fed group.
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Table 20.
Effect of fat-feeding on final tissue metabolite levels
Lactate







Long chain acyl CoA 
(n mol/g wet w t ) 14.5 + 0.8 19.7 + 1.7 **
Long chain acyl carnitine 
(n mol/g wet w t ) 242 + 34 259 + 24
Carnitine 
(n mol/g wet wt) 660 + 70 540 + 7 0
ATP
^  mol/g wet w t ) 1.58 + 0.11 1.29 + 0.07
Creatine phosphate 
(^mol/g wet wt ) 1.71 + 0.09 0.99 + 0.10
* **
Values are mean + S.E.M.
Differences between normally-fed and fat-fed values are 
indicated as follows:
* P < 0.05
** P < 0.02
*** P < 0.01
All hearts were perfused at 4 ml/min.
Adrenaline was infused after 30 min perfusion. Hearts were 
freeze-clamped at 60 min.
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SECTION C . Effect of pacing
1. General
In the previous section adrenaline-induced changes in 
developed tension were frequently offset by opposing rate effects.
To obviate this problem hearts were paced at a constant beat 
rate throughout the perfusion. This enabled a separation to 
be made between the effects on heart rate and developed tension, 
with changes in mechanical performance expressed solely as changes 
in developed tension.
Normally-fed and fat-fed hearts perfused at 9 ml/min or 4 ml/min 
were paced at 350 bt/min. This rate was chosen since it was in 
excess of the highest rate observed at peak adrenaline response 
in the high-flow hearts. Thus the maximum adrenaline response 
did not increase the heart rate above that imposed by pacing.
2. Effect of pacing on hearts perfused at 9 ml/min.
The effects of pacing on hearts perfused at 9 ml/min are 
shown in Appendix A. At the beginning of the pre-adrenaline 
phase, when the heart rate was increased by pacing from 
approximately 220 bt/min to 350 bt/min there was a significant 
reduction in developed tension in both normally-fed and 
fat-fed hearts. The product of heart rate and developed tension 
was unchanged by pacing however. This was accompanied by a 
significant increase in the %  oxygen extraction and MVO^.
Pacing also did not cause any significant changes in resting 
tension, the incidence of arrhythmias or in any of the 
measured metabolic parameters.
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Following the adrenaline challenge the developed tension 
declined further and the %  oxygen extraction was greater than 
in unpaced hearts from either type of animal. However, pacing 
had no significant effect on the adrenaline-induced rise in 
resting tension or the incidence of arrhythmias, which were 
the two most sensitive indicators of deteriorating performance 
in the unpaced hearts.
The final tissue metabolite levels were also unchanged.
3. Effect of pacing on hearts perfused at 4 m l / m i n .
a ) Pre-adrenaline
The effects of pacing on the pre-adrenaline mechanical 
performance are shown in Table 21. It can be seen that the 
increase in. heart rate was accompanied by a decrease in developed 
tension. Resting tension was unaffected in the normally-fed 
hearts, but the fat-fed group showed a significant increase. Pacing 
h a d  no effect on the incidence of arrhythmias in either group 
Table 22 shows the metabolic parameters of the hearts before 
(unpaced control phase) and after the initiation of pacing.
Pacing did not appear to induce changes in glucose uptake, lactate 
out-put, or %  glucose appearing as lactate in either type 
of heart. However, in the normally-fed hearts the glucose 
uptake of the paced group was higher both before and after 
the initiation of pacing than in unpaced hearts. In both 
groups pacing resulted in significant increases in oxygen 
extraction and MVO^ and a significant decrease in MVO^/beat.
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Table 21
Effect of pacing on tbe pre-adrenaline mechanical performance of

















4.32 + 0.46 4.18 + 0.53
2.78 + 0.45^ 2.34 + 0.08^


















1.5 + 1.5 2.0 + 2.0
Values are mean + S.E.M.
* indicates that normally-fed and fat-fed values are significantly
different (P < 0.05)
/  indicates that value with pacing is significantly different from
the pre-pacing value (P < 0.05)
Values before pacing are for the first 10 min, of the perfusion.
Pacing was initiated after 10 min. recirculating perfusion. Values 
with pacing are for the subsequent 20 min. period.
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Table 22
Effect of pacing on tbe pre-adrenaline metabolism of normally-fed
and fat-fed hearts perfused at 4 ml/min.
Normally-fed Fat-fed
Perfusate glucose uptake Before pacing 8 1 . 1 + 2 5 . 5  3 1 . 7 + 3 . 5
mol/g wet wt/hr)
With pacing 8 2 . 7 + 1 0 . 2  3 3 . 2 + 4 . 7 **
Perfusate lactate output Before pacing 77.8 + 5.8 
(y / m o l / g  wet wt/hr)




%  glucose metabolised 
to lactate
Before pacing 45.3 + 9.5 51.3 + 7.8
With pacing 43.9 + 4.2 52.6 + 8.9
% oxygen extraction Before pacing 
With pacing




MVOg mol/g/min) Before pacing 3.17 + 0.01 3.07 + 0.05
3.28 + 0.0 3 ^  3.24 + 0.02^With pacing
MVOg/beat (n mol/g/bt) Before pacing 15.7 + 1.3
With pacing 9.4 + 0.1/
14.6 + 1.4
9.2 + 0.1/
Values are mean + S.E.M. n = 5 for both groups 
Differences between normally-fed and fat-fed values are 
indicated as follows: * P < 0.05; ** P < 0.01; *** P <. 0.001
/  indicates that value with pacing is significantly different from
the pre-pacing value (P < 0.05).
Values before pacing are for the first 10 min. of the perfusion.
Pacing was initiated after 10 min. recirculating perfusion. Values 
with pacing are for the subsequent 20 min. period.
152.
b ) Responses to adrenaline
Table 23 shows the effect of pacing on the peak mechanical 
adrenaline response. Adrenaline induced a significant 
stimulation of developed tension in the first phase with no 
significant difference in response between the normally-fed 
and fat-fed hearts. The %  stimulation of developed tension 
also did not differ from that observed in unpaced hearts.
The second phase mechanical response of paced hearts to 
adrenaline is shown in Table 24. Developed tension 
deteriorated by 50% in the normally-fed and 26% in the fat-fed 
hearts. The decline in the fat-fed group did not differ 
significantly from that of its unpaced controls, but the normally 
fed group did deteriorate further.
The fihal level of resting tension was significantly 
higher in the fat-fed group, rising to 7.42 ± 0.58 g compared with 
5.44 + 0.42 g in the normally-fed hearts. Pacing had no effect 
on the post-adrenaline incidence of arrhythmias, which remained 
greater in the fat-fed group.
Although adrenaline appeared to induce the same rise in 
resting tension in paced normally-fed and fat-fed hearts the 
total rise resulting from pacing and adrenaline challenge was 
greater in fat-fed hearts. In neither normally-fed nor fat-fed 
hearts did the total rise in resting tension differ significantly 
from that seen in the controls. Pacing thus did not alter the 




Effect of pacing on tbe peak response to adrenaline challenge of








Peak developed tension as % 
of paced pre-adrenaline phase
137 + 4 144 + 9
Heart rate x developed tension 
(g. bt/min)
1336 + 227 1173 + 65
Values are mean + S.E.M.
Differences between paced pre-adrenaline phase (Table 21) 
and peak response are indicated as follows :
* P <  0.05 
** P < 0.001
Adrenaline was infused at 30 min, after 20 min pacing.
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Table 24
Effect of pacing on tbe second phase response to adrenaline in








Developed tension as %  of 
paced pre-adrenaline phase
50 + 6 7 4 + 8
Heart rate x developed 
tension (g. bt/min)
490 + 99^^ 596 + 55^
Rise in resting tension (g) 3.57 + 0.37^^ 3.54 + 1.18^
Final resting tension (g) 5.44 + 0.42 7.42 + 0.58
Incidence of arrhythmias 
(% time)
19.3 + 19.3 50.0 + 25.4
Values are mean + S.E.M.
* indicates that normally-fed and fat-fed values are 
significantly different (P <  0.05)
Differences between these values and those of the paced 
pre-adrenaline phase are indicated as follows:
/  P <  0.05
/ /  P <  0.01
155.
Table 25 shows the post-adrenaline metabolic response of 
the paced hearts. Glycogen mobilization in the normally-fed 
hearts was increased by pacing to the rate observed in the 
fet-fed group, but the mobilization rate in the fat-fed hearts 
was unaffected. The rates of glucose uptake, lactate output 
and %  glucose + glycogen appearing as lactate in both groups of 
hearts were not different from those of the unpaced controls. 
Adrenaline increased the %  oxygen extraction, MVO^ and therefore 
MVOg/beat in both normally-fed and fat-fed hearts. The 
post-adrenaline %  oxygen extraction and MVO^ was significantly 
higher than in their unpaced controls.
c ) Tissue metabolite levels
The final tissue metabolite levels for the paced hearts are 
shown in Table 26. In normally-fed paced hearts the metabolites 
differed significantly from the unpaced control levels only in a 
lower level of long chain fatty acyl CoA in the normal group,.
In the paced fat-fed group tissue lactate tended to be. lower 
than in the unpaced fat-fed group.
Comparing normally-fed with fat-fed paced hearts the 
tissue lactate level was significantly lower and long-chain 
fatty acyl CoA higher in the fat-fed hearts. The only changes 
observed from the pattern in the control hearts were a 
significantly lower free carnitine level in the fat-fed group 
and a loss of statistical significance in the differences in 
A T P  and creatine phosphate levels.
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Table 25,
Effect of pacing on the metabolic responses to adrenaline
challenge in normally-fed and fat-fed hearts perfused at 4 ml/min,
Glycogen mobilisation 







Perfusate glucose uptake 
( ^ m o l / g  wet wt/hr)
106 + 10 60.8 + 3.2
Glucose + glycogen 
utilisation mol/g wet wt/hr)
132 + 12 90.3 + 1.2
Perfusate lactate output 
(yU mol/g wet wt/hr)
69.9 + 5.8 50.0 + 5.6
% of glucose + glycogen 
metabolised,to lactate
33.2 + 4.3 27.5 + 3.2'
Values are mean j- S.E.M. For the 30 min post-adrenaline period 
$ indicates that normally-fed and fat-fed values are significantly 
different ( P <  0.05)
* indicates that the value in paced hearts is significantly
different from the value in unpaced hearts (Table 17), ( P <  0.01) 
/  indicates that perfusate glucose uptake was significantly greater 
(P <  0.05) after adrenaline than during the paced pre-adrenaline 
p h a s e .
/ indicates that the % of glucose + glycogen metabolised to lactate 




Effect of pacing on final tissue metabolite levels in normally-fed
and fat-fed hearts perfused at 4 ml/min.
Normally-fed (n = 5) Fat-fed (n = 5)
Lactate
(yL6 mol/g wet wt) 1.98 + 0.19 1.52 + 0.09
Long chain acyl CoA
(n mol/g wet wt) 11.7 + 0.9 17.7 + 2.1
Long chain acyl carnitine
(n mol/g wet wt) 263 + 34 268 + 35
Carnitine ,
(n mol/g wet wt) 550 + 60 320 + 20
AT P  (yt mol/g wet wt) 1.75 + 0.15 1.33 + 0.40
Creatine phosphate
mol/g wet wt) 2.17 + 0.61 1.82 + 0.62
Values are mean + S.E.M.
Differences between normally-fed and fat-fed hearts are 
indicated as follows:
* P <  0.05 
** P < 0 . 0 1
/  indicates that values from paced and unpaced hearts (Table 20) 
are significantly different (P < 0.05)
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Thus the only observed effects of the additional workload 
imposed by pacing were an increase in oxygen consumption, and a 
small increase in resting tension before adrenaline in the fat- 
fed hearts.
4. Contribution of heart rate and developed tension to the 
w o r k  done by the h e a r t .
At the onset of pacing in both high-flow and low-flow hearts 
the increase in heart rate was accompanied by a decrease in the 
developed tension. The product of heart rate and developed 
tension was almost unchanged. There was a significant increase 
in the %  oxygen extraction and MVO^. These observations show 
that both developed tension and heart rate make significant 
contributions to the w ork done by the heart since there was a 
reciprocal change in these parameters. However, the oxygen 
c o n s u m p t i o n  increased as the contribution of heart rate to rate 
X tension increased and that of developed tension decreased , 
suggesting that heart rate is more important than developed 
tension as a determinant of oxygen consumption. This is in 
accord with in vivo findings (Sonnenblick and Skelton, 1971).
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SECTION D. Effect of antilipolytic agents in hearts perfused
at 4 ml/min.
1. General
The data in section B demonstrated that there were 
significant differences between the normally-fed and fat-fed 
hearts in their responses to adrenaline. In the fat-fed 
group both the rise in resting tension and the incidence of 
arrhythmias were greater and the perfusate glucose uptake and 
lactate output were less than in the normally-fed hearts.
Tissue levels of long chain acyl CoA were higher and ATP, 
creatine phosphate and lactate levels were lower than in the 
normally-fed hearts. Thus the reduced carbohydrate utilization 
and increased lipid metabolism in the fat-fed hearts were 
associated with a greater degree of deterioration of mechanical 
performance and lower tissue levels of AT P  and creatine phosphate.
To investigate further the relative influences of 
carbohydrate and lipid utilization on the mechanical and metabolic 
responses to adrenaline, antilipolytic agents modifying the 
relative utilization of these substrates were included in the 
perfusate prior to the adrenaline challenge. The effects of 
dichloroacetate (DCA), which inhibits lipolysis by the activation 
of pyruvate dehydrogenase (Whitehouse et al., 1974), and 
2-broraopalmitate (2-BP), which inhibits fatty acid oxidation 
(Burges et al. 1968), are described. (Details of these agents 
are given in the introduction).
The effects of insulin, nicotinic acid and elevated perfusate 
calcium concentration were also investigated. Further reference
to these agents is made in section E.
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2. Effects of dichloroacetate and 2-broinopalroitate during 
pre-radrenaline phase.
DCA or 2-BP were introduced into the perfusate after 20 min. 
recirculating perfusion and their effects were observed for a 
further 20 min. before the infusion of adrenaline.
In the normally-fed group infusion of DCA to a final perfusate 
concentration of 2 mM tended to cause a decrease in heart rate.
This was accompanied by a balancing increase in developed tension, 
so that the product of rate and developed tension was unaffected.
DCA had no effect on the measured parameters of mechanical 
performance in the fat-fed hearts (data for the pre-adrenaline 
phase with DCA is shown in Table 27; for 2-BP in Table 28).
Infusion of 2-BP to a final concentration of 0.8 mM was 
followed by a transient decline in heart rate, which returned 
rapidly towards the pre-drug level. However, the heart rate 
remained slightly but statistically significantly depressed.
Again this was accompanied by a balancing increase in developed 
tension such that rate x tension did not differ from that of 
the pre-drug phase.
Despite pre-drug glucose uptake rates in this series of 
rats being lower than in earlier groups there was a marked tendency 
for both DCA and 2-BP to stimulate uptake in both normally-fed 
and fat-fed hearts (Table 29). In addition, the perfusate
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Table 27.
Effect of dichloroacetate (2 mM) on the performance of normally-fed 
and fat-fed hearts perfused at 4 ml/min.
Normally-fed hearts (n = 5)
Heart rate (bt/min)
Developed tension (g)
Heart rate x developed 
tension (g. bt/min)
Pre-DCA 
182 + 12 
6.04 + 0.16
1096 + 55
Incidence of arrhythmias (% time) 15.6 + 7.5
With DCA 
166 + 15 
6.77 + 0.30
1262 + 137 
18.6 + 13.3
Fat-fed hearts (n = 5)
Heart rate (bt/min)
Developed tension (g)
Heart rate x developed 
tension (g. bt/min)
Pre- DCA 
194 + 14 
6.22 + 1.19
1137 + 108
Incidence of arrhythmias (% time) 20.0 + 15.5
W ith DCA 
184 + 15 
6.95 + 1.23
1273 + 60 
13.0 + 8.9
Values are mean + S.E.M.
Pre-DCA period was 0 - 2 0  min. recirculating perfusion. 
Phase with DCA was 20 - 40 min.
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Table 28
Effect of 2-BroiPopalmitate (0.8 mM) on the performance of
normally-fed and fat-fed hearts perfused at 4 ml/min.
Normally-fed hearts (n = 6)
Heart rate (bt/min)
Developed tension (g)






1088 + 83 
0
With 2-BP 




Fat-fed hearts (n = 5)
Heart rate (bt/min)
Developed tension (g)
Heart rate x developed 
tension (g. bt/min)







173 + 14* 
5.98 + 1.14
966 + 109
20.0 + 15.5 13.0 + 8.9
Values are mean + S.E.M.
* indicates that values from pre-2-BP phase and phase with 
2-BP were significantly different ( P <  0.05)
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Table 29
Effects of DCA and 2-BP on perfusate glucose uptake in
normally-fed and fat-fed hearts perfused at 4 ml/min
DCA
Normally-fed hearts 
(n = 6 )
Pre-DCA With DCA





31.7 + 2.2* 42.2 + 7.3* 32 + 17
2-BP
Normally-fed hearts 
(n = 6 )
Pre-2-BP With 2-BP




(n = 5) 2 2 . 6 + 3 . 1  3 5 . 6 + 7 . 6 62 + 26
Values are mean + S.E.M. mol/g wet wt/hr 
* indicates that normally-fed and fat-fed values are 
significantly different ( P <  0.05)
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lactate output (Table 30) was reduced by at least 50% and 
consequently the fraction of glucose appearing as lactate 
(Table 31) was significantly reduced by both agents in hearts 
from both types of rats. This marked reduction in the fraction 
of glucose metabolised by glycolysis alone must have been the 
result of an increase in the fraction of glucose oxidised.
Neither drug had any significant effect on the rate of 
oxygen consumption in either group of hearts (Table 32). As 
no change in the oxygen consumption could be detected this 
implies a reduction in some alternative energy source. Since 
these agents are known to be antilipolytic the most likely 
source would be endogenous lipid.
An antilipolytic effect would account for a greater fraction 
of the oxygen consumed being directed towards carbohydrate 
oxidation.
3. Effects of DCA and 2-BP on 1st phase response to adrenaline 
Neither DCA nor 2-BP significantly affected the response to 
adrenaline of heart rate (Table 33), developed tension (Table 34) 
or the product of rate and developed tension (Table 35).
Therefore any changes in mechanical performance or metabolism 
during the second phase should be the result of a direct effect 




Effects of DCA and 2-BP on perfusate lactate output in normally-fed




Pre-DCA With DCA %  change
43.8 + 2.8 17.8 + 2.5 - 6 6 . 4  + 6.4 * **
Fat-fed hearts 






P re-2-BP With 2 - B P  %  change
55.8 + 6.8 22.8 + 5.3 - 4 7 . 2  + 11.0
/ * *30.8 + 5.3^ 11.6 + 4.6 - 5 8 . 2  + 10.3
Values are m e a n  + S.E.M.ycmol/g wet wt/hr 
Significant %  changes are indicated as follows:
* P <  0.05
** P  < 0.01
*** P <  0.001
/ indicates that normally-fed and fat-fed values are s i g n i f i c a n t l y  
different ( P <  0.05)
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Table 31.
Effects of DCA and 2-BP on the % glucose metabolised to lactate




Pre-DCA Wi th DCA %  change
47.2 + 5.3 11.5 + 1.6 - 68.6 + 2.2 **
Fat-fed hearts 




Pre-2-BP With 2-BP %  change
70.8 + 7.5 41.0 + 11.6 40.2 + 19.1
Fat-fed hearts 
(n = 5) 49.1 + 15.9 17.1 + 4.5 72.3 + 9.6
Values are mean + S.E.M.
Significant %  changes are indicated as follows:
* P <  0.05 
** P < 0.01
/ indicates that normally-fed and fat-fed values are significantly 
different ( P <  0.02)
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Table 32
Effects of DCA and 2-BP on the % oxygen extraction in normally-fed
and fat-fed hearts perfused at 4 ml/min
DCA Pre- DCA W i t h  DCA
Normally-fed hearts 
(n = 6 ) 83.9 + 1.0 83.6 + 0.6
Fat-fed hearts 
(n = 5) 85.8 + 0.9 85.7 + 0.6
2-BP Pre-2-BP With 2 -BP
Normally-fed hearts 
(n = 6) 83.4 + 1.0 84.4 + 1.0
Fat-fed hearts 
(n 5) 83.1 + 1.0 82.1 + 0.8
Results are mean + S.E.M.
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Table 33.
Effect of DCA and 2-BP on the peak heart rate response to
adrenaline in normally-fed and fat-fed hearts perfused at 4 ml/min
Normally-fed hearts 
Control hearts (n = 9) 
DCA hearts (n = 5) 
2-BP hearts (n = 6)






166 + 15 245 + 5 52 + 12
206 + 10 276 + 5 36 + 7
Fat-fed hearts
Control hearts (n = 7) 212 + 8 295 + 18 39 + 7
DCA hearts (n = 5) 184 + 15 254 + 9 42 + 11
2-BP hearts (n = 5) 173 +
*14 235 + *12 35 + 3
Values are mean + S.E.M. beats/min.
Significant differences between drug treated hearts and their 
controls are indicated as follows :
* P < 0.05 
** P < 0.02
In drug-treated hearts the pre-adrenaline phase refers to 
the period between infusion of the drug and infusion of adrenaline.
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Table 34.
Effect of DCA and 2-BP on the peak developed tension response to
adrenaline in normally-fed and fat-fed hearts perfused at 4 ml/min,
Normally-fed hearts Pre-adrenaline phase Peak response %  change
Control hearts (n = 9) 5.09 + 0.37 7.47 + 0.68 46 + 6
DCA hearts (n = 5) 6.77 + 0.30* 8.28 + 0.20 23 + 4^^
2-BP hearts (n = 6 ) 5.04 + 0.35 8.03 + 0.42 62 + 11
Fat-fed hearts
Control hearts (n = 7) 5.16 + 0.41 7.46 0.89 46 + 6
DCA hearts (n = 5) 6.95 + 1.23 8.70 + 1.26 28 +
2-BP hearts (n = 5) 5.98 + 1.14 8.08 + 1.07 44 + 14
Values are mean + S.E.M. gram.
* indicates that a value in the DCA-treated hearts was 
significantly different from that of the control group (P < 0.01) 
Differences between the %  change in the DCA-treated hearts 
and the control group are indicated as follows :
/  P <  0.05 
// P <  0.01
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Table 35
Effect of DCA and 2-BP on the peak heart rate x developed tension
response to adrenaline in normally-fed and fat-fed hearts perfused
at 4 ml/min.
Normally-fed hearts Pre-adrenaline phase Peak response %  change
Control hearts (n = 9) 1097 + 93
DCA hearts (n = 5) 1105 + 63
2-BP hearts (n = 6) 1052 + 62
2043 + 200 
2026 + 57
8 5 + 6
8 5 + 8
2237 + 153 115 + 15
Fat-fed hearts 
Control hearts (n = 7) 
DCA hearts (n = 5 ) 
2-BP hearts (n = 5)
1081 + 73 2177 + 268 99 + 17
1218 + 99 2179 + 254 78 + 10
1012 + 105 1799 + 153 83 + 16
Values are mean + S.E.M. g bt/min
In drug-treated hearts the pre-adrenaline phase refers to 
the period between infusion of the drug and infusion of adrenaline.
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4. Effects of DCA and 2-BP on the 2nd phase response to adrenaline
a) Heart rate (Fig. 24)
In the presence of DCA the heart rate remained at 22 + 6% above 
its pre-adrenaline level in the normally-fed group whereas there 
was a fall of 15 + 7% in the control group. DCA did not modify 
the heart rate response in fat-fed hearts.
Perfusion of normally-fed hearts with 2-BP resulted in a 
significantly higher heart rate (250 + 13 bt/min) than in the 
controls (185 + 1 9 )  before adrenaline challenge. This was also 
reflected after adrenaline in the 22 + 6%  increase above the 
pre-adrenaline rate. In the parallel control group there was 
a 1 5 + 7 %  decline in heart rate after adrenaline. In the fat-fed 
group also the heart rate after adrenaline was maintained at a 
level significantly above its pre-adrenaline value. This 
contrasted with the fat-fed control group, where a significant 
fall was observed after adrenaline.
b) Developed tension (Fig. 25)
Perfusion of normally-fed hearts with DCA caused a greater 
deterioration in developed tension than in the untreated control 
hearts. In the presence of the drug developed tension declined
to 47 + 5% of its pre-adrenaline value compared with 81 + 7% 
of the pre-adrenaline value in the controls. In the fat-fed 
hearts the deterioration in developed tension was not affected 
by DCA.
In normally-fed hearts perfused with 2-BP the developed 
tension showed a trend towards a greater deterioration than in 
t h e  untreated control hearts. This was not statistically
HZ.
Fig. 24
Effect of antilipolytic agents on the second phase response to











Effect of antilipolytic agents on the second phase response to adrenaline 










significant. In fat-fed hearts 2-BP did not affect the 
deterioration in developed tension.
Summary of DCA and 2-BP effects on heart rate and developed 
tension after adrenaline
DCA had no marked effect on the overall contractile 
performance of the hearts. The amelioration in heart rate in 
the normally-fed group was accompanied by a deterioration in 
developed tension.
In the normally-fed group treated with 2-BP the amelioration 
in heart rate was accompanied by a trend towards a decline in 
developed tension, compared with the controls. Only in the fat-fed 
hearts did 2-BP appear to ameliorate overall performance: the
improved heart rate was not accompanied by a fall in developed 
tension.
c) Resting tension (Fig. 26)
In normally-fed hearts the resting tension rise after 
adrenaline was greater in DCA-treated hearts than in the control 
group. In fat-fed hearts perfused with DCA the rise was 
significantly less than that observed in the control hearts.
A  similar pattern was observed in 2-BP-perfused hearts.
The normally-fed group showed a greater rise in resting tension 
than their control group whereas the fat-fed hearts treated with 




Effect of antilipolytic agents on tne second phase response to adrenaline
of hearts from normally-fed and fat-fed rats perfused at 4 ml/min.
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♦ Significantly different from controls (i<0.C2)
Fig. 27
Effect of anti lipolytic agents on the second phase response to adrenaline
of hearts from normally-fed and fat-fed rats perfused at 4 ml/min.













* Significantly ::ffirent from controls (P<0.03) 
(*- 0.001)
175.
THUS, both drugs exhibited a marked saving effect in the 
fat-fed hearts. This was also accompanied by a stimulation 
of heart rate after adrenaline. Although the drugs appeared 
to increase the deterioration in resting tension in normally- 
fed hearts when compared with their controls, the resting tension 
rise in these hearts was no greater than in the fat-fed group 
treated with the same drug.
The additional deterioration in the normally-fed drug-treated 
hearts compared with their control group may be partly due to the 
elevated heart rate which remained above the pre-adrenaline level 
after adrenaline. Heart rate is an important determinant of 
energy consumption (See sections A  and C) and hence AT P 
utilization. Thus the greater energy utilization of these hearts may 
h a v e  further depleted tissue high energy phosphate compounds resulting 
in a small additional rise in resting tension.
d) Incidence of arrhythmias (Fig. 27)
DCA produced a statistically significant amelioration of 
the adrenaline-induced increase in arrhythmias in both normally-fed 
and fat-fed hearts. 2-BP also had a marked ameliorating effect 
in both groups of hearts. The reduction of post-adrenaline 
arrhythmic activity with 2-BP was even greater than that observed 
with DCA,
e) Glycogen mobilisation (Fig. 28)
To estimate the contribution of glycogen to total 
carbohydrate utilization the amount of glycogen mobilised during
176 
Fig. 28
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the 30 min post-adrenaline period was measured. Tissue glycogen 
concentration was measured in hearts freeze-clamped after 40 min 
perfusion, at the time at which adrenaline would have been infused.
The mobilisation during the post-adrenaline period was estimated 
as the difference between the level obtained from these hearts 
and the level measured in tissue freeze-clamped at the end of 
the 30 min post-adrenaline period.
As observed in section C glycogen made a significant 
contribution to carbohydrate utilization after adrenaline. Since 
mobilisation was greater in the fat-fed group, measurement of 
Ihis contribution was necessary to obtain an accurate assessment 
of the difference in carbohydrate utilization between the two 
groups. In addition, the exclusion of glycogen from the 
calculation of the proportion of carbohydrate substrate appearing 
as lactate would give an overestimate of this figure for the 
post-adrenaline phase.
DCA did not affect the adrenaline-induced stimulation of 
glycogen mobilisation in either normally-fed or fat-fed hearts.
2-BP produced a significant increase in the rate of glycogen 
degradation in both normally-fed and fat-fed hearts. The rate 
observed in the fat-fed group may indeed be an underestimate of 
the true rate, since the final tissue glycogen level was found to 
be 2 . 6 ^ mol/g wet wt. If this is an irreducible minimum value then 
it may have been reached before the end of the post^adrenaline phase, 
the glycogen being degraded in less than 30 min.
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f) Glucose and glycogen utilization (Fig. 29)
When normally-fed hearts were perfused with DCA the
stimulation of glucose and glycogen mobilisation after adrenaline 
appeared to be marginally less than in the control group. 
Carbohydrate utilization in fat"fed hearts treated with DCA tended 
to be greater than in the controls. Glucose and glycogen 
utilization in normally-fed hearts tended to be stimulated more 
after adrenaline in those treated with 2-BP than in the controls.
In fat-fed hearts 2-BP had no effect.
g) Perfusate lactate output (Fig. 30)
In normally-fed hearts after adrenaline lactate output fro
ri.se less in DCA treated than in the control hearts. Fat-fed 
hearts perfused with DCA were no different from their controls 
in this respect.
Lactate output in normally-fed hearts tended to be less 
stimulated after adrenaline in 2-BP treated-hearts than in the 
controls. The fat-fed group perfused with 2-BP however, showed 
a significantly greater stimulation in lactate output than the 
control group.
h) Conversion of glucose arid glycogen to lactate (Fig. 31) 
Perfusion of either normally-fed or fat-fed hearts with DCA
had no effect on %  conversion of glucose and glycogen to lactate.
In normally-fed hearts 2-BP treatment may have tended to 
increase the fraction of carbohydrate substrate appearing as 
lactate compared with the controls. In fat-fed hearts, however.
17%.
Fig. 30.
Effect of antilipolytic agents on tne second phase response to
adrenaline of hearts from normally-fed and fat-fed rats perfused
at 4 ml min.
(vii) Lactate production.
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the trend was more marked, and in the opposite direction,
i) %  Oxygen extraction (Fig. 32)
Neither DCA nor 2-BP had any significant effect on the %  
oxygen extraction although it appeared to be marginally 
lower in the presence of 2-BP.
j) MVO^ (Fig. 33)
In the normally-fed hearts MVO^ with either drug was 
marginally lower than, but essentially similar to, that of the 
control group. In the fat-fed hearts it was significantly lower 
than in the controls. The effects, however, were very small in 
comparison with the increases in %  oxygen extraction and MVO^ 
induced by adrenaline.
k) MVjQ^/beat (Fig. 34)
Since heart rate was better maintained after adrenaline 
in the presence of DCA and 2-BP than in the controls, and MVO^ 
was relatively unaffected, the increase in MVO^/beat observed 
after adrenaline in the control groups of both normally- and 
fat-fed hearts was abolished by both agents. Thus in the 
normally-fed hearts both drugs produced a reduction in MVO^/beat 
compared with the pre-adrenaline phase and in normally- and 
fat-fed hearts treated with 2-BP the MVO^/beat was significantly 
l e s s  than in their untreated controls. This suggests an 
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1 ) Final tissue metabolite levels
Tissue metabolite levels were measured in hearts freeze- 
clamped 30 min after the adrenaline infusion.
Both DCA and 2-BP produced highly significant reductions in 
tissue lactate levels (Fig. 35) compared with the controls in 
both normally-fed and fat-fed hearts; DCA appeared to have an 
even more marked effect than 2-BP. This could be a further 
indication of the greater degree of carbohydrate oxidation in 
hearts treated with the antilipolytic agents.
In the normally-fed hearts DCA significantly reduced the 
tissue long chain acyl CoA concentration (Fig. 36) from
14.5 + 0.8 to 9.17 + 1.25 n mol/g wet weight. In the fat-fed 
hearts DCA produced a marked trend in this direction, the long 
chain acyl CoA level falling from 19,7 ± 1.7 to 14.6 + 2.0 n mol/g 
w e t  weight. Thus the antilipolytic effect of DCA was observed 
as a reduction of the accumulation of long chain acyl CoA arising 
from the mobilisation of endogenous triglycerides.
2-BP produced a significant increase in long chain acyl CoA 
concentration in normally-fed hearts and a trend in this direction 
in the fat-fed group, in contrast to the decrease observed with 
DCA. However, it is possible that the 2-BP itself was interfering 
with the assay, since the 2-BP added to the perfusate would be partly 
converted to 2-bromopalmitoyl CoA within the cell and would 
contribute to the perchloric acid-insoluble precipitate in which 
long chain acyl CoA was determined.
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Fig. 36
Effect of anti lipolytic_ agents on ttie second pnase response to adrenaline 
of hearts from normally-fed and fat-fed rats perfused at I ml min.










♦ Significantly different from con trois 
( P< O.Ol)
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Normally-fed Hearts perfused witH these agents tended to 
show better maintained A T P  levels (Fig. 37) than the controls 
but the effects were not statistically significant.
In the fat-fed hearts perfused with DCA there was a marked 
trend towards better maintained A T P  levels than in the controls, 
Thus it fell to 1.29 + 0.0'^mol/g wet wt. in the controls but 
was maintained at 1.65 + O.lO^mol/g wet wt. with 2-BP and at
1.70 + 0.1(^mol/g wet wt. with DCA, Treatment of fat-fed 
hearts with 2-BP had a greater ameliorative effect. The A T P  
level was significantly higher than in the control group.
The levels obtained in the fat-fed hearts after perfusion 
with either drug were not significantly different from that of 
the normally-fed control group, indeed showing a tendency to be 
better maintained. Thus the additional decline in the fat-fed 
hearts was abolished by treatment with DCA and 2-BP.
186
Fig. 37
Effect of antilipolytic agents on the second phase response to










* Significantly different from controls 
( P< C.02 ) .
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SECTION E Relationships between mechanical and metabolic parameters
1. General
To investigate further the relationships between the mechanical 
and metabolic parameters referred to in the previous sections, 
linear regression analysis has been applied to data from hearts 
which were subjected to a number of different perfusion conditions. 
The data are drawn from the following groups: 
normally-fed and fat-fed hearts perfused at high-or low-flow, 
with pacing, with the antilipolytic agents DCA or 2-BP, and 
additionally w ith insulin, nicotinic acid, or an elevated perfusate 
calcium concentration as described in Appendix B.
The equations for the regression lines give the slope and 
intercept + the standard error of the mean.
2, Correlations between substrate utilization and mechanical 
p e r f o r m a n c e .
Fig. 38 shows the relationship between the post-adrenaline 
utilization of glucose and glycogen and the rise in resting 
tension in normally-fed hearts perfused at 4 ml/min.
The regression line describing the relationship was:
resting tension (g) = -0.0710 + 0.0161 x (g l u c o s e + g l y c o g e n ) +
(^mol/g)
9.67 +  0.91 
r =-0.610 p < 0 . 0 0 1  (n = 30)
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Figure 38
Effect of glucose + glycogen utilization after adrenaline on the









Post-adrenaline glucose + glycogen utilization 
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Thus the rise in resting tension in these hearts was 
inversely proportional to the total utilization of glycolytic 
substrate, suggesting that in normally-fed hearts glucose and 
glycogen played a major role in reducing the extent of 
deterioration expressed as the rise in resting tension. However, 
in the fat-fed hearts there was no clear relationship between 
glucose + glycogen utilization and resting tension (r = 0.125, 
p > 0 . 4  N  = 34). In addition, in the controls and insulin- 
treated fat-fed hearts a given rate of glucose + glycogen 
utilization was associated with a higher resting tension than 
in the corresponding hearts in the normally-fed family, suggesting 
that some factor other than lack of carbohydrate substrate was 
responsible for the additional deterioration of these fat-fed 
h e a r t s .
A  negative correlation was observed between resting tension
and post-adrenaline perfusate lactate production in normally-fed
hearts perfused at 4 ml/min (Fig. 39). Lactate output was
inversely related to resting tension according to the equation:
resting tension = -0,0562 + 0.0051 x (lactate) + 7.62 + 0.51 
(g) ( ^ m o l / g )
r = -0.570 p <  0.001 (n = 35)
There was no clear relationship between resting tension 
æ d  lactate output in fat-fed hearts (r < 0.1, p > 0.5, n = 34).
Thus the relationship between resting tension and perfusate lactate 
output appeared to reflect that observed for resting tension 
with glucose + glycogen utilization.
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Fig. 39
Effect of perfusate lactate output after adrenaline on the final 
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There was no relationship apparent in either normally-fed 
or fat-fed hearts between the post-adrenaline glucose and 
glycogen utilization and the post-adrenaline %  deterioration 
of the product of heart rate and developed tension.
In normally-fed hearts, r <  0.100, p > 0.5, n = 31 
and in fat-fed hearts, r = -0.303 p > 0.1 n = 30
The product of heart rate and developed tension represents 
an approximate measure of the overall deterioration of the hearts. 
It takes into account the observation that some hearts exhibited 
deterioration as a fall in heart rate, others as a decline in 
developed tension. It therefore reflects the deterioration more 
fully than heart rate or developed tension alone.
The data therefore, suggests that the change in contractile 
performance, unlike resting tension, was not closely related to 
or determined by, the post-adrenaline utilization of glucose and 
glycogen.
3. Correlations between resting tension and final tissue 
metabolite concentrations
a ) Final resting tension vs final tissue A T P  concentration 
The final tissue A T P  concentration was inversely proportional 
to the final resting tension in both normally-fed and fat-fed 
hearts (see Figs. 40 and 41). The equations describing the
192.
Fig. 40
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Fig. 41
Effect of final tissue ATP concentration on final resting 
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relationships were as follows :
In normally-fed hearts:
resting tension(g) = -2.41 + 0.39 x AT P  + 9.92+ 0.77; (n = 31)
/Cmol/g wet wt.
the correlation coefficient (r) was -0.757 and p<^0.001
In fat-fed hearts:
resting tension(g) = -2.94 + 0.36 x A T P  + 11.1 + 0,7 (n = 32)
y&mol/g wet wt.
r = -0.827; p ^  0.001 (n = 32)
Thus the correlation between final resting tension and A T P  is 
highly significant in both cases. Furthermore, the slopes and 
intercepts of the regression lines are not significantly different, 
indicating that the strong relationship between AT P  and resting 
tension was independent of any of the interventions affecting 
substrate utilization. Resting tension was therefore a good 
predictor of tissue A T P  concentration, reflecting the degree 
of inhibition of energy generation within the cell.
b) Final resting tension vs final tissue long chain acyl 
CoA concentration (see Figs. 42 and 43)
There was a highly significant positive correlation 
between the final resting tension and the final tissue long 
chain acyl CoA concentration in both groups of hearts.
In normally-fed hearts:
resting tension = 0.300 + 0.064 x long chain fatty acyl CoA +
(g) (n mol/g wet w t )
1.45 + 0.81 
r = 0.691 p < 0 . 0 0 1  (n = 26)
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Fig. 42
Effect of final tissue long chain acyl CoA concentration on 
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Fig. 43
Effect of final tissue long chain acyl CoA concentration on final 
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and in fat-fed hearts :
resting tension = 0.306 + 0.056 x long chain fatty acyl CoA +
(g) (n mol/g wet wt)
1.04 + 0.83
r = 0.750 p < 0 , 0 0 1  (n = 25)
Both the slopes and intercepts of the regression lines were 
almost identical, indicating that resting tension was strongly 
related to the tissue long chain fatty acyl CoA concentration 
irrespective of flow rate, or the pattern of substrate utilization 
whether determined by diet, or by infusion of drugs during the 
perfusion. This strongly suggests that long chain acyl CoA 
was very closely related to the inhibition of energy generation 
which resulted in a rise in resting tension.
c ) Final resting tension vs final tissue lactate concentration 
(See Figs. 44 and 45)
The resting tension was directly related to the final tissue 
lactate concentration in both normally-fed and fat-fed hearts, 
according to the following regression equations.
In normally-fed hearts:
resting tension = 1.68 + 0.40 x Tissue lactate + 1.58 + 0.80 
(g) (j.tmol/g wet wt)
r = 0.564 p <  0.001 (n = 40)
and in fat-fed hearts:
resting tension = 2.92 + 0.62 x Tissue lactate + 1.903 + 0.94 
(g) ^ m o l / g  wet wt)
r = 0.578 p < 0.001 (n = 47)
The slopes of the regression lines, although not statistically 
significantly different, showed a marked trend towards a given 
resting tension deterioration being correlated with a lower lactate 
concentration in the fat-fed hearts. This observation would suggest
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Fig. 44
Effect of final tissue lactate concentration on final resting 
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Fig. 45
Effect of final tissue lactate concentration on final resting 
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that tissue lactate may not be as closely related as long chain acyl 
CoA to the rise in resting tension. The tissue lactate could 
rather be a reflection of the amount of carbohydrate utilization.
d ) Final resting tension vs final tissue long chain 
carnitine concentration (See Figs. 46 and 47)
Resting tension also correlated directly with the final tissue 
concentration of long chain carnitine (See Figs. 46 and 47).
The equations describing the relationships were as follows.
In normally-fed hearts:
resting tension = 0.0138 + 0.0035 x long chain carnitine +
(g) (n mol/g wet wt)
0.929 + 0.98
r = 0.664 p < 0 . 0 0 1  (n = 22)
In fat-fed hearts:
resting tension = 0.0107 + 0.0030 x long chain carnitine +
(g) (n mol/g wet wt)
2.75 + 0.91
r = 0.598 p <  0.01 (n = 24)
Neither the slopes nor the intercepts of the two regression 
lines were significantly different, suggesting that the relationship 
between long chain carnitine and resting tension in all hearts 
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Fig. 47
Effect of final tissue long chain acyl carnitine concentration on 
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e ) Final resting tension vs final tissue free carnitine 
concentration (See Figs. 48 and 49)
In both normally-fed and fat-fed hearts there was a w eak 
inverse relationship between the final resting tension and the 
final tissue free carnitine concentration.
The equations describing the relationships were as follows:
In normally-fed hearts:
resting tension (g) = -0,053 + 0,01 x free carnitine + 0,86 + 0,07
(n mol/g wet wt)
r = -0,651 p 0,001 (n = 23)
In fat-fed hearts:
resting tension (g) = -0,031 + 0,01 x free carnitine + 0,66 + 0,06
(n mol/g wet w t )
r = -0,486 p <  0,01 (n = 31)
The lower free carnitine in the more deteriorated hearts 
could be explained by conversion to long chain carnitine (elevated 
levels were observed in deteriorated hearts in (d) above) or by 
net loss of carnitine from the tissue, A  plot of total carnitine 
(i,e, free carnitine + long chain carnitine) vs resting tension 
for normally-fed or fat-fed hearts did not reveal clear evidence 
of a fall in total carnitine with an elevated resting tension, 
although the fat-fed hearts taken as a group appeared to have a 
lower total carnitine and higher resting tension than the normally- 
fed hearts. Therefore there was some evidence that tissue loss 
of carnitine may have contributed to the lower free-carnitine levels
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Fig. 48
Effect of final tissue free carnitine concentration on final
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Fig. 49
Effect of final tissue free carnitine concentration on final 
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The uncertainty may be partly due to the poor precision of the 
carnitine method.
4. Correlations between resting tension and oxygen consumption 
Since the %  oxygen extraction after adrenaline was close to 
100%  and differed very little between groups of hearts perfused 
under different conditions, oxygen extraction did not correlate with 
1he final resting tension. As MVO^ was proportional to the %  oxygen 
extraction there was also no correlation between MVO^ and resting 
tension. Variations in MVO^/beat were due almost exclusively to 
changes in heart rate; MVO^/beat did not correlate with resting 
tension, nor did heart rate itself.
5. Correlations of the incidence of arrhythmias with final tissue 
metabolite concentrations and mechanical performance.
In notmally-fed and fat-fed hearts the post-adrenaline incidence 
of arrhythmias did not correlate with the final tissue levels of 
ATP, lactate, long chain acyl CoA, carnitine or long chain acyl 
carnitine. There was also no correlation with the final resting 
tension or post-adrenaline developed tension, (In all cases, 
r < 0 .1, p >  0.1 )
6. Correlations between parameters of contractile activity and 
final tissue metabolite concentrations
Neither developed tension nor the product of heart rate and 
developed tension showed any significant correlation with ATP, 
long chain acyl CoA, lactate, free carnitine or long chain carnitine.
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Thus the average performance for the 30 min post-adrenaline 
period does not appear to be related to instantaneous metabolite 
levels measured at the end of this period. It is more likely 
to be influenced by performance and metabolite levels before 
a d r e n a l i n e .
7. Correlations between individual final tissue metabolite levels
a) A T P  vs long chain acyl CoA
The final tissue A T P  concentration was inversely related 
to the final tissue long chain acyl CoA concentration in both 
normally-fed and fat-fed hearts (see Figs. 50 and 51).
In normally-fed hearts:
A T P  = -0.0782 + 0.0177 x (long chain fatty acyl CoA) + 2.69 + 0.23
mol/g wet wt n mol/g wet wt.
r = -0.647 p < 0 . 0 0 1  (n = 29)
and in fat"fed hearts:
A T P  = -0 . 0 8 5 4  4- 0.0163 x (long chain fatty acyl CoA) + 2.93 + 0.24 
mol/g wet wt n mol/g wet wt
r = -0.723 p < 0 . 0 0 1  (n = 27)
Points from normally-fed and fat-fed hearts appeared to lie 
on the same line, w ith neither the slopes nor the intercepts of the 
two regression lines being significantly different. Thus the decline 
in A T P  in the heart appears to be closely related to the accumulation 
of long chain acyl CoA, irrespective of the pattern of substrate 
utilization, perfusate flow or treatment with drugs and hormones 
and may be a factor directly responsible for this decline, as 
suggested in 3a and 3b of this section.
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Fig. 50
Relationship between final tissue long chain acyl CoA and final 
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Relationship between final tissue long chain acyl CoA and final
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b) ATP vs lactate
Tissue A T P  concentration was inversely correlated with 
tissue lactate concentration (Figs, 52 and 53). The regression 
equations are as follows 
in normally-fed hearts:
A T P  = -0.562 ± 0.16 x (lactate) + 2.886 + 0.31
(^mol/g wet wt) (^mol/g wet wt)
r =-0.542 pc^O.Ol (n = 30)
in fat-fed hearts :
A T P  = -0.877 + 0.22 x (lactate) + 2.95 ± 0.31
(^mol/g wet wt) ^ m o l / g  wet wt)
r =-0.568 p ( 0 . 0 0 1  (n = 34)
The slopes of the regression lines, although not significantly 
different, clearly show a tendency towards a lower AT P  concentration 
in the fat-fed hearts at a given lactate concentration than in 
normally-fed hearts.
c ) AT P  vs long chain carnitine
Final tissue long chain carnitine concentrations did not 
correlate significantly with A T P  in either normally fed or fat-fed 
hearts.
d ) AT P  vs free carnitine
In normally-fed hearts there appeared to be a w e a k  positive 
correlation between the final tissue levels of carnitine and AT P  
indicating that tissue free carnitine tended to fall as the ATP 
concentration declined.
r = 0.448, p < 0 . 0 5 ,  (n = 25)
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Fig. 52
Relationship between final tissue lactate and final tissue ATP 
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Fig. 53.
Relationship between final tissue lactate and final tissue ATP
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There was no clear correlation between these parameters 
in the fat-fed hearts (r = 0.21, p > 0.2, n = 29), However, 
the fat-fed group taken as a whole appeared to have a lower range 
of carnitine and AT P  levels than the normally-fed group. The 
same pattern was observed in plots of total carnitine (i.e. free 
carnitine + long chain acyl carnitine) vs A T P  with normally-and 
fat-fed hearts.
These observations provide further evidence suggesting that 
the more deteriorated hearts with the lower ATP concentrations 
were suffering a net loss of carnitine from the tissue.
An explanation of the correlation between A T P  arid free carnitine 
would be that a higher A T P  level was an indication of a better 
maintained membrane integrity, thereby reducing net carnitine loss 
to the perfusate.
e) Long chain acyl CoA vs lactate
There was a highly significant positive correlation between 
tissue long chain fatty acyl CoA and tissue lactate in both groups
of hearts, (Figs. 54 and 55) but the slopes of the regression
lines were significantly different (p ̂  0 .01).
In normally-fed hearts;
tissue lactate = 0.107 + 0.017 x (Tissue long chain acyl CoA) +
( ^ m o l / g  wet wt) (n mol / g  wet wt)
0.616 + 0.191 
r = 0.813 p < 0 . 0 0 1  (n = 23)
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Fig. 54
Relationship between final tissue long chain acyl CoA and 
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Fig. 55.
Relationship between final tissue long chain acyl CoA and final
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and in fat-fed hearts:
tissue lactate = 0,0509 + 0.0087 x (Long chain fatty acyl CoA) + 
^ m o l / g  wet w t ) (n mol/g wet w t )
0.553 + 0.141
r = 0.725 p<; 0.001 (n = 33)
The different regression lines indicate a lower lactate 
concentration in the fat-fed hearts at a given long chain fatty 
acyl CoA concentration and reflect the lower carbohydrate 
utilization, and greater lipid mobilization of the fat fed 
hearts as suggested by the data in section B. Thus, for every 
set of perfusion conditions the fat-fed hearts had higher 
long chain acyl CoA but lower tissue lactate levels than the 
normally— fed hearts. Since the fat-fed hearts showed a greater
decline in A T P  levels and a greater deterioration in resting 
tension, this again suggests that an increase in long chain fatty 
acyl CoA is more closely related than lactate to the process of 
deterioration. Since normally-fed and fat-fed
hearts give the same regression lines for long chain acyl CoA with 
resting tension or tissue ATP, this argument is applicable to 
both normally-fed and fat-fed hearts.
Thus elevations of both tissue lactate and long chain acyl 
CoA correlate strongly with elevated resting tension or a low 
tissue ATP, indicating that both could be causative factors in 
the mechanical and metabolic deterioration after adrenaline 
challenge. However, the data suggest that long chain acyl CoA 
is likely to be a more important factor than lactate since long 
chain acyl CoA bore the same relationship to resting tension or 
ATP in normal— and fat-fed hearts, whereas lactate in fat-fed
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hearts was associated with a higher resting tension and A T P  than 
in normal hearts. In addition, the higher levels of lactate 
attained in the normally-fed control hearts - less than 2 . 5 ^ m o l / g  
wet wt. are low in comparison with those reported by others in 
ischaemic hearts, suggesting that in this model the detrimental 
effects of lactate may not have been expressed fully.
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SECTION F. Perfusion of hearts with pyruvate as sole exogenous 
su b s t r a t e .
1. General
The rise in resting tension and increase in arrhythmias 
have been shown in previous sections to be reduced by increased 
glucose and glycogen utilization. Since the capacity of the 
heart to generate AT P  is inhibited at reduced flow rates 
(Neely et al., 1973), glycolytically-generated A T P  may be a most 
significant source of energy under these conditions. In addition 
it has been argued that glycolytic ATP has a particularly 
important role in the maintenance of membrane integrity 
(McDonald et al., 1971).
In an attempt to investigate the contribution of glycolytic 
A T P  to the performance of this model the sole exogenous substrate 
was changed from glucose to pyruvate, which can only be oxidised 
and therefore cannot generate glycolytic ATP. Pyruvate itself 
is an inhibitor of glycolysis (Williamson, 1965).
2. Perfusion of normally-fed hearts at high-flow rate (9 ml/min)
a) Pre-adrenaline phase (Table 36)
Only hearts from normally-fed animals were used in these 
experiments. Table 36 compares the performance and metabolism 
of pyruvate-perfused hearts and glucose-perfused hearts at the 
higher flow rate of 9 ml/min. A  marginal rise in resting tension 
was observed during 30 min. perfusion in the pyruvate-perfused hearts
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Table 36.
Effect of perfusion with pyruvate (11 mM) on performance and
metabolism of hearts from normally-fed rats perfused at 9 ml/min.
Heart rate (bt/min)
Glucose-perfused Pyruvate-perfused 
(n = 5 )  (n = 5)
217 + 6 246 + 10
Developed tension (g) 11.0 + 1.2 5.26 + 0.46 **
Rise in resting tension (g) O 0.36 + 0.29
Incidence of arrhythmias (% time) O 1.0 + 1.0
Perfusate lactate output 
( ^ m o l / g  wet wt/hr)
4.5 + 1.6 9.49 + 1.98
%  oxygen extraction 76.4 + 3.0 84.0 + 0.9
M V O  (y^ mol/g/min) 5.85 + 0.23 6.45 + 0.07
MVOg/beat (n mol/g/beat) 2 7.0 + 1.0 27.5 + 1.5
Values are mean + S.E.M.
Significant differences between the groups are indicated 
as follows:
* P <  0.05 
** P <  0.001
Values are for the 0 - 3 0  min period of the perfusions.
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There was no significant difference in the incidence of arrhythmias. 
The heart rate was higher and the developed tension lower in the 
pyruvate-perfused hearts. The %  oxygen extraction and MVO^ were 
higher in hearts perfused with pyruvate, but there was no significant 
difference between the groups in MVO^/beat. The higher oxygen 
consumption in the pyruvate-perfused hearts ma y  be a reflection 
of the higher heart rate, which is a more important determinant of 
oxygen consumption than developed tension as discussed in 
Sections A  and C.
The perfusate lactate output was significantly higher in the 
pyruvate-perfused hearts. This output could be accounted for 
entirely by glycogen degradation. The greater lactate output 
of this group may reflect the greater oxygen consumption and 
possibly greater work which may have caused a small stimulation 
of glycolysis.
Thus under conditions of adequate oxygenation .judged by the 
low rate of perfusate lactate output and the submaximal oxygen 
consumptionjperfusion with pyruvate had no effect on the resting 
tension aid the incidence of arrhythmias rose only marginally.
b ) Responses to adrenaline (Table 37).
Resting tension rose significantly in pyruvate-perfused 
hearts whereas in the glucose-perfused hearts it did not. The 
incidence of arrhythmias was not significantly different, although 
there was a trend towards . greater arrhythmic activity in the 
pyruvate-perfused hearts. Both groups showed a very large increase 
in oxygen utilization above their pre-adrenaline rates.
221.
Table 37 .
Effect of perfusion with pyruvate (11 mM) on the response to
adrenaline in normally-fed hearts perfused at 9 ml/min.
First phase












Rise in resting tension (g)
Perfusate lactate output 
( ^  mol/g wet wt/hr)
%  oxygen extraction
MVOg ( ^ m o l / g / m i n )
MVOg/beat (n mol/g/beat)
Pyruvate-perfused
260 + 25 235 + 28
5.93 + 0.70 3.24 + 0.31
0.05 + 0.04 1.93 + 0.59
41.6 + 12.3 56.0 + 10.9
56.0 + 7.7 26.2 + *3.1
93.7 + 1.1 95.0 + 0.9
7.16 + 0.09 7.26 + 0.06
24.3 + 0.7 31.5 + *1.3
Values are mean + S . E . M . ; n = 5 for both groups.
* indicates that glucose-perfused values and pyruvate-perfused 
values are significantly different ( P <  0.01)
/  The perfusate lactate output is calculated for the entire 
post-adrenaline period (30 - 60 min) rather than the second 
post-adrenaline phase (40 - 60 min).
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The %  oxygen extraction was stimulated in both groups from 
approximately 8 0 %  to 95%. Perfusate lactate output was also 
greatly increased in both groups. The stimulation of lactate 
output indicates that both glucose-perfused and pyruvate- 
perfused hearts became partially anaerobic when treated with 
adrenaline. The rate of lactate output in the pyruvate-perfused 
hearts was half that of the glucose perfused group and could be 
accounted for by approximately half of the degraded glycogen 
being converted to lactate. Under such conditions the hearts 
perfused with glucose would be able to obtain some energy from 
anaerobic glycolysis whereas those perfused with pyruvate would 
be much less able to do so, the limited glycogen degradation 
providing the only source. This would be a possible explanation 
for the greater post-adrenaline deterioration in resting 
tension and possibly in arrhythmias observed in the pyruvate- 
perfused hearts.
c ) Tissue metabolite levels (Table 38)
Comparison of tissue metabolite levels at the end of the 
perfusion in pyruvate-perfused hearts w ith those of the glucose- 
perfused group shows that there were no significant differences 
in creatine phosphate, long chain acyl CoA, long chain carnitine 
or glycogen. There was a trend towards a lower A T P  level in 
the pyruvate-perfused hearts. Together with the slightly 
greater deterioration in these hearts, the data supports the 
argument that resting tension is closely related to tissue 
A T P  levels. The tissue lactate level was significantly lower
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Table 38
Effect of perfusion with pyruvate (11 mM) on final tissue
metabolite levels in normally-fed hearts perfused at 9 ml/min
Glucose-perfused Pyruvate-perfused
(n = 5 )  (n = 5)
Lactate
(y< mol/g wet wt) 0 . 9 2 + 0 . 0 3  0 . 4 2 + 0 . 0 8
Long chain acyl CoA
(n mol/g wet wt) 6.72 + 1.41 6.71 + 0.36
Long chain acyl carnitine
(n mol/g wet wt) 147 + 18 166 + 21
Carnitine ^
(n mol/g wet wt) 790 + 40 600 + 30
ATP
( ^ m o l / g  wet wt) 2.44 + 0.27 1.78 + 0.16
Creatine phosphate
(y/.mol/g wet wt) 2.65 + 0.13 2.52 + 0.30
Glycogen
( ^  mol/g wet wt) 12.2 + 1.2 11.3 + 1.3
Values are mean + S.E.M.
Differences between glucose-perfused and pyruvate-perfused 
values are indicated as follows:
* P <  0.01
** P <  0.001
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in the pyruvate-perfused hearts.
The results from high-flow perfusion show that before 
adrenaline the oxygen supply was in excess of the demand 
as indicated by the %  oxygen extraction and the low rate of 
lactate production in the glucose-perfused hearts. Under 
these conditions there was no difference between glucose- and 
pyruvate-perfused hearts in the incidence of arrhythmias or 
the rise in resting tension.
The adrenaline-induced increase in w o r k  imposed a mild
degree of hypoxia upon these hearts, as indicated by the %
oxygen extraction and the increased rate of lactate production. 
This resulted in a trend towards a greater incidence of 
arrhythmias and rise in resting tension in the pyruvate-perfused 
hearts. : A s  these hearts were unable to metabolise glucose 
the data suggest that in glucose-perfused hearts energy from 
anaerobic glycolysis may have played an important role in 
reducing the rise in resting tension and the increase in 
arrhythmias after adrenaline challenge.
3. Perfusion of normally-fed hearts at low flow rate (4 ml/min)
a) Pre-adrenaline phase (Table 39)
Table 39 shows the effect of a reduction in flow rate 
on the performance and metabolism of pyruvate-perfused hearts 
in comparison with hearts perfused w i t h  glucose at low flow.
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Table 39
Effect of perfusion with pyruvate (11 mM) on performance and
metabolism of Hearts from normally-fed rats perfused at 4 ml/min.
Glucose-perfused Pyruvate-perfused
( n = 9 )  (n = 5)
Heart rate (bt/min) 215 + 7 117 + 21**
Developed tension (g) 5.09 + 0.37 5.03 + 0.20
Rise in resting tension (g) 0 2.98 + 0.76
Incidence of arrhythmias (% time) 2.2 + 2.2 34.8 + 11.1
Perfusate lactate output
(yx. mol/g wet wt/hr) 57.0 + 7.4 18.0 + 4.8*
%  oxygen extraction 85.0 + 2.3 84.6 + 0.9
MVOg ( ^  m o l / g / m i n ) 2.94 + 0.08 2.89 + 0.03
MV O  /beat (n mol/g/beat) 13.0 + 0.6 26.9 + *4.1
**
Values, are mean + S.E.M.
Significant differences between the groups are indicated 
as follows:
* PC 0.02
** P <  0.01
Values are for the 0 - 3 0  min. period of the perfusions.
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During 30 min perfusion the resting tension was stable at 2 g in 
the glucose-perfused hearts but there was a highly significant 
rise to 4.98 + 0.76 g in the pyruvate-perfused group. The 
incidence of arrhythmias was also very greatly increased from 
2.2 + 2.2 to 34.8 + 11.1 %  of the time. The heart rate in the 
pyruvate-perfused hearts was only 54% of that of glucose-perfused 
hearts but developed tension was unaffected. Perfusion with 
pyruvate did not affect the %  oxygen extraction or MVO^ but 
MVOg/beat and MVO^/r x T in the pyruvate group was twice that 
of the glucose group. The latter observation was entirely due 
to the lower heart rate of the pyruvate-perfused group.
Compared with the high-flow values (Table 36 ) the MVO^/beat was 
unchanged by flow reduction in the pyruvate hearts whereas it fell 
from 24.3 + 0.7 to 13.0 + 0.6 in the glucose-perfused
hearts. This suggests that most of the energy was derived from 
oxidative metabolism in the pyruvate-perfused hearts and that the 
w o r k  done was closely related to MVO^. In the glucose-perfused 
hearts however, some additional energy was presumably made available 
at low^flow from anaerobic glycolysis. Thus the decline in w o r k  
with flow reduction was not as great as the decline in MVO^.
Perfusate lactate output was significantly lower in the 
pyruvate-perfused hearts. Together with the greater oxygen 
cost per beat this suggests that whilst metabolism of the 
pyruvate group was largely aerobic considerable energy in the 
glucose-perfused group was derived from anaerobic glycolysis, 
with accompanying lactate production .
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The lack of glycolytic capacity under conditions of oxygen 
deficiency in the pyruvate-perfused hearts was associated with 
a much greater rise in resting tension and a very large increase 
in the incidence of arrhythmias.
b ) Responses to adrenaline (Table 40)
Again adrenaline induced a rise in resting tension. This 
was greater in pyruvate-perfused hearts than in those perfused 
with glucose. The post-adrenaline incidence of arrhythmias 
was very similar in pyruvate-and glucose-perfused hearts, at 
approximately 30% of the time. Thus there was virtually no 
further increase with adrenaline in the pyruvate-perfused 
group but a very large increase in the glucose perfused hearts 
from a very low pre-adrenaline level so that the incidence 
reached that of the pyruvate-perfused group. Heart rate and 
developed tension stayed lower in the pyruvate perfused hearts. 
Oxygen extraction and MVO^ were stimulated to the same extent in 
both groups compared w ith pre-adrenaline values. MVO^/beat however, 
tended remain higher in the pyruvate-perfused group.
Perfusate lactate output was almost doubled in the glucose 
group but was virtually unaltered in the pyruvate hearts.
Thus the additional w o r k  imposed by adrenaline infusion 
increased the deterioration in both types of heart but the 
performance and resting tension of the pyruvate-perfused group 
remained markedly worse than the hearts perfused with glucose.
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Table 40
Effect of perfusion with pyruvate (11 mM) on the response to
adrenaline in normally-fed hearts perfused at 4 ml/min.














Rise in resting tension (g)
Final resting tension (g)
Incidence of arrhythmias (% time)
Perfusate lactate output^ 
(J^mol/g wet wt/hr)
%  oxygen extraction 




196 + 32 
4.17 + 0.53 
2.92 + 0.22 
4.74 + 0.22 
30.9 + 8.8
91.1 + 9.6





157 + 14 
3.28 + 0.19 
3.53 + 0.76 
8 .50 + 0.64**
28.6 + 9.8
**30.0 + 3.7
93.9 + 0.4 
3.20 + 0.02
21.0 + 2.1
Values are mean + S.E.M.
* indicates a significant difference between the groups ( P < 0 . 0 1 ) ;  
** indicates P <  0.001
/  The perfusate lactate output is calculated for the entire 
post-adrenaline period (30 - 60 m i n . ) rather than the second 
post-adrenaline phase (40 - 60 min).
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c) Tissue metabolite levels (Table 41).
Table 41 shows that tissue A T P  and creatine phosphate, 
glycogen, lactate and long chain acyl CoA at the end of the 
perfusion were all lower in pyruvate-perfused hearts than in 
glucose-perfused hearts. The lower A T P  and creatine phosphate 
levels are consistent with the higher resting tension. Lactate 
aid long chain acyl CoA were lower in spite of this greater 
deterioration. This indicates that additional factors besides 
accumulation of these metabolites may be responsible for the 
greater deterioration occurring in the pyruvate-perfused hearts. 
The inability to generate A T P  anaerobically from glucose could 
be an important factor as discussed above.
4. Relationships between tissue metabolites and resting tension 
The concentration of tissue metabolites at the end of the 
perfusion in individual hearts have been plotted against the 
corresponding values of the final resting tension to investigate 
the relationships between them.
The final tissue long chain acyl CoA, tissue lactate and 
A T P  all correlated w ith the final resting tension in pyruvate- 
perfused hearts (Figs. 56, 57 and 58) where the points are shown 
about the regression lines obtained with glucose-perfused hearts, 




Effect of perfusion with pyruvate (11 mM) on final tissue
metabolite levels in normally-fed Hearts perfused at 4 ml/min.
Lactate
( ^  mol/g wet wt)
Glucose-perfused Pyruvate-perfused
(n = 9) (n = 5)
2.44 + 0.13 1.05 + 0.19 ***
Long chain acyl CoA 
(n mol/g wet w t ) 14.5 + 0.8 9.25 + 1.89
Long chain acyl carnitine 
(n mol/g wet wt) 242 + 34 183 + 31
Carnitine 
(n mol/g wet w t ) 660 + 70 770 + 120
A T P
( ^  mol/g wet wt) 1.58 + 0.11 0.71 + 0.08 ***
Creatine phosphate 
( ^  mol/g wet wt) 1.71 + 0.09 0.66 + 0.19 **
Glycogen
ijX mol/g wet wt ) 9.23 + 1.37 5.03 + 0.26
Values are mean + S.E.M.
Differences between the groups are indicated as 
follows :
* P <  0.05
** P < 0.01
*** P <  0.001
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Fig. 56.
Effect of final tissue long chain acyl CoA concentration on final










Tissue long chain acyl CoA (n mol/g wet wt)
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Fig. 57
Effect of final tissue lactate concentration on final resting 





Tissue lactate mol/g wet wt)
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Fig. 58
Effect of final tissue AT P  concentration on final resting tension 










0.5 3.01.0 1.5 2.52.0
ATP (/^mol/g wet wt)
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(i) resting tension = 0.532 + 0.20 x long chain fatty acyl CoA +
2.24 + 1.63
r = 0.704 p 0.05 (n = 9)
(ii) resting tension = 3.69 + 1.14 x tissue lactate + 2.89 + 1.08
r = 0.753 p <; 0.01 (n = 10)
(iii) resting tension = -3.36 + 0.93 x A T P  + 11.2 + 1.5
r = -0.805 p <  0.01 (n = 9)
The relationship of A T P  w ith resting tension is close to 
that observed with glucose-perfused hearts, appearing to be 
independent of substrate utilization, flow rate and hormone or 
drug treatment as was observed with the glucose-perfused hearts.
The regression lines for resting tension vs lactate and 
resting tension vs long chain acyl CoA do not appear to fit 
the glucose population. These observations may be explained 
by an additional deteriorating factor operating in the pyruvate- 
perfused hearts resulting in a greater resting tension in these 
hearts for a given lactate or long chain CoA concentration than 
in the glucose-perfused hearts. Such a factor may be the 
reduced capacity for the generation of glycolytic ATP.
DISCUSSION
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SECTION A Effect of flow rate and adrenaline challenge in
normally-fed hearts.
1. Summary of results
Mechanical performance was stable without drug interventions 
for at least 70 min. at flow rates of 9 ml/min and 4 ml/min. 
Resting tension was stable and the incidence of arrhythmias was 
low at both flow rates.
At 4 ml/min glycolysis was stimulated as indicated by the 
increased perfusate glucose uptake and lactate output compared 
with 9 ml/min. There was a reduction in the oxygen cost of 
w o r k  (MVO^/beat) which could be explained by an increased 
contribution of glycolysis to energy production.
Adrenaline infusion elicited a biphasic response at both 
flow rates: 1) a "first phase" of stimulated mechanical
performance followed by a period of decline, followed by 
2 ) a new stable level of performance, "the second phase".
Resting tension was unaffected by adrenaline in the high-flow 
hearts but increased significantly in the low-flow group. 
Adrenaline increased the incidence of arrhythmias at both flow 
rates, but there was no difference in incidence between the 
high-flow and low-flow groups.
Adrenaline stimulated glucose utilisation and lactate output 
at both flow rates but the absolute rates of uptake and output 
remained significantly higher at the flow rate of 4 ml/min.
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At 4 ml/min the fraction of glucose and glycogen that was 
oxidised was increased by adrenaline, but still remained lower 
than the fraction oxidised at 9 ml/min.
Adrenaline increased the oxygen cost of w o r k  (MVO^/beat) 
at 4 ml/min.
End-of-perfusion tissue levels of carnitine, A T P  and creatine 
phosphate were lower and lactate, long chain acyl CoA and long 
chain acyl carnitine were higher in hearts perfused at 4 ml/min.
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2. The Model
The experimental model used in this study was a 
recirculating Langendorff perfusion system in which the 
whole heart was regarded as a metabolically and mechanically 
homogeneous tissue. It has the advantage of providing a 
simple and reproducible system for investigating the overall 
mechanical performance and metabolism of the rat heart. The 
closed system enables rates of perfusate uptake and output to 
be measured over a period of at least 1 hour without the expense 
of large volumes of albumin-containing perfusate. In addition, 
larger and therefore more easily measured changes in perfusate 
concentration of substrates and products occur than in a single 
pass system. The exogenous substrate supplied from the perfusate 
was found to be not greatly depleted. The 'arterial* oxygen 
tension was,maintained by reoxygenation of perfusate on each 
c i r c u i t .
This model does not have the overall pattern of metabolism 
of an infarcted or regionally ischaemic model where there is a 
region of graded flow determined by the collateral circulation 
(Jennings and Ganote, 1976).
In vivo at the cellular level there appears on the basis of 
microscopic examination to be a poorly defined border around 
an infarct, containing a mixture of dead, dying and living cells.
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Evidence from models of regional ischaemia also appears 
to show a gradation from aerobic to anaerobic metabolism on 
the basis of rates of glucose utilization, with metabolic 
changes bearing a direct relationship to the degree of flow 
reduction (Opie, 1976).
Other criteria suggest a sharp border between aerobic and 
anaerobic tissue. Chance (1976$ has argued for a sharp border 
with respect to oxygen utilization operating over inter- 
mitochondrial distances. This border would be within the 
region of intermediate flow and would occur where the oxygen 
supply falls below a critical concentration for mitochondrial 
function, by virtue of the impaired rate of oxygen supply. It 
nay also move as the oxygen demand changes relative to the supply, 
Mitochondria within such cells would be either fully functioning 
or fully inactive but on a statistical level such cells would 
be in an intermediate state between aerobic and anaerobic 
metabolism.
The whole heart ischaemia imposed in our global model has 
been regarded as a uniform flow reduction throughout the heart, 
giving a mechanically and metabolically homogeneous unit 
(Kligfield et al., 1976). However, a border zone has also 
been reported in globally ischaemic models. Thus Nishiki 
et al. (1979) have demonstrated a border between well-perfused 
and poorly-perfused tissue in a globally or ischaemic model
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perfused with red-cell-free solutions. Steenbergen et al 
(1977a) and Steenbergen et al (1978) have also shown the globally 
ischaemic model to have an u neven distribution of coronary 
perfusion, with anoxic areas appearing where the flow was 
most restricted, Barlow and Chance (1976) have shown by 
surface measurements of N A D H  fluorescence that global ischaemia 
is not homogeneous, and that there are areas of varying 
vulnerability to anoxia (Chance, 1976$.
Thus the globally ischaemic model has itself a pattern 
of non-uniform flow which ma y  correspond to a zone of non-uniform 
flow within a regional model of ischaemia. However, the 
average effects on mechanical performance and metabolism of 
flow reduction to a certain level can be determined in the 
global model more readily than in a regional model, where it is 
difficult to sample the perfusate flowing from a particular 
region because of dilution from other regions.
The border which appears to be present in both regional 
and global models of ischaemia m a y  have a special electrophysiological 
significance for the development of re-entrant or slow conduction 
arrhythmias (Bruyneel, 1975; Lubbe et al., 1974). Arrhythmias 
were an important measure of deterioration in our model. Results 
from our model may have some relevance to the 'in vivo' situation 
(Wing to the inhomogeneity of flow common to both systems.
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3. High-flow perfusion
Evidence from in vivo work (Selkurt, 1971) suggests that 
the oxygen requirement of the working heart is approximately 
2 7 0 ^ m o l / g  wet wt/hr. It is likely that the working heart 
in vivo would require more oxygen than the Langendorff model 
as the latter does not perform external contractile work. At 
the high-flow rate of 9 ml/min the rate of oxygen supply was 
approximately 3 9 0 ^ mol/hr. Thus the oxygen supplied to the 
perfusate should have been adequate at this flow rate to meet 
the requirements for oxidative metabolism in this model.
This conclusion was supported by the very low lactate output and 
negligible glycogen degradation, indicating that metabolism 
was almost completely oxidative. In addition, when the flow 
rate was increased from 4 ml/min to 9 ml/min (data not shown) 
the hearts extracted from the perfusate lactate which had been 
produced during the low-flow period. Thus they could oxidise 
lactate at the higher flow rate. This is in agreement with 
B r o w n s e y (1975) in a study of graded ischaemia w h o  suggested 
that the oxygen supply was adequate at flow rates of 7-8 ml/min 
and above. This was based on the observation that the MVO2
rose less per unit of coronary flow as the flow rate was 
increased above 7-8 ml/min. This flow rate was also regarded 
as 'full flow' by Kligfield et al (1976) in a study of graded 
ischaemia in the Langendorff rat heart model.
The present model showed stable resting tension, heart 
rate and developed tension and a stable rate of glucose uptake
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for at least 70 min. Therefore changes in these parameters 
following infusion of a drug or of adrenaline occurring during 
this period could be attributed to the agents themselves.
4, Low-flow perfusion
In this Langendorff model the rates of oxygen and substrate 
supply could be reproducibly controlled by altering the speed of 
the peristaltic pump. Reduction of the flow rate imposes both 
reduced oxygen supply (hypoxia) and reduced substrate supply and 
clearance of metabolites (ischaemia). This differs from simple 
hypoxia in which the flow is unchanged but the oxygen tension 
of the perfusate is reduced.
At the lower flow rate of 4 ml/min the oxygen supply was 
approximately 170y4mol/hr, which is less than the theoretical 
requirement in vivo for full performance. However, the 
reduced oxygen supply was matched by reduced mechanical performance 
so that a new balance between oxygen supply and performance was 
reached. Kligfield et al. (1976) also observed a reduction 
in performance, measured as heart rate x systolic pressure, 
in proportion to the flow reduction. This decline in 
mechanical performance in our model was reversible, since on 
returning to the higher flow rate the original level of 
performance was achieved (data not shown).
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The decline in performance on flow reduction is 
unphysiological because the hearts were free of the humoral control 
which would act to maintain cardiac output as far as possible. 
However, the hearts did extract a greater fraction of the 
perfusate oxygen and as a consequence were more susceptible 
than the high flow hearts to deterioration in conditions of 
increased oxygen demand. Such conditions followed treatment 
with adrenaline.
These results compare with those of Kligfield et al. (1976) 
wh o  showed that oxygen extraction became maximal at approximately 
2 ml/min and that below this flow rate the oxygen consumption 
was directly proportional to flow rate.
Reduction of the flow rate to 4 m l/min resulted in a 
stimulation of glucose uptake and a greater stimulation of 
lactate output into the perfusate. This indicates that 
anaerobic glycolysis was stimulated. Thus the reduced oxygen 
supply led to a Pasteur effect with a stimulation of anaerobic 
pathways of energy generation. That a stimulation of glucose 
uptake occurred indicates that the hearts were subjected 
to only mild ischaemia as reported by Neely et al. (1975).
Thus, the accumulation of lactate and hydrogen ions was 
insufficient to inhibit glycolysis as has been shown to occur 
in more severely ischaemic models (Rovetto et al. 1975). Any 
beneficial effects of accelerated anaeitbic glycolysis were 
therefore able to be expressed in this model.
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5, Effect of adrenaline
Adrenaline produced an increase in the w o r k  done by the 
heart. Oxygen extraction was reproducibly increased to 
almost 100%. This increased oxygen consumption continued 
for longer than the increased mechanical responses to 
adrenaline. It was present for the whole of the 30 min. 
post-adrenaline period in low-flow hearts and only began to 
fall marginally at 15 min after adrenaline in high-flow hearts.
This indicates that adrenaline induced a marked oxygen debt 
where oxygen demand exceeded supply, and that the effect 
persisted to the end of the perfusion.
The stimulation of glucose uptake was also maintained for 
the remainder of the perfusion, which suggests that the stimulation 
of anaerobic glycolysis and anaerobic ATP generation was arranged 
to maximise the energy available for maintenance of A T P  levels.
This stimulation was more extensive in the low-flow hearts 
presumably because they suffered a greater oxygen debt. As 
expected perfusate lactate output was greatly stimulated by 
the adrenaline challenge. It declined during the 30 min post­
adrenaline phase and thus progressively more of the glucose taken 
up was oxidised to lactate. This suggests that the balance 
between energy supply and demand was gradually but relatively 
slowly being restored after the initial adrenaline challenge. 
Despite the progressive decrease in anaerobic metabolism 
judged by decreasing conversion of glucose to lactate, there 
was no improvement in mechanical performance towards the end
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of the perfusion. This suggests that the adrenaline challenge 
caused irreversible deterioration of contractile performance 
in the low-flow hearts. Deterioration of mechanical 
performance after isoproterenol in hypoxic hearts was reported 
by Bing et al (1972).
As the post-adrenaline level of mechanical performance was 
less than before adrenaline it would appear that more oxygen 
was required for less work. The MVO^/bea.t remained elevated 
for the whole of the post-adrenaline phase, suggesting an 
increase in the oxygen cost of work. No increase in MVO^/beat 
was observed by Brownsey (1975) in a similar ischaemic model 
where a decrease in MVO^ occurred after adrenaline challenge.
The results of the present w ork may indicate that there was a 
lipid-induced oxygen wastage after adrenaline (as discussed 
later).
At the end point of the perfusion tissue levels of A T P  and 
creatine phosphate were significantly lower in the low-flow hearts 
than in the high-flow group. This suggests that whole tissue energy 
levels were still markedly depleted as late as 30 min after 
adrenaline challenge. This was in spite of the fall in the 
proportion of glucose appearing as lactate which would suggest 
that a gradual reduction in the degree of hypoxia was occurring.
The large fall in A T P  despite the partial recovery from the 
oxygen debt is further evidence of irreversible damage.
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Further striking evidence of irreversible deterioration 
after adrenaline was the very marked rise in resting tension and 
the increased incidence of arrhythmias in the low-flow hearts.
The resting tension rise occurred almost entirely during the 
10 minute period following the chronotropic (increased heart 
rate) and inotropic (increased developed tension) responses to 
adrenaline. During this period the energy deficit, as judged 
by the rapid rise in oxygen extraction, was most acute, and 
anaerobic glycolysis showed the maximum stimulation.
6. Possible causes of irreversible damage
Possible causes of the irreversible damage were (1) the 
oxygen deficiency,affecting the rate of aerobic A T P  generation,
(2) lactate acidosis and (3) long chain acyl CoA which accumulated 
in the tissue. Both acidosis and long chain acyl CoA have been 
implicated in the mechanism of deterioration in ischaemia (as 
discussed later in this section). In these experiments 
perfusate glycerol output was elevated after adrenaline, 
indicating that endogenous lipolysis was stimulated by the 
action of adrenaline on hormone-sensitive lipase (as described 
in the introduction). In the oxygen-deficient conditions, 
when oxidation of the liberated fatty acids would be impaired, 
the free fatty acids or their long chain acyl CoA derivatives 
might accumulate within the tissue. Indeed higher levels of 
long chain acyl CoA were measured in the low-flow than in the 
high-flow hearts.
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7. Detrimental fatty acid and long chain acyl CoA effects
Shug et al. (1975) showed that accumulated long chain 
acyl CoA inhibited adenine nucleotide translocase (ANT) in 
ischaemic dog heart. The same group subsequently related the 
effect of atractyloside oP inhibiting ANT to decreased tissue 
A T P  and creatine phosphate and ST segment elevation (Shug et 
a l.,1977). This suggests that such inhibition may be an 
important factor during the onset of ischaemia. Rosenshtraukh 
et al. (1978) have suggested that creatine phosphate plays a 
major role in the specific transport of energy from the 
mitochondria via the cytoplasm to sites of utilization such 
as the myofibrils and cell membranes. Inhibition of ANT would 
interrupt this sequence by preventing transfer of freshly 
generated AT P  to the outside of the inner mitochondrial membrane. 
It might be expected that the consequence of such an inhibition 
would include both reduced contractile performance and an 
increased likelihood of arrhythmias because of the dependence 
of the myofibrillar and m e mbrane function on adequate ATP supplies
Idell-Wenger et al (1978) showed that approximately 95% of 
the total tissue CoA is located in the mitochondria. They 
also showed that its distribution is unaffected by ischaemia 
so that the majority of long chain acyl CoA accumulating under 
such conditions is i n t r a m i t o c h o n d r i a l . It is therefore 
generated in the same compartment as AN T  and could influence
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its activity. Inhibition of AN T  could increase the relative 
importance of anaerobically-generated A T P  for energy-using 
sites outside the mitochondria such as the myofibrils or 
membrane-located ion pumps.
Despite the predominantly mitochondrial location of 
long chain acyl CoA an increase in the cytosolic concentration 
of long chain acyl CoA is also theoretically possible in 
ischaemic conditions (Idell-Wenger et al., 1978). Such changes 
in the cytoplasmic levels are also likely to have inhibitory 
effects on enzymes such as glucose 6-phosphate dehydrogenase 
(for references see the introduction) which would directly inhibit 
glycolysis and anaerobic A T P  production. They observed that 
carnitine species were located primarily in the cytoplasm with 
8%  intramitochondrial in aerobic hearts and 25% in ischaemic 
hearts. The long chain acyl CoA levels obtained in our hearts 
(10 - 18 n mol/g wet wt) appear to be slightly lower than those 
reported by Shug et al. (1978) in a Langendorff model. They 
obtained values of 14 n mol/g wet wt. in aerobic tissue and 
35 n mol/g wet wt. in anoxic tissue. It is possible that 
there was some loss during extraction in our model, since losses 
can occur in a few hours (Garland, 1974).
The elevation in long chain carnitine in the cytoplasm 
during ischaemia could inhibit the (Na^, K^)-ATP ase (Wood et al, 
1977) which is intimately involved in the maintenance of 
sarcolemmal and sarcotubular system membrane function. Again
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such an effect could lead to the genesis of arrhythmias by 
disrupting membrane function. (Dhallay1977). The tissue 
long chain acyl carnitine levels obtained in Our model^in 
the order of 150 - 200 n mol/g wet wt^are of the same order 
as those of Shug et al. (1978) in a Langendorff rat heart model 
under aerobic (110 n mol/g wet wt) or anoxic conditions 
(190 n mol/g wet wt).
Accumulation of free fatty acid C FFA ) in ischaemia (which 
may result from reduced activation because of lower CoASH 
levels (Whitmer et al., 1978)) could also lead to arrhythmias. 
Free fatty acids have been shown to inhibit (Na^, K^) - AT P  ase 
(Lamers and Hulsmann., 1977).
The deleterious effects of endogenously-generated fatty 
acids were demonstrated by Brownsey and Brunt (1977). In 
ischaemically perfused hearts from normally-fed rats adrenaline 
challenge increased the rate of endogenous lipolysis, and this 
was associated with deterioration in performance. Both the 
rate of lipolysis and the degree of deterioration were greatly 
reduced by the antilipolytic agent nicotinic acid.
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8. Detrimental effects of lactate acidosis
In the present model lactate accumulation in the tissue 
was minimal with final tissue levels of only 2-3 mol/g wet wt. 
and a tissue : perfusate lactate gradient in the order of 2 : 1. 
These levels were much lower than those reported by Kligfield 
et al., (1976) in the severely ischaemic group in their study 
of graded ischaemia which were in the order of 7 - 1 2 ^ mol/g wet 
wt. The levels of 2 - mol/g wet wt. are in accord with those 
observed in the hypoxic perfused rat heart of Williamson (1966). 
By this criterion our model appeared to be hypoxic rather than 
ischaemic, in contrast to the frankly ischaemic hearts of 
Kligfield et al. which exhibited impaired lactate clearance 
from the tissue. It also indicates that a n y  beneficial effects 
of glycolytic ATP should have been fully expressed.
Williamson et al., (1975) found that tissue levels of 
high energy phosphate compounds were maintained as mechanical 
performance declined with the onset of respiratory acidosis 
(induced by increasing the perfusate pCO^). Steenbergen et al. 
(19771*) confirmed these findings in hearts w ith metabolic 
acidosis (induced by using artificial buffers of low pH). In 
their ischaemic model the fall in effluent pH paralleled the 
decline in pressure development. Thus they proposed that the 
fall in intracellular pH rather than a decline in high energy 
phosphate levels was the primary determinant of the decline in 
mechanical performance during the early stages of ischaemia.
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The decline in performance with flow reduction in our model 
suggests that there was some accumulation of protons in the 
low-flow hearts. However, such proton accumulation must 
have been limited since accumulation of H^ and lactate have 
been reported in the rat heart to be the primary causes of 
glycolytic inhibition, (Rovetto et al, 1975) and no such 
inhibition was observed in our model.
Steenbergen et al (1978) have shown further that changes 
in intracellular energy stores were due primarily to the 
effect of oxygen deficiency resulting from flow reduction 
lather than to intracellular acidosis per se. They were able 
to separate these effects in a model exhibiting severe 
respiratory acidosis. In this model acidosis caused local 
vascular constriction which gave rise to discrete zones of anoxia 
surrounded by well oxygenated tissue. pH gradients within 
the tissue were minimal so that the tissue comprised two distinct 
and relatively homogeneous populations of cells, one of which 
was aerobic, the other anaerobic. In such a model exhibiting 
non-ischaemic respiratory acidosis (at pH 6.75) there was no 
significant impairment of energy production and lactate did not 
accumulate. Thus the fall in high energy phosphate intermediates 
and accumulation of tissue lactate in ischaemic tissue is a 
function of the restricted coronary flow rate and oxygen 
supply, and not of intracellular acidosis per se. Thus the 
depletion of A T P  and creatine phosphate observed in our model
251.
can be accounted for by the hypoxic conditions and the 
additional oxygen demand imposed by adrenaline rather than 
by an accumulation of or of lactate within the tissue. 
However, the decline in mechanical performance was probably 
caused by intracellular acidosis.
9. Further w ork
The relatively long term effects of adrenaline on 
contractile performance, arrhythmias and substrate 
utilization have been measured in this study by extending 
perfusion for 30 min. after adrenaline challenge to enable 
a new steady state to be~reached. This enables changes in 
substrate utilization following adrenaline to be measured.
A  further and more critical evaluation of the factors which 
from this w o r k  appear most likely to be responsible for the 
deterioration or amelioration could be made by freeze clamping 
hearts when performance is deteriorating most rapidly, judged 
for example as the instant at which resting tension is rising 
most rapidly. The metabolites would then be measured at 
the time of maximum expression of any effect on performance.
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SECTION B Perfusion of hearts from fat-fed rats.
1. Summary of results
Before adrenaline challenge fat-fed hearts perfused at the 
lower flow rate of 4 ml/min did not differ in contractile 
performance, resting tension or incidence of arrhythmias from 
the normally-fed hearts.
The fat-fed hearts utilized less glucose and glycogen and 
more endogenous lipid than the normally-fed hearts.
The peak mechanical responses to adrenaline were identical 
to those of the normally-fed group, but they subsequently 
deteriorated further with respect to the rise in resting tension 
and the incidence of arrhythmias.
After adrenaline there was no difference between normally-fed 
and fat-fed in the oxygen consumption but the glucose and glycogen 
utilisation remained lower in the fat-fed group. This suggests that 
lipid oxidation continued to account for a greater fraction of the 
oxygen consumed in the fat-fed hearts.
Further indicators of greater lipid utilisation in the fat-fed 
hearts were the higher final tissue level of long chain acyl CoA 
and lower tissue lactate level.
The smaller amount of glucose utilised by the fat-fed hearts 
before and after adrenaline indicates that they were deriving less 
energy from anaerobic glycolysis.
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2. General
Perfusion of hearts from rats fed prior to perfusion 
on a diet rich in saturated fat provided a model for the 
investigation of the metabolic changes underlying the deterioration 
caused by ischaemia and adrenaline i n f u s i o n . . This was possible 
because an increase in the contribution of lipid to oxidative 
metabolism,on the evidence of reduced carbohydrate oxidation 
with unchanged oxygen consumption, was accompanied in these 
hearts by changes in performance. The fat-fed hearts continued 
to obtain some energy from carbohydrate oxidation although the 
proportion was markedly less than the normally-fed hearts, as 
demonstrated by the lower rates of glucose and glycogen oxidation 
than the normally-fed group. This model was less dependent on 
lipid than the fat-fed hearts of Brownsey and Brunt (1977) which 
was almost entirely dependent upon endogenous lipid.
3. Low-flow perfusion
The mechanical performance at low-flow in the absence of 
any further challenge was stable for at least 70 min. and did 
not differ in any of the measured parameters from the normally 
fed group. In contrast the fat-fed hearts of Brownsey and 
Brunt showed depressed performance in comparison with their 
normally-fed group and continued to deteriorate further with 
increasing perfusion time. In our model these differences 
in substrate utilization were present throughout the perfusion 
but were expressed as differences in performance only after 
adrenaline challenge. An advantage of this less extreme fat-fed 
model is that any difference between normally-fed and fat-fed
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hearts in the mechanical response to adrenaline could be easily 
assessed and could be attributed to the difference in substrate 
utilization.
4. Responses to adrenaline
The peak mechanical responses to adrenaline did not differ 
from those of the normally fed group so that an equal amount of 
w ork was done by both groups.
There was no difference between the groups in the post­
adrenaline deterioration in heart rate and developed tension.
However, the rise in resting tension and the incidence of 
arrhythmias were very much greater in the fat-fed than in the 
normally-fed hearts. As observed in the normally-fed group 
the resting tension rise occurred almost entirely during the 
10 minute period following the adrenaline infusion.
The end point tissue A T P  levels were further depressed, 
indicating that the fat-fed group were even less able to 
maintain A T P  levels after adrenaline challenge.
Adrenaline stimulated the oxygen extraction to the same 
degree in both groups but in the fat-fed group carbohydrate accounted 
for much less of the oxygen consumed. Therefore a greater 
percentage of the oxygen consumed must have been accounted for 
by lipid oxidation. Thus after adrenaline the fat-fed hearts 
continued to show the shift to more lipid utilization. Less
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efficient AT P  generation due to the lower P/0 ratio of lipid 
oxidation compared witn carbohydrate oxidation could nave 
contributed to the lower AT P  levels.
Snow (1978) has shown that the short chain fatty acid 
butyrate gave a higher MVO^ than glucose in rabbit papillary muscle 
under normoxic conditions. This was attributed to a greater 
oxidation of N A D H  by the respiratory chain for a given increment 
of  work. Thus both mechanical performance and metabolism were 
affected by the redox state of the cell. Similar results have 
been reported by Bing et al. (1976), by Hassinen and Hiltunen 
(1975) and Williamson et al (1976) who also showed a regulatory effect 
of electron transport on respiration. Snow also observed the effect 
in hypoxic muscle. Additional mechanical damage in butyrate- 
perfused tissue during hypoxia was attributed to a greater energy 
deficit between supply and demand than with glucose resulting 
from the greater oxygen cost of work with butyrate as substrate.
Thus the difference in MVO^ between glucose and butyrate became 
important only in oxygen-limiting conditions.
In addition, the total capacity for generation of A T P  from 
anaerobic glycolysis was markedly reduced in the fat-fed hearts, 
since the total carbohydrate utilization was lower than in the 
normally-fed group with the same proportion converted to lactate. 
Impaired glycolytic A T P  generation has been implicated in the 
mechanism of deterioration in ischaemic hearts. Thus Apstein
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et al (1976) reported the deterioration of performance of 
hypoxic hearts after administration of the ^  -agonist 
i s o p r e n a l i n e , Amelioration of the deterioration of performance 
was observed in the presence of high glucose concentrations.
This has been argued to indicate that glycolytic A T P  is important 
in the maintenance of mechanical performance. It might be 
anticipated that such an effect would occur if the mobilization 
of FFA and FFA derivatives was reduced by such glycolytic 
intermediate mobilization.
The final tissue level of long chain acyl CoA was also higher 
in the fat-fed group. The data on oxygen uptake and carbohydrate 
utilization suggest that there was also more lipid oxidation in 
the highly deteriorated fat-fed hearts. Taken together these 
observations suggest that the increase in mobilization of 
endogenous lipid was greater than the increase in fatty acid 
oxidation. The excess long chain acyl Co A  accumulation above 
that seen in the normally-fed hearts could be a further reason 
for the poorer mechanical performance of the fat-fed group.
Whitmer et al. (1978) using a perfused rat heart model 
observed only a slight increase in tissue triglyceride in 
ischaemia with no significant alteration in the incorporation 
of labelled exogenous palmitate into triglyceride. They 
propose that this is due to the cytoplasmic location of 
0^-glycerophosphate and the primarily mitochondrial location 
of long chain acyl CoA which would restrict the rate of estér­
ification. The lower rate of incorporation of label would 
suggest that in these conditions futile cycling of fatty
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acid with the triglyceride pool was not a major mechanism 
for an oxygen wasting effect of fatty acid. However, there 
was no catecholamine challenge in their system in contrast 
to the present model, where a significant increase in glycerol 
output was observed after adrenaline in both normally-fed and 
fat-fed hearts. Such catecholamine-stimulated lipolysis has 
been demonstrated in the isolated rat heart by many groups 
(See Introduction). The triglyceride concentration in 
ischaemia has, however, been shown to remain almost unchanged 
(see Introduction). Taken together these observations suggest 
an increased turnover of tissue triglyceride and fatty acid 
(Opie, 1975) which could result in a futile cycle with energy 
wastage in the cytoplasm.
Kjekshus et a l . (1980) have shown that the changes in 
respiratory quotient on increased FFA utilization in the presence 
of catecholamines were too small to account for the increased 
oxygen uptake. They suggest that the prerequisite for the 
calorigenic action of fatty acids is the stimulation of hormone 
sensitive lipase: in the absence of catecholamines there is an
inhibition of intracellular LPL by increased levels of 
intracellular fatty acids (Nikkila et al., 1968) which limits 
further endogenous T G  breakdown. Catecholamines stimulate 
the intracellular HSL however, (Khoo et aL, 1977) overcoming 
the inhibition and recycling FFA. Under oxygen limiting
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conditions with inhibition of ÏFA oxidation and with elevated 
levels of glycerophosphate the necessary preconditions for 
triglyceride synthesis would exist. These conditions would 
lead to triglyceride -FFA cycling and hence energy wastage.
Such conditions would be similar to those of our model after 
adrenaline challenge so that such oxygen and energy wastage could 
h a v e  contributed to the observed deterioration in performance of 
the fat-fed group.
Opie et al (1979) observed an oxygen wasting effect in 
well-oxygenated catecholamine-treated working rat hearts. This 
was manifested as a reduction in mechanical efficiency. They 
attributed the effect to increased calcium influx as well as 
to increased lipolysis. However, in a coronary artery ligated 
model no clear evidence for the role of calcium in the 
impairment of performance could be obtained.
A  similar oxygen wasting effect is suggested by the results 
of Takenaka and Takeo (1976) who found enhanced incorporation of 
exogenous fatty acid into endogenous triglyceride following 
isoproterenol infusion in well oxygenated rat hearts perfused 
with glucose. Enhanced triglyceride turnover after adrenaline 
has been described by Mathur and Mokler (1975).
Uncoupling of oxidative phosphorylation has been observed 
in mitochondria w i thin 1 hr of coronary artery ligation (Lochner 
et al., 1975), Since both fatty acids and increased catecholamine
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levels occur in sucn conditions they could be among the
causative factors. Wolkowicz and McMillin Wood (1980)
Have shown that elevated levels of palmitoyl CoA may act 
2+on a specific Ca -carrier complex at the inner mitochondrial
2+membrane to increase rates of Ca cycling in and out of
mitochondria. Asimakis and Sordahl (1977) observed that
2 +palmitoyl CoA could discharge accumulated Ca from isolated
mitochondria by a mechanism associated with ANT. Such cycling 
2+of Ca would be energy wasting and contribute to impaired 
mechanical performance. Similar effects were found for long 
chain acyl CoA by Harris (1977).
Bremer (1976) has suggested that there may be a fatty acid 
dependent N ADH oxidation sequence in mitochondria involving 
N ADH : N A D P  transhydrogenase, an NADP-linked enoyl CoA 
reductase and acyl CoA dehydrogenase with an effective P : O 
ratio of 1 rather than 3, which may make some contribution 
towards the oxygen-wasting effect of fatty acids.
Our results confirm the findings of Brownsey and Brunt (1977) 
with a model of graded ischaemia in rats fed on a normal or 
high fat diet. In their model the hearts from rats fed a diet 
rich in saturated fat had higher endogenous triglyceride stores 
and a higher basal lipolytic rate. Such hearts showed evidence 
of a deteriorating heart rate and a significant rise in resting 
tension in the absence of adrenaline. The MVO^ was 50% higher
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than in the normal hearts indicating a significant oxygen-
wasting effect (see later in discussion). Their absolute
nechanical response to adrenaline was depressed but despite the
smaller additional w o r k  load the heart-rate fell further and
there was a highly significant increase in ventricular
arrhythmias and fibrillation. This was accompanied by a further
i n c r e a s e  in FFA release and in the MVO„ and MVO^/beat. Thus2 2
fatty acids could have been responsible for the oxygen wastage 
in this model also and could have contributed to the additional 
deterioration.
The final tissue lactate level was lower in the fat-fed group 
than in the normally-fed group. Since the fat-fed group showed 
greater deterioration it appears that tissue lactate accumulation 
per se was not the primary cause of deterioration in this model.
It could, however, have been a contributory factor. (See sections 
A  and E of discussion).
5, Summary
The fat-fed model confirmed many of the observations of 
the normally-fed model. Thus there was an irreversible deterioration 
in both models after adrenaline challenge. It is argued that the 
increased energy demand resulting from adrenaline challenge exceeded 
the capacity of the tissue to respond by increased energy output.
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Of the measured parameters of mechanical performance only 
the incidence of arrhythmias and the rise in resting tension 
appeared to be closely related to the degree of energy depletion, as 
measured by the final tissue A T P  level.
The greater mechanical deterioration in the fat*fed group 
was associated with a number of metabolic changes. There was 
a reduced capacity for the anaerobic generation of glycolytic 
ATP. The intermediates of endogenous lipid utilization, measured 
as long chain acyl CoA showed a greater accumulation. There 
was also an increase in the fraction of oxygen devoted to lipid 
oxidation. Each of these three metabolic changes has been 
implicated in the mechanism of mechanical deterioration in 
ischaemic hearts. It is not possible to distinguish between 
them in this work.
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SECTION C Effect of pacing 
1. Summary of results
At the higher flow rate (9 ml/min) in both normally-fed
a n d  fat-fed hearts the increase in heart rate to 350 bt/min
was accompanied by a decrease in developed tension. The 
resting tension and incidence of arrhythmias were unaffected.
The %  oxygen extraction and MVO^ were increased but there were 
no other significant metabolic changes.
After adrenaline challenge the rise in resting tension and
the increase in the incidence of arrhythmias did not differ from
the unpaced hearts. Final tissue metabolite levels were also 
unaffected.
At the lower flow rate (4 ml/min) developed tension decreased 
at the onset of pacing. Resting tension was unaffected in the 
normally-fed but rose slightly in the fat-fed group. The 
incidence of arrhythmias was unaffected in both normally-fed and 
fat-fed hearts. The %  oxygen extraction and MVO^ were increased 
and MVO^/beat decreased but there were no other significant 
metabolic changes.
After adrenaline the incidence of arrhythmias was unaffected 
by pacing. The total rise in resting tension in paced hearts 
remained significantly greater in the fat-fed than in the normally- 
fed group. Glycogen mobilisation was increased in the normally-fed
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hearts but there were no other differences in substrate 
utilization from that of the unpaced hearts. The %  oxygen 
extraction and MVO^ remained higher in paced hearts after 
adrenaline.
When the heart rate was increased by pacing the oxygen 
consumption increased. The product of heart rate and developed 
tension was unchanged. These observations suggest that an 
increase in heart rate increases oxygen consumption more than 
an increase in developed tension.
264.
2. Effect of pacing on performance and metabolism
In the previous section changes in the energy status of the 
cell were shown to be less closely related to heart rate and 
developed tension (DT) than to resting tension and the incidence 
of arrhythmias. However, changes in performance as measured 
by heart rate and DT were difficult to assess because both were 
affected when the flow rate was reduced or w h e n  adrenaline was 
infused. To simplify the interpretation of such changes the 
heart rate was maintained in some experiments by pacing at a 
constant level of 350 bt/min throughout the perfusion and at 
both flow rates. Thus changes in mechanical performance were 
expressed solely as changes in developed tension. Taylor and 
Cerny (1976) have shown that the performance of the Langendorff 
rat heart model is stable at heart rates of up to 450 bt/min.
When pacing was initiated the DT fell to compensate for 
the increase in heart rate so that the product of heart rate 
and developed tension was almost unchanged. However, this 
adjustment involved greater energy consumption, since oxygen 
consumption always increased significantly.
Since more w ork was performed and a greater fraction of 
the oxygen was extracted,oxygen supply was not the primary 
factor limiting the w o r k  done in this system.
265.
The increased 0^ consumption of the paced hearts is in 
agreement with observations made in vivo that heart rate is 
more important than developed tension as a determinant of 
oxygen consumption. (Sonnenblick and Skelton,1971). The 
increased oxygen extraction before adrenaline was the only 
statistically significant metabolic effect of pacing to be 
observed. The greater MVO^ suggests that the higher heart 
rate with pacing imposed a greater e n ergy demand upon the 
heart. Thus the pre-adrenaline rise in resting tension observed 
in the fat-fed group is likely to be caused by a depletion of 
tissue energy levels. The contracture could be explained by 
the increased energy demand at the higher heart rate exceeding 
the capacity to increase supply. A T P  was not measured at the 
end of the pre-adrenaline phase to confirm this. This deterioration 
was greater" in fat-fed hearts, which provides further evidence that 
the fat-fed group had a poorer capacity than the normally-fed group 
to respond to increased w ork demand by increasing the rate of 
energy supply.
3. Effect of adrenaline
The total rise in resting tension during the perfusion 
was marginally greater in paced than in unpaced hearts for both 
normally-fed and fat-fed groups. This again suggests a greater 
energy demand in paced hearts. These results are consistent 
w ith those of Kannengiesser et al (1975). They showed that it 
was the chronotropic rather than the inotropic effect of 
isoproterenol that led to the greater imbalance between oxygen 
supply and demand although the inotropic effect did make some
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demand. The chronotropic effect of the drug was suggested 
to be the cause of the subsequent negative inotropic effect.
An additional cause of the increased resting tension rise 
in paced hearts could be tachycardia-induced regional ischaemia. 
This would occur particularly in the subendocardium as a result of 
the shorter diastolic filling time.
Pacing had only a marginal effect on the metabolism of 
the hearts after adrenaline. End-of-perfusion levels of ATP, 
lactate and long chain a cyl CoA were not greatly affected. Any 
stimulation of carbohydrate utilization was slight. Thus 
variations between hearts in the responses of heart rate and 
developed tension to the interventions in these experiments 
were not reflected in the metabolism of the hearts.
4. Summary
Pacing simplified the interpretation of the mechanical 
responses and had no effect on the incidence of arrhythmias.
It had minor but expected effects on metabolism before 
adrenaline. The behaviour of the paced hearts confirmed 
conclusions made from unpaced hearts regarding the metabolism 
of the normally- and fat-fed groups.
It increased the rise in resting tension after adrenaline 
but did not affect the differences between the normally- and 
fat-fed groups.
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A  comparison of the performance of the paced hearts 
w ith that of the unpaced hearts shows that there was no 
clear relationship between contractile performance (heart 
rate and developed tension) and the extent of deterioration 
of the hearts measured as the fall in ATP, rise in resting 
tension or arrhythmias.
The results also demonstrate that both paced and unpaced 
hearts have a mechanism for partially balancing energy supply 
and demand so that similar changes in performance were observed 
in paced and unpaced hearts. This validates conclusions with 
regard to mechanical performance made in subsequent experiments 
on unpaced h e a r t s .
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SECTION D Effect of antilipolytic agents in hearts perfused
at 4 ml/min.
1. Summary of results
In normally-fed and fat-fed hearts perfused at 4 ml/min 
dichloroacetate (DCA) and 2-bromopalmitate (2-BP) did not affect 
pre-adrenaline performance or oxygen consumption. Both agents 
increased carbohydrate oxidation, apparently at the expense of 
endogenous lipid.
The first phase mechanical response to adrenaline was 
unaffected by either agent.
Resting tension rose further after adrenaline in normally-fed 
hearts treated with these agents but the final levels were lower 
than in the fat-fed control group. In the drug-treated fat-fed 
hearts, the'rise in resting tension was significantly less than 
in the fat-fed controls. Both drugs significantly reduced the 
post-adrenaline incidence o f  arrhythmias, with 2-BP showing a 
greater effect than DCA.
During the second phase DCA had no significant overall effect 
on contractile performance: an improvement in heart rate in the
normally-fed group was offset by a further decline in developed 
tension. In 2-BP-treated hearts the heart-rate was better 
maintained than in the controls, but in the normally-fed group 
this was accompanied by a trend towards a decline in developed tension
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The post-adrenaline rate of glycogen mobilisation was 
unaffected by DCA but was increased by 2-BP.
The fraction of glucose that was oxidised after adrenaline 
appeared to be increased in normally-fed hearts treated with DCA 
compared with their controls. In fat-fed hearts DCA appeared to 
increase glucose + glycogen utilisation and therefore glycolytic 
A T P  production. It also increased glucose oxidation, compared 
with the control group.
In normally-fed hearts 2 -BP increased glucose + glycogen 
utilization after adrenaline so that glycolytic A T P  generation 
would be increased. It reduced the stimulation of lactate output 
compared with the control group, suggesting that there was also 
greater carbohydrate oxidation. In fat-fed hearts the significantly 
greater lactate output indicated that glycolytic A T P  production was 
s timu l a t e d .
Both DCA and 2 -BP abolished the increase in MVO^/beat observed 
after adrenaline in control hearts.
Final tissue metabolite levels in hearts treated with these 
agents showed evidence of their continuing antilipolytic effects, 
and of greater carbohydrate oxidation. Thus both agents 
significantly reduced final tissue levels of lactate. In DCA- 
treated hearts long chain acyl CoA was lower. In 2-BP-treated
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hearts long chain acyl CoA levels were higher but this may have 
been an artefact caused by the drug itself,
A T P  levels tended to be better maintained in the drug 
treated hearts than in their controls.
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2. General
In section B the rise in resting tension and increased 
incidence of arrhythmias were observed to be most strongly 
associated with increased lipid utilization and a reduced 
capacity to generate glycolytic ATP. In the deteriorated 
hearts there was an accumulation within the tissue of long 
chain acyl CoA. A  greater fraction of the glucose and glycogen 
consumed appeared as lactate, suggesting an increased fraction 
of oxygen devoted to lipid oxidation and a reduced rate of 
glycolytic AT P  generation. In an attempt to ameliorate the 
deterioration which may have resulted from these factors hearts 
were treated with the antilipolytic agents DCA and 2-BP.
DCA stimulates PDH activity thereby stimulating carbohydrate 
oxidation and shifting oxidative m e tabolism away from lipid 
(see Introduction).
2-BP inhibits fatty acid oxidation thereby producing a secondary 
shift towards greater carbohydrate u tilization (see Introduction).
3. Pre-adrenaline effects
Treatment of normally-fed and fat-fed hearts at low-flow 
with either drug did not cause any significant change in mechanical 
performance. Thus the drugs did not show any toxic side-effects 
in this assay. Both agents however had the expected metabolic 
effect of increasing carbohydrate oxidation, measured as a
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decrease in the proportion of glucose and glycogen consumed 
which appeared as lactate. This was presumably at the expense, 
of lipid oxidation, as the oxygen consumption was unchanged.
The first 20 min of the perfusion acted as a control 
phase for each heart in the DCA and 2-BP perfusions.
4. Peak adrenaline response.
Neither drug had any effect on the inotropic or chronotropic 
response to adrenaline of normally-fed or fat-fed hearts. The 
increase in energy demand imposed by adrenaline was therefore 
unaffected by the drugs.
The different actions of DCA and 2BP on the stimulation 
of glucose -and glycogen utilization and the resulting effects 
on performance may be explained from the known modes of action 
of these agents on carbohydrate and lipid metabolism.
5. Dichloroacetate
The significant changes in mechanical performance in DCA- 
perfused hearts were marked ameliorative effects on the post­
adrenaline rise in resting tension in the fat-fed group (Results 
Section 4c) and a large reduction in the incidence of arrhythmias 
(Results Section 4 d ) in both normal and fat-fed hearts.
273.
In the normally-fed hearts during the post-adrenaline 
phase DCA caused no further stimulation of glucose utilization 
than was observed in the control group but a smaller fraction 
may have been converted to lactate, which is consistent with 
a greater fraction oxidised and with PDH stimulation (Results 
Section D,4,f, g and h).
In the fat-fed hearts there was a trend towards a greater 
post-adrenaline stimulation of glucose utilization with DCA 
than in the controls which would increase glycolytic A T P  
production. The stimulation of perfusate lactate output was un­
changed suggesting that there was also a further shift towards 
more carbohydrate oxidation.
The lower final tissue levels of long chain acyl CoA and 
of lactate in normally-fed and fat-fed hearts treated with DCA 
are also consistent with a shift to more carbohydrate oxidation 
at the expense of lipid. Such a stimulation of carbohydrate 
oxidation would result from stimulation of PDH by DCA. This 
model can be compared with that of McAllister et al. (1973).
In hearts perfused w ith glucose, insulin and acetate, DCA was 
shown to shift substrate utilization from oxidation of acetate 
towards greater glucose oxidation. The proposed mechanism 
involves a reduction in tissue citrate concentration. This 
would cause a relief of the citrate-induced inhibition of PF K 
resulting in an acceleration of glycolysis and a lowering of 
glucose-6-phosphate concentration. Since the hearts were 
insulinised, the greater glycolytic rate would be met by a
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stimulation of glucose uptake, rather than by an increase in 
glycogen breakdown as was observed in alloxan-diabetic rat hearts 
under hypoxic conditions by Allison et al. (1976). A  similar 
result was observed in the present model (Results Section D.4.e) 
The DCA-treated hearts had significantly better maintained final 
tissue AT P  levels (Results Section D.4.1). This is consistent 
with the greater energy supply derived from increased glycolysis 
or carbohydrate oxidation.
The fat-fed hearts showed a greater stimulation of 
carbohydrate utilization than the controls both as increased 
glycolysis and as a shift to more carbohydrate oxidation. They 
also showed an amelioration in resting tension to the level 
observed in the normally-fed group.
The contribution of glycolytic A T P  generation may be 
particularly important. Other workers have shown that it 
contributes significantly to rescuing ischaemic hearts. Thus 
glycolytic A T P  provided 24% of the total A T P  in ischaemic 
(20% of full-flow) glucose-perfused hearts of Bricknell and 
Opie (1978) and up to 60% in hearts w i t h  a partially inhibited 
respiratory chain (Nishiki, 1979). Glycolytic ATP can account 
for half the total energy needs of the Langendorff perfused rat 
heart (Opie, 1971/2).
The w ork of Grey et al. (1977) showed that the development 
of hypoxic contracture was related primarily to the ratio of
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energy supply and demand. The fat-fed hearts treated with 
DCA in this w ork showed an improvement in resting tension and also 
had a greater stimulation of glycolytic A T P  production than 
their control group. The normally-fed hearts did not show a 
fu r t h e r  increase in glycolytic AT P  production after adrenaline 
and showed no improvement in resting tension compared with their 
controls. Thus glycolytic A T P  may have been the major ameliorating 
factor in the fat-fed hearts in the conditions of the increased 
energy demand of the adrenaline challenge.
The reduction in the incidence of arrhythmias brought about 
by DCA treatment in both normal and fat-fed hearts may also be 
related to the increased glycolytic A T P  production since glycolytic 
A T P  has been proposed to have a special role in the maintenance 
of membrane electrical activity (see Introduction).
The improvements observed with DCA may also have been 
especially associated with the reduced accumulation of lipid 
metabolites such as long chain acyl CoA as discussed in Section A. 
Long chain acyl CoA has been shown to inhibit intracellular 
adenylate translocation and therefore energy production.
Since the P/0 ratios for carbohydrate and lipid oxidation 
are 3.0 and 2.8 respectively, it is possible that the shift from 
lipid to carbohydrate may have had some effect on the amount of 
ATP generation oxidatively. Such an effect was discussed in 
Section B.
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Under the oxygen-limiting conditions of this system 
beta-oxidation is the rate-limiting step of endogenous lipid 
utilization. Since long chain CoA accumulation was lower in 
DCA-treated hearts than in untreated controls, it appears that 
the net rate of endogenous lipolysis declined at least as much 
as that ofyg-oxidation.
6 . 2-Bromopalmitate
In 2 -BP treated hearts there were very marked reductions 
in the incidence of arrhythmias after adrenaline in both 
normally-fed and fat-fed hearts. The improvement was greater 
than that observed with DCA. The rise in resting tension 
was significantly reduced in the fat-fed hearts to that 
observed in the normally-fed group.
In the normally-fed hearts treated with 2-BP there 
was a slight increase in post-adrenaline glucose and glycogen 
utilization, suggesting a continued increase in carbohydrate 
oxidation. There was also a greater conversion of the 
carbohydrate substrates to lactate by 2-BP which was more 
extensive than in DCA treated hearts. In the fat-fed hearts 
2 - B P  did not appear to affect the post-adrenaline stimulation 
by adrenaline of carbohydrate utilization. The increase in 
lactate output was significantly greater, however, which suggests 
that anaerobic glycolysis was stimulated. The lower final 
tissue lactate levels in normal and fat-fed 2-BP treated hearts
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are consistent with greater oxidation of the carbohydrate 
utilized. Tissue A T P  levels were also better maintained 
than in the controls. Thus 2-BP appeared to stimulate 
both carbohydrate oxidation and anaerobic glycolysis.
These results further support the argument from the DCA” 
treated hearts that glycolytic ATP has a special role in the 
prevention of contracture and in the maintenance of membrane
function. In addition, the greatest reduction in the incidence
of arrhythmias was observed in the 2-BP treated hearts, which 
were those with the greatest stimulation of glycolytic A T P
There was no detectable change in the amount of energy 
generated oxidatively since the oxygen extraction did not 
change. However there could have been an improvement in 
efficiency of energy generation is a consequence of the shift
from lipid to carbohydrate as discussed for DCA. Thus the
predominant metabolic effect of 2-BP appears to have been to 
stimulate glycolytic A T P  generation.
The fat-fed hearts treated with 2-BP also appeared to 
have a better maintained heart rate after adrenaline. A 
marked de-repression of glycolysis and a stimulation of 
carbohydrate oxidation by 2-BP was shown by Higgins et al. (1978) 
in hearts from starved rats perfused with glucose, insulin and 
palmitate. In addition the mechanical efficiency was significantly 
improved. Glycolysis was also markedly de-repressed. They
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argued that the glycolytic ATP so generated m a y  have contributed 
to the improved efficiency. They also suggested that 
inhibition of fatty acid oxidation or of carnitine palmitoyl 
transferase I by 2-BP which would give lower intramitochondrial 
long chain acyl CoA levels could relieve the inhibition of 
mitochondrial adenine nucleotide transferase by long chain acyl 
CoA which may occur in tissue met a b o l i s i n g  predominantly 
fatty acids (Shrago Relief of such inhibition would
enhance the transport of oxidatively-generated AT P  to the 
contractile apparatus in the cytoplasm.
They did not observe improved e f f i c i e n c y  with DCA, which 
stimulated carbohydrate oxidation to a similar extent but did 
not produce such an increase in the rate of glycolysis. DCA 
also had "no overall effect on the ef f i c i e n c y  of contractile 
performance in our model. The lack of saving effect on resting 
tension in normally-fed hearts perfused w i t h  DCA or 2-BP may 
suggest that glycolytic ATP is more c l o sely linked to a 
membrane-associated pool than to the myofibrils.
The final long chain acyl CoA levels in 2-BP treated 
hearts appear to be higher than in the controls. This is 
likely to be due to the accumulation of 2 - B P  CoA which would 
be measured as fatty acyl CoA in the a s s a y  system used.
Fatty acids and presumably 2-BP are taken u p  by concentration- 
dependent diffusion across the cardiac cell membrane. A
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perfusate 2-BP concentration of 2 m M  is approximately one 
hundred times the intracellular level of 15 - 2 mol/1 of long 
chain acyl CoA, It is therefore possible that the uptake 
and activation to 2-bromopalmitoyl CoA of only a very small 
fraction of the 2 -BP could cause a relatively large %  change 
in the apparent tissue long chain acyl CoA concentration. It 
is unfortunate that this does not allow any objective observation 
of the state of lipolysis.
The reduction in the intramitochondrial long chain acyl 
CoA concentration which ma y  result from the inhibition of 
fatty acid oxidation by 2-BP could result in an increase in the 
intramitochondrial free CoA concentration. Such an effect 
would reduce the acetyl CoA/CoA ratio, which could activate 
PDH via inhibition of PDH kinase (Cooper et al., 1975).
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SECTION E Relationships between mechanical and metabolic parameters 
1. Summary of results
In normally-fed hearts carbohydrate utilization and perfusate 
lactate output were both inversely related to the degree of 
deterioration measured as resting tension. These relationships 
did not hold for the fat-fed hearts. A  given rate of carbohydrate 
utilization was associated with a higher resting tension in the 
fat-fed hearts than in the normally-fed hearts which suggests that 
there was some factor in the fat-fed hearts which caused the 
additional deterioration.
The final resting tension correlated well with final tissue 
A T P  concentration irrespective of nutritional history, perfusion 
flow rate or drug treatment.
There were direct correlations between resting tension and 
tissue long chain acyl CoA, lactate and long chain acyl carnitine. 
The same regression line for resting tension with long chain acyl 
CoA or long chain acyl carnitine appeared to fit both the normally- 
fed and the fat-fed groups.
Free carnitine appeared to be inversely related to the 
final resting tension.
Oxygen extraction did not correlate w i t h  final resting 
tension.
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The incidence of arrhythmias, developed tension and heart 
rate x developed tension did not show any significant correlation 
with any of the metabolic parameters.
The final tissue A T P  concentration was inversely related 
to tissue long chain acyl CoA, lactate and long chain acyl 
carnitine in normally-fed and fat-fed hearts and showed a weaker 
direct correlation with free carnitine in the normally-fed group. 
The same regression line for A T P  with long chain acyl CoA or 
long chain acyl carnitine appeared to fit both the normally-fed 
and fat-fed groups.
Long chain acyl CoA showed a highly significant direct 
correlation with tissue lactate in normally-fed and fat-fed 
hearts but the slopes of the regression lines were significantly 
different. Thus for all perfusion conditions the fat-fed hearts 
had a higher long chain acyl CoA and lower tissue lactate levels 
than the normally-fed hearts.
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2. General
The application of linear regression analysis to the data 
drawn from individual hearts perfused under a number of different 
conditions enables a more extensive investigation to be made 
of relationships between metabolic and mechanical parameters.
Included in the analysis are data from hearts perfused
under conditions not so far discussed. They are from hearts
perfused with insulin (100 mU/ml) added at the start of
“  6recirculating perfusion, with nicotinic acid (5 x 10 M) 
according to the usual drug protocol, w i t h  a higher adrenaline 
concentration (10 ^M), or with an elevated perfusate calcium 
concentration.
Insulin was included to determine whether the hearts were 
fully insulinised by endogenous insulin. There were increases 
in glucose uptake and lactate output in both normally-fed and 
fat-fed hearts. The difference between the two groups was 
maintained however. The mechanical performance before and 
after adrenaline was not affected by insulin in either group.
The continued impairment of glucose uptake in the fat-fed hearts 
suggests some insulin resistance in that group.
Nicotinic acid has been reported to inhibit lipolysis 
(Kjekshus and Mjjrfs,1973). No effect was observed on performance 
or metabolism in this model, however.
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The higher adrenaline concentration caused greater 
deterioration in performance but the differences between the 
normal and fat-fed groups were lost, reducing the usefulness 
of the model.
A  higher perfusate calcium concentration (40% increase 
to 56mM) introduced as a bol.us injection had no clearly 
reproducible effect on performance beyond a brief inotropic 
effect.
3. Correlations between resting tension and final tissue 
metabolite concentrations (Results Section E.3.a-e ),
The very close inverse correlation between final resting 
tension and the final tissue A T P  level irrespective of flow 
rate, drug treatment, adrenaline dose or predisposition of the 
tissue to metabolise lipid or carbohydrate indicates that 
resting tension could be used as a non-invasive index of tissue 
A T P  and hence of energy status during a perfusion. Hearse 
et al. (1977) have shown that the time of onset of contracture 
was related to the energy status of the heart. The onset 
of contracture appeared to occur when whole tissue A T P  levels 
had fallen to 2.4y^mol/g wet weight irrespective of the 
perfusion conditions. This is in agreement with the present 
work, where extrapolation of the regression line for ATP vs 
resting tension shows the onset of above the initial resting tension 
of 2 gram at 3.1-3.3^4mol ATP/g wet wt. It has been argued 
that the development of contracture is accompanied by an
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acceleration of A T P  hydrolysis resulting from the formation 
of the rigor complexes themselves (Katz and Tada, 1977). These 
could contribute further to the depletion of A T P  in the 
cytoplasmic compartment in conditions of inhibited energy 
transfer from the mitochondria to the cytoplasm, as could 
occur in ischaemic hearts with elevated long chain acyl CoA 
levels (See Section A). This could further predispose the 
heart toward the genesis of arrhythmias (See Section F).
The w o r k  of Grey et al. (1977) also supports the hypothesis 
that contracture is related primarily to the energy status of 
t h e  heart.
Calcium ions have also been shown to be involved in the
extent of contracture (Hearse et al. 1977). However, the
decline in A T P  levels appears to be the primary cause of
2+contracture. Thus Nayler et al. (1978) removed Ca from
the extracellular phase of hearts after 5 minutes of hypoxia
when the developed tension had already fallen. The rise in
resting tension was not prevented. In our model a 40% .
2+increase in perfusate Ca concentration did not appear to 
increase the extent of contracture. Thus the system 
appeared to be saturated with respect to calcium ions.
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4. Substrate utilization and mechanical performance 
(Results Section E.2)
Regression analysis of the dependence of resting tension 
on glucose + glycogen consumption in individual hearts supports 
the argument that in normally-fed hearts an increase in 
carbohydrate utilization reduces the post-adrenaline rise in 
resting tension. As resting tension is inversely related to 
A T P  this suggests that increased carbohydrate utilization resulted 
in a better maintained tissue A T P  level.
In the fat-fed there was no clear relationship between 
carbohydrate utilization and resting tension. Comparing the 
family of points from the fat-fed hearts w ith those from the 
normally-fed hearts there appeared to be a greater resting 
tension associated with a given rate of carbohydrate utilization 
in the fat-fed series. This suggests that an additional deter­
iorative factor was present in the fat-fed hearts. This could 
be the elevated long chain acyl CoA or other lipid induced 
effects as discussed earlier.
The regression analyses of the dependence of resting 
tension on perfusate lactate output give analogous results 
to those for total carbohydrate utilization: the %  conversion
of glucose and glycogen to lactate after adrenaline varied 
little among all the normally-fed or fat-fed hearts, so that 
the regression analysis using lactate output would be expected 
to reflect those with total carbohydrate utilization.
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5. Correlation of final tissue A T P  concentration and of 
resting tension with final tissue long chain acyl CoA 
concentration. (Results Section E.3,6 and 7a)
In normally-fed and fat-fed hearts there was a very good 
inverse correlation between tissue A T P  and tissue long chain 
acyl CoA for hearts perfused under all the conditions studied.
(N, r = -0.647; FF r = -0.723). There was also a good 
direct correlation between final resting tension and long 
chain acyl CoA (N, r = 0.691; FF r = 0.750). For ATP vs 
long chain acyl CoA and for resting tension vs long chain 
acyl CoA there was virtually no difference between the regression 
lines for the normal and fat-fed groups. This observation that 
one regression line can describe each relationship for all 
hearts provides further strong evidence that elevated long 
chain acyl CoA is associated with depletion of tissue AT P  and 
probably as a consequence of this w ith elevated contracture.
6 . Correlation of final tissue A T P  concentration and of 
resting tension with final tissue lactate concentration 
(Results Section E.3.C and 7.b)
There was a good inverse c o r r elation between the final 
tissue A T P  and tissue lactate concentration for both the 
normal and the fat-fed hearts perfused under all the conditions 
studied (N, r = -0.542; FF, r = -0.568). There was also a 
good direct relationship between the final resting tension and 
tissue lactate. (N, r = 0.564? FF, r = 0.578). However, in
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both cases the slopes of the regression lines for the 
normal and fat-fed hearts tended to be different, although 
this did not reach the level of statistical significance 
in either case.
Thus a particular A T P  concentration or final resting 
tension was associated w ith a lower tissue lactate concentration 
in the fat-fed hearts than in the normally-fed hearts. This 
apparent difference between the relationships in normal and 
fat-fed hearts supports the conclusion made earlier (Section A) 
that tissue lactate was not as closely related as long chain 
acyl CoA to the degree of deterioration. The levels of tissue 
lactate observed in this ischaemic model were very low (see 
Section A). Thus any deteriorative effects of endogenously 
generated lactate ma y  not have been fully expressed. If 
lactate were a primary deteriorative factor it would be necessary 
to argue that the fat-fed hearts were more sensitive than the 
normally-fed to the effects of the same concentration of lactate.
It ma y  rather be that the tissue lactate was a reflection of the 
amount of carbohydrate substrate utilized. A  lower tissue lactate 
would result from a lower rate of glucose and glycogen 
utilization, which has already been shown to be associated 
w ith more extensive deterioration because of the lower rate of 
energy generation. This argument was made by Apstein et al (1977) 
who observed that the extent of hypoxic contracture in an isolated 
rat heart model was inversely related to the perfusate lactate 
output.
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7, Correlation of final tissue A T P  concentration and of resting 
tension with final tissue long chain acyl carnitine 
concentration. (Results Section E.3.d and 7.c)
The final tissue long chain acyl carnitine concentration 
correlates well with the final resting tension but does not 
show a clear relationship with the final tissue ATP. Thus 
the evidence for a primary role of long chain acyl carnitine 
in the process of deterioration is less strong than that of 
long chain acyl CoA in this model. However, long chain acyl 
carnitine has been shown to irreversibly inhibit Na^, - A T P  ase 
in ischaemic heart tissue at the concentration found in ischaemic 
hearts ( Adams et al. 1979).
The loss of free carnitine also appeared to be associated 
with depletion of tissue AT P  and the rise in resting tension 
(Results Section E.3.e)
Thus the observed fall in free carnitine and rise in long 
. chain carnitine in the more deteriorated hearts are consistent 
with the observations made by other workers. Both could have 
contributed to the development of deterioration in the ischaemic 
hearts. Carnitine loss from the tissue as acetyl carnitine has
b een reported by Schwartz (1976) to be extensive in acute ischaemia 
and in chronic ischaemia ( S c h w a r t z S u c h  losses may further 
inhibit long chain fatty acid oxidation in ischaemia by reducing 
the rate of transport into the mitochondrial matrix, and could 
contribute to accumulation of long chain acyl CoA or free fatty 
acid in the cytoplasm.
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Net tissue carnitine loss could also create conditions 
where re-esterification of fatty acids would occur rather 
than oxidation. Such an effect has been observed in 
parenchymal liver cells following extensive carnitine loss 
(Christiansen et al., 1976). In the present model this could 
contribute to an oxygen-wasting effect of fatty acid-triglyceride 
cyclings in the presence of catecholamines (See Section B). Net 
loss of carnitine in the face of elevated long chain acyl CoA 
levels may also contribute to decreased energy production since 
carnitine, which can reverse the long chain acyl CoA inhibition of 
adenine nucleotide translocase (Shug et al.>1975), would be 
unavailable for this purpose. Carnitine has been proposed to play 
a role in buffering changes in the intramitochondrial acetyl 
CoA/CoA ratio (Pearson and T u b b s ^1967) and has been suggested to 
relieve the acetyl CoA inhibition of PDH by transferring acetyl 
units to carnitine via carnitine acetyl transferase (Pande, 1974; 
Shug et a l . , 1978). Loss of carnitine from the tissue could reduce 
the effectiveness of this mechanism and contribute to the inhibition 
of PDH with the consequent lactate accumulation and impairment of 
oxidative metabolism.
8 . Correlation between resting tension and oxygen consumption 
(Results Section E.4)
There was no correlation between the final resting tension 
and oxygen utilization since the oxygen extraction was almost 
maximal in all hearts. Thus the deterioration after adrenaline 
was due entirely to effects of hypoxia. Tissue accumulation of 
metabolites such as long chain acyl CoA or loss of carnitine may 
have prevented the utilization of the residual perfusate oxygen 
after adrenaline.
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Such metabolic changes have been shown to inhibit 
mitochondrial transport processes and could therefore 
inhibit respiration as already discussed.
9. Correlation of arrhythmias with final tissue metabolite 
levels and mechanical performance. (Results Section E.5)
There was no clear correlation between the incidence of 
arrhythmias and developed tension, heart rate or final tissue 
metabolite levels. The tissue metabolite levels are whole-tissue 
concentrations which are average values for the tissue. If the 
incidence of arrhythmias is related to metabolite concentrations 
in a membrane-associated compartment this could explain the lack 
of correlation with tissue metabolite levels. Such compartmentation 
was referred to in the introduction.
Lactate, long chain carnitine and carnitine, which are located 
predominantly in the cytoplasm, could also be present in a 
membrane-associated pool. The two compartments may not be in 
equilibrium, so that cytoplasmic levels need not be an accurate 
measure of the concentration at the cell membrane. The onset of 
arrhythmias is likely to follow a very small change in the energy 
change of the whole cell since it is one of the most sensitive 
indicators of cardiac cell damage, preceding the loss of 
metabolites or enzymes from the tissue and the onset of irreversible 
contracture (Burton et al., 1980). Consequently gross changes in 
A T P  concentration measured at the end of the persusion are unlikely 
to be directly related to the degree of arrhythmic activity. In 
addition some A T P  may be compartmentalised into a membrane 
associated pool so that whole tissue levels of ATP would not give 
a true indication of the concentration at the cell membrane.
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SECTION F Perfusion of hearts with pyruvate as sole exogenous 
substrate
1. Summary of results
The following results were obtained in normally-fed pyruvate- 
perfused hearts in comparison with those perfused with glucose.
At the higher flow rate (9 ml/min) oxygenation was adequate 
as judged by the submaximal oxygen extraction and the low rate 
of perfusate lactate output. Performance before adrenaline was 
u n a f f e c t e d .
Adrenaline challenge increased the oxygen extraction.
Perfusate lactate output increased but was only half that of the
glucose-perfused hearts. The resting tension rise was significantly
greater and the incidence of arrhythmias tended to be higher.
Tissue A T P  levels tended to be lower.
At the lower flow rate (4 ml/min) the resting tension rose
throughout the pre-adrenaline phase. Heart rate was lower than 
in the glucose-perfused hearts. The oxygen cost of work (MVO^/beat) 
was unchanged by flow reduction whereas it decreased with glucose 
as substrate. Thus the metabolism of the pyruvate-perfused group 
was almost entirely aerobic.
Adrenaline treatment caused a greater rise in resting tension. 
The incidence of arrhythmias remained at the high pre-adrenaline
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level. Contractile performance remained depressed compared 
with the glucose-perfused hearts.
Final tissue levels of ATP, creatine phosphate, glycogen, 
long chain acyl CoA and lactate were all lower than in the 
glucose-perfused hearts.
The final resting tension showed a direct correlation 
with long chain acyl CoA and with tissue lactate and was 
inversely related to the A T P  concentration.
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2. General
The data in earlier sections strongly implicated 
glycolytically-generated AT P  in the amelioration of deterioration 
of resting tension and arrhythmias after adrenaline challenge 
in normally-fed and fat-fed hearts. By perfusion w ith pyruvate 
in place of glucose only oxidatively generated ATP'is 
available and thus the contribution of glycolytic A T P  to 
stability would be absent. Thus an estimate of the 
contribution of glycolytic A T P  could be made by comparison 
with glucose-perfused hearts. Substitution of pyruvate for 
glucose should ensure that carbohydrate oxidation is maximally 
stimulated, as pyruvate stimulates PDH activity (Linn et a l , 1969).
The effect of pyruvate perfusion on the relationships 
between tissue lactate, tissue long chain acyl CoA and the 
degree of deterioration were also examined.
3. High-flow perfusion (9 ml/min) (Results Section F.2)
At the flow rate of 9 ml/min oxygen extraction was 
submaximal (75 - 80%), perfusate lactate output was low and 
metabolism was shown to be almost completely oxidative (See 
Section 1), Before adrenaline challenge the mechanical 
performance of pyruvate-perfused hearts did not differ 
markedly from that of glucose-perfused hearts. There was 
no significant difference between the groups in the incidence 
of arrhythmias (a sensitive indicator of deterioration in 
this model). There was only a minor rise in resting tension
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in the pyruvate perfused group. Thus it appears that 
pyruvate was able to satisfy the energy demands of the 
hearts under these conditions.
Adrenaline challenge imposed an additional w ork load on 
glucose and pyruvate perfused hearts alike, and 0^ extraction 
rose to and remained at 95%, which was close to the maximum 
for the system given the errors in measurement, in both groups. 
Thus both became hypoxic after adrenaline challenge. Under 
these conditions the pyruvate-perfused group was unable to 
generate glycolytic A T P  other than from glycogen mobilization. 
The small increase in perfusate lactate output suggests that 
there was a small amount of glycogen mobilization. The 
mechanical consequences were a significantly greater rise in 
resting tension and more arrhythmic activity in the pyruvate 
perfused group. The final tissue A T P  levels also tended to 
be lower. Long chain acyl CoA levels were no greater than 
in the glucose-perfused hearts. These observations suggest 
that glycolytic A T P  made a significant contribution towards the 
maintenance of tissue levels and hence to the amelioration of 
deterioration in the glucose-perfused group in the relatively 
hypoxic conditions after adrenaline challenge.
4. Perfusion at 4 ml/min (Results Section F.3)
A  decrease in the flow rate to 4 ml/min will reduce the 
oxygen supply to 45% of that at 9 ml/min. The accompanying 
increase in oxygen extraction was only in the order of 10%
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Thus even more intense oxygen-limiting conditions were 
present at this flow rate.
The total oxygen utilization was greatly reduced. As 
expected,this greatly reduced the w o r k  done. In the glucose 
perfused hearts at the low-flow rate a new balance between 
energy supply and demand was established (Results Section A).
Their low-flow performance was stable with little evidence of 
arrhythmias and with no change in the resting tension, indicating 
that the hearts were not deteriorating. The stimulation of 
glycogen mobilization, glucose uptake and lactate output in 
this group all indicated a contribution to the energy generated 
from anaerobic glycolysis.
By contrast hearts perfused with pyruvate at 4 ml/min showed 
from the beginning of the perfusion a continuing rise in resting 
tension and were very much more arrhythmic. This poorer 
performance could not be due to the performance of greater 
contractile w o r k  than the glucose perfused hearts since this 
was reduced to a similar extent in both groups. The only 
apparent factor which can account for the greater deterioration 
with pyruvate is the lack of significant glycolytic energy 
production. In accord with this, the pyruvate-perfused hearts showed 
no change in MVO^/beat after adrenaline challenge, whereas the 
glucose-perfused group showed a marked reduction, which could 
have been caused by the glycolytically-generated fraction of the 
ATP. In contrast, the very close relationship between the 
oxygen consumed and the w o r k  done in these pyruvate-perfused
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hearts demonstrates the almost total dependence of the 
pyruvate-perfused hearts on energy from oxidative sources.
The very large increase in arrhythmic activity in the 
absence of glycolytic ATP, which would be generated in the 
cytoplasm, further suggests that this source of A T P  may be 
functionally involved in the maintenance of membrane ion 
currents as discussed above (Section E).
Poorer performance in pyruvate-perfused hearts was 
observed after the adrenaline challenge: the resting tension
rise was much greater in these hearts than in the glucose- 
perfused group. A T P  and creatine phosphate levels were also 
significantly lower. The incidence of arrhythmias did not 
increase, but remained at the high pre-adrenaline level.
The adrenaline challenge imposed a further energy demand 
on the low-flow hearts. Unlike the glucose-perfused group, 
the pyruvate-perfused hearts were unable to respond to this 
demand by stimulating glycolysis other than from the limited 
glycogen stores. They were able to obtain further energy 
only by increasing oxygen extraction, the capacity for which 
was limited.
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5. Correlations between final resting tension and tissue
metabolites (Results Section F.4. ),
The similarity of the regression lines relating resting 
tension to AT P  for pyruvate-perfused hearts with that for glucose- 
perfused hearts emphasises the strong inverse relationship between 
resting tension and ATP.
The slopes and intercepts of the regression lines relating 
resting tension to tissue lactate or long chain acyl CoA differed 
in pyruvate-perfused hearts from those of the glucose-perfused 
hearts. The relationships predicted more deterioration in the 
pyruvate-perfused hearts than in the glucose-perfused group at a 
given concentration of these metabolites. This again suggests 
that the inability to generate glycolytic ATP, rather than the 
elevated levels of these metabolites, was the primary cause of 
deterioration in the pyruvate-perfused group. The effects of 
these metabolites appeared to be superimposed on those of 
glycolytic AT P  deficiency.
These results are in agreement with those from the ischaemic 
heart model of MacGregor et al. (1975) who related the onset of 
contracture to the cessation of glycolytic A T P  production.
Jarmakani et al. (1978a; 1978b) have shown that in hypoxically-
perfused neonatal rabbit hearts enhanced flux through glycolysis 
contributed to normal A T P  levels and to better-maintained function. 
In contrast adult hearts, with a lower glycolytic flux, suffered
298.
deterioration of developed tensions and a rise in resting 
tension which were paralleled by a decrease in AT P  concentration. 
In addition the relative decrease in A T P  was less than the 
decrease in mechanical function, which suggests that AT P  depletion 
from specific compartments was occurring.
The importance of glycolytic A T P  in the perfused rat heart 
has been demonstrated by Opie (1971/1972), who showed that it 
could account for half of the energy needs of the Langendorff 
perfused heart.
Nishiki et al. (1979) showed that glycolysis could provide 
up to 60% of the total A T P  in the perfused rat heart when the 
respiratory chain was inhibited by amytal.
In the globally ischaemic Langendorff-perfused rat heart 
Bricknell and Opie (1978) found that the incidence of ventricular 
arrhythmias on reperfusion was greater in pyruvate-perfused than 
glucose-perfused hearts. The rate of glycolytic ATP production 
in the pyruvate-perfused hearts was one-fifth that of the glucose- 
perfused group. The total tissue contents of AT P  and creatine 
phosphate were similar, however, further supporting the argument 
for the involvement of a small membrane-associated pool of ATP 
in the maintenance of ion gradients. The difference in final 
A T P  levels between glucose and pyruvate perfused hearts in the 
present model may be due to the additional workload of the 
catecholamine challenge.
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They also found that the incidence of arrhythmias and 
post-ischaemia loss of tissue LDH were greater in palmitate- 
perfused or acetate-perfused than in pyruvate-perfused hearts, 
suggesting the involvement of a 'l i pid-effect’ in deterioration 
such as fatty acid or long chain acyl CoA effects. Any additional 
deterioration with acetate-perfused hearts must have been due 
to some other cause such as the oxidation of acetate. The 
acetate-perfused hearts appeared to use more oxygen than the 
pyruvate-perfused hearts during normoxic perfusion, but the 
reverse was true during ischaemia. Thus less oxidative A T P 
was generated in acetate-perfused hearts during ischaemia.
The greater glycogen degradation in these hearts suggests that 
they were energy-deficient and that there was a greater contribution 
from glycolytic A T P  in an attempt to maintain A T P  levels. A  
similar effect was observed in the energy-deficient fat-fed hearts 
perfused with glucose in the present model. Thus the greater 
deterioration observed on reperfusion of acetate hearts may have 
been due to less efficient or less extensive oxidation of acetate 
than pyruvate.
The present w o r k  extends the observations of Bricknell and 
Opie by combining a glycolytic ATP-deficient state w i t h  the 
effects of endogenous lipolysis and catecholamines. The effects 
were found to be additive but the removal of glycolytic A T P  appeared 
to be more detrimental than fatty acid or catecholamine effects.
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Cowan and Vaughan-Williams (1980) have proposed that glycogen 
has a special protective role in the hypoxic heart. In a study 
of Langendorff rat hearts subjected to successive cycles of 
hypoxia and reperfusion the maintenance of the action potential 
d uration appeared to be closely related to the degree of glycogen 
mobilization. Glycogen appeared to be m uch more effective than 
glucose in this respect. They suggest that glycogen-derived 
glycolytic A T P  may be more closely related to membrane function 
than that from external glucose. This could not be tested in 
our model since the increased energy demand imposed by adrenaline 
exceeded the total AT P  available from glycogen, so that in 
pyruvate-perfused hearts glycogen stores were almost completely 
m o b i l i s e d .
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Further work
1) Freeze-clamping of hearts during the period of developing 
contracture would give further information regarding the
relative importance of metabolites such as long chain acyl CoA,
long chain acyl carnitine and lactate in the process of 
d eterioration.
2) Measurement of long chain acyl carnitine in the 2-BP treated 
hearts would give evidence on the status of lipid metabolism
of these hearts. The long chain acyl CoA levels measured to date 
may have been artefactual because of the drug itself.
3) Perfusion with exogenous carnitine has been reported to 
reverse the long chain acyl CoA-induced inhibition of adenine
nucleotide translocase (Folts et al., 1976).Carnitine loss from the 
tissue was observed in the present model. It appeared to be
broadly related to the degree of injury. Perfusion with
exogenous carnitine would give further information regarding 
the role of long chain acyl CoA in the observed deterioration.
4) Effects of endogenously generated fatty acid metabolites 
may be further enhanced by perfusion with albumin-free buffers, 
which might inhibit release of fatty acids from the cell.
5) A more sensitive method for measuring glycerol release 
into the perfusate would enable the degree of triglyceride 
hydrolysis to be measured more precisely.
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6 ) The control of activation of lipolysis and glycolysis 
with adrenaline challenge may be investigated by measuring 
the protein kinase activity ratio. The degree of activation, 
the time course of activation and any effect of flow rate 
could be important factors in determing the extent of 
deterioration.
7) The contribution of acidosis to the degree of deterioration 
might be reduced by including Tris buffer in the perfusate.
8 ) A more precise assessment of the contribution of glycolytic 
ATP to the total energy generating capacity of the ischaemic 
heart could be obtained by measuring the flux through glycolysis 
This may be achieved by measuring tritiated water production 




Effect of pacing on the pre-adrenaline mechanical performance
of normally-fed and fat-fed hearts perfused at 9 ml/min










Developed tension (g) Before pacing 
W ith pacing
9.39 + 0.24 8.45 + 0.71 
6.48 + 0.66^ 5.74 + 0.93^




2287 + 75 
2268 + 230
1875 + 131 
1943 + 277






Incidence of arrhythmias 






Values are mean + S.E.M.
* indicates that normally-fed and fat-fed values are significantly 
different (P <  0.05)
/  indicates that value with pacing is significantly different 
from pre-pacing value (P <  0.05)
Values before pacing are 0 - 1 0  min of perfusion 
Values with pacing are 10 - 30 min of perfusion.
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Table B
Effect of pacing on pre-adrenaline metabolism of normally-fed and
fat-fed hearts perfused at 9 ml/min
Normally-fed Fat-fed
Perfusate glucose uptake 
( ^ m o l / g  wet wt/br)
Before pacing 30.4 + 7.6
With pacing 2 9 . 4 + 5 . 0  3 2 . 5 + 8 . 1
Perfusate lactate output 
mol/g wet wt/br)
Before pacing 1 4 . 0 + 3 . 5  9 . 8 0 + 3 . 9 8
Witb pacing 21.5 + 6.6 20.9 + 7.3
%  glucose metabolised 
to lactate
Before pacing 25.6 + 7.8
Witb pacing 39.6 + 4.6 12.0 + 3.3
%  oxygen extraction Before pacing 80.2 + 1.0 79.3 + 1.8
Witb pacing y87.2 + 0.6' 88.3 + 3.0
^ ^ ^2 /^ m o l / g / m i n ) Before pacing 
Witb pacing
6.14 + 0.07 6.09 + 0.14
6.69 + 0.05^ 6.78 + 0.24^
MVOg/beat (n mol/g/bt) Before pacing 
W itb pacing
24.4 + 1.0 26.6 + 1.5
1 9 . 1 + 0 . 1 ^  1 9 . 4 + 6 . 6
Values are mean + S.E.M. n = 5 for botb groups.
* indicates tbat normally-fed and fat-fed values are 
significantly different (P <  0.02)
/  indicates tbat value witb pacing is significantly different 
from pre-pacing value ( P <  0.02)
Values before pacing are for 0 - 1 0  min of perfusion 
Values witb pacing are for 10 - 30 min of perfusion
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Table G
Effect of pacing on the peak response to adrenaline challenge of






8.80 + 0.61** 7.24 + 0.82*
Peak developed tension as %  of 
paced pre-adrenaline phase 138 + 6 132 + 11
Heart rate x developed tension 
(g. bt/min) 3080 + 213** 2534 + 286*
Values are m ean + S.E.M.
Differences between paced pre-.adrenaline phase (Table A) 
and peak response are indicated as follows:
* P <  0.01
** P C  0.001
Adrenaline was infused at 30 min, after 20 min pacing.
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Table D
Effect of pacing on the second phase response to adrenaline







4.21 + 0.65 4.01 + 0.74//
Developed tension as %  of paced 
pre-adrenaline phase 64 + 6 6 9 + 4
Heart rate x developed tension 
(g. bt/min) 1453 + 223 • 1402 + 259^^
Rise in resting tension (g) 0.47 + 0.30 1.39 + 0.52/
Incidence of arrhythmias (% time) 13.4 + 13.4 14.0 + 14.0
Values are mean + S.E.M.
Differences between these values and those of the paced
pre-adrenaline phase are indicated as follows:
/  P <  0.05
/ /  P <  0.01
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Table E
Effect of pacing on the metabolic responses to adrenaline
challenge in normally-fed and fat-fed hearts perfused at 9 ml/min
Normally-fed (n = 5) Fat-fed (n = 5)
Glycogen mobilisation ,,
mol/g wet wt/hr) 20.2 + 2.4 29.2 + 1.8
Perfusate glucose uptake , .
m o l/g wet wt/hr) 91.0 + 2.9 6 2 . 5 + 8 . 8
Perfusate lactate output
y( u m o l / g  wet wt/hr) 65.4 + 6.5 38.0 + 4.9*
%  glucose + glycogen
metabolised to lactate 29.8 + 2.5 18.4 + 2.2
Values are mean + S.E.M. for the 30 min post-adrenaline period 
* indicates that normally-fed and fat-fed values are significantly 
different ( P <  0.02)
Differences between post-adrenaline values and paced 
pre-adrenaline values are indicated as follows:
/  P <  0.05
/ /  P <  0.001
^ indicates that value in paced hearts differs from that in
unpaced hearts (Table 25) ( P <  0.05)
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Table F
Effect of pacing on the final tissue metabolite levels in
normally-fed and fat-fed hearts perfused at 9 ml/min
Lactate







Long chain acyl CoA 
(n mol/g wet wt) 5.73 + 0.83 7.85 + 1.19
Long chain acyl carnitine 
(n mol/g wet wt) 203 + 25 197 + 12
Carnitine (n mol/g wet wt) 680 + 70 480 + 60
A T P  mol/g wet wt) 2.79 + 0.28 2.49 + 0.05
Creatine phosphate 
ijji mol/g wet wt) 3.23 + 0.24 3.23 + 0.30
* indicates that normally-fed and fat-fed values are 
significantly different ( P <  0.05)
Appendix B
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Appendix B shows the results obtained in hearts treated 
with insulin, nicotinic acid, higher adrenaline dose or a higher 
Ca^^ concentration. Insulin 0.1 m U/ml was added to the perfusate 
prior to perfusion.
Nicotinic acid (final perfusate concentration 5 juM) was 
infused in a volume of 1 ml after 20 min. recirculating 
perfusion according to the usual drug protocol.
The 'high adrenaline* hearts were treated with lOyuM 
adrenaline instead of 1 jUiM adrenaline.
In the'high calcium'hearts calcium chloride solution 
was added as a bonus after 20 min. recirculating perfusion. 
This raised the perfusate calcium concentration from 2.54 mM 
to 3.56 mM.








High adrenaline N 
FF
High Ca^^ N 
FF
Heart Rate (bt/min 
Pre-
adrenaline 
(n=5) 206 + 13
(n=5) 173 + 10
(n=6) 208 + 18
(n=5) 241 + 11
(n=5) 170 + 9
(n=5) 153 + 13
(n=3) 180 + 8
(n=4) 178 + 4
P eak
adrenaline 
288 + 10 
256 + 7 
291 + 18 
309 + 6 
224 + 6 
209 + 5 












Table H Developed tension (g)
Pre- P e a k 2nd Post-
adrenaline adrenaline adrenaline phase
Insulin N 5.26 + 0.64 7.40 + 0.67 4.34 + 0.67
FF 5.27 + 0.42 7.36 + 0.66 3.29 + 0.43
Nicotinate N 4.67 + 0.41 7.06 + 0.96 2.61 + 0.23
FF 4.38 + 0.35 7.36 + 0.47 2.97 + 0.20
High adrenaline N 6.08 + 0.28 7.20 + 0.50 3.91 + 0.44
■ FF 5.96 + 1.51 6.95 + 2.18 2.82 + 0 40
2 +High Ca N 5.79 + 0.29 6.70 + 1.35 4.09 + 0.94
FF 5.81 + 0.55 6.58 + 0.68 4.24 + 0.74
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Table I
Insulin N  
FF
Nicotinate N  
FF
High adrenaline N  
FF
High Ca^* N  
FF
Resting tension (g )
At 30 min (pre-adrenaline) At 60 min (post-adrenaline)
1.93 + 0.07 
1.99 + 0.04 
1.82 + 0.04 
2.04 + 0.12 
1.69 + 0.08 
1.64 + 0,11 
2.17 + 0.28 
3.73 + 0.75
4.46 + 0.45 
7.01 + 0.38 
6.42 + 0.55 
7.13 + 0.38 
7.27 + 0.21 
7.56 + 1.03 
6.81 + 0.85 
8.79 + 0.65





Insulin N 2.6 + 2.6 35.2 + 14.6
FF 17.5 + 16.5 59.3 + 7.1
Nicotinate N 0 36.6 + 11.7
FF 0 23.0 + 12.0
High adrenaline N 3.2 + 2.1 52.4 + 18.6
FF 10.8 + 10.8 44.3 + 20.2
High Ca^+ N 47.7 + 24.8 49.0 + 28.8
FF 11.0 + 4.0 18.5 + 13.0
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Table K. Perfusate glucose + glycogen utilisation mol/g wet wt/br)
Pre-adrenaline Post-adrenaline
(O - 30 min) (30 - 60 min)
Insulin N  8 2 . 2 + 6 . 6  137 + 11
FF 63.7 + 2.2 121 + 4
Nicotinate N  51.8 + 8.8 93.7 + 5.7
FF 33.2 + 6.4 68.8 + 5.4
Higti adrenaline N  67.2 + 11.2 105.7 + 3.0
FF 3 7 . 3 + 6 . 6  8 8 . 1 + 1 1 . 0
2+High Ca N  70.1 + 13.9 115 + 9
FF 28.7 + 5.2 76.2 + 4.1
Table L. Perfusate lactate output ^  mol/g wet wt/br)
Pre-adrenaline Post-adrenaline
(O - 30 min) (30 - 60 min)
Insulin N  94.8 + 5.8 119.4 + 6.8
FF 78.6 + 10.0 116.4 + 7.0
Nicotinate N  62.8 + 11.6 90.6 + 10.4
FF 32.5 + 6.4 66.4 + 5.5
High adrenaline N  4 3 . 1 + 3 . 2  5 3 . 0 + 2 . 9
FF 31.7 + 1.1 56.6 + 10.4
High Ca^+ N 50.4 + 15.6 55.8 + 10.2
FF 21.5 + 2.9 49.0 + 10.0
313.
Table M. Final tissue metabolite levels
Lactate ( mol/g wet weight)
Normally-fed Fat-fed
Insulin 2.40 + 0.12 2.19 + 0.08
Nicotinate 2.33 + 0.27 1.66 + 0.20
High adrenaline 2.42 + 0.10 1.80 + 0.07
2+High Ca 2.55 + 0.05 1.49 + 0.13




High Ca" 12.2 + 0.3
High adrenaline 
2 +
18.2 + 0.6 
18.2 + 2.7





510 + 10 
540 + 120
370 + 40 
400 + 50





1.08 + 0.12 
1.77 + 0.20
0.88 + 0.08 
1.29 + 0.12
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Table N. Final tissue metabolite levels (contd)
Normally-fed




2+High Ca 1.69 + 0,29
Fat-fed
1.09 + 0.13





11.0 + 1.8 
10.3 + 1.4 
8.34 + 0.31 
10.9 + 0.75
6.6 + 1.2 





Abood, L.G. and Matsubara, A. (1968), Biocbim. biopbys. acta.
1 6 3 , 539-549.
Adams, R.J., Pitts, B.J., Woods, J.M., Gende, O.A., Wallick, E.T. and 
Schwartz, A. (1979) J. Mol. Cell. Cardiol., 1^, 941-959.
Allison, T.B., Bruttig, S.P., Crass, M.F., Eliot, R.S. and 
Ship, J.C. (1976), Am. J. Physiol. 230, 1744-1751.
Alousi, A.A. and Mallov, S. (1965), Am. J. Physiol. 2 0 6 , 603-609. 
Apstein, C.S., Bing, O.H.L. and Levine, H.J., (1976) J. Mol. Cell.
Cardiol. 8 , 627-640.
Apstein, C.S., Mueller, M. and Hood, W.B., (1977), Circ. Res. 4 1 , 
206-217.
Armiger, L.C., Gavin, J.B. and Herdson, P.B., (1974) Lab. Invest.
3 1 , 29-33.
P s i m a k i s ,  Ç.K, ar\eK Sordahf  ̂ L  A r c k .  S i o c h e m  . , 2o o  - 2 / 0 .
Ballard, F.B., Danforth, W.H., Naegle, S. and Bing, R.J., (1960),
J. Clin. Invest. 717-723.
Barlow, C.H. and Chance, B . , (1976), Science 19 3 , 909-910.
Biale, Y. , Gorin, E. and Shafrir, E. (1968), Biochim. biophys. acta 
1 5 2 , 28-39.
Bing, O . H . L . , Brooks, W.W. and Messer, J.V. (1972) J. Mol. Cell.
Cardiol. 4, 319-328.
Bing, O.H.L., Brooks, W.W. and Messer, J.V. (1976) J. Mol. Cell.
Cardiol. 205-215.
Bing, R.J., Siegel, A., Ungar, I . and Gilbert, M . , (1954) Am.J. Med. 
1 6 , 504-515.
Bishop, V.S., Kaspar, R.L., Barnes, G.E., Kardon, M.B. (1974)
J. Appl. Physiol. 37, 785-793.
316.
0 / o o r ,  C . M . ( 1978)  ,  C o . r c * i o c  P a h h o / o ^ .  Lipf>incohh Si Co.̂ Philadciphi'tt.
Bjürntorp, P and Furman, R.H. (1962), Am. J. Physiol. 2 0 3 , 323 326. 
Borensztajn, J., Rone, M.S. and Sandros, T. (1975) Biochim. biophys.
acta 3 9 8 , 394-400.
Borrebaek, B . , Christiansen, R . , Christophersen, B.O. and Bremer, J.
(1976), Circ. Res. 38, (Supp. I) I 16-20.
Brachfeld, N. (1969) Circ. Res. 202-219.
Braunwald, E. (1971) Am. J. Cardiol. 416-432.
Braunwald, E . , Maroko, P.R. and Libby, P. (1974) Circ. Res. 34,feuppI I I ) ,
Bremer, T. (IA76) Circ. «es. 11 /Supp l)  17*1. IA2-20J .
Bremer, J. (1977) Trends in Biochemical Sciences, 207-209.
Bremer, J. and Norum, K.R. (1967), J. Biol. Chem. 2 4 2 , 1744-1748.
Bricknell, O.L. and Opie, L.H. (1978) Circ. Res. 4^, 102-115.
*
Brownsey, R.W. (1975) Ph.D. dissertation, Bath University.
Brownsey, R.W. and Brunt, R.V. (1977) Clin. Sci. Mol. Med. 53,
513-521.
Brutsaert, D.L. and Sonnenblick, E.H. (1969) Circ. Res. 24, 137-149. 
Brutsaert, D.L., Claes, V.A. and Sonnenblick, E.H. (1971) Circ. Res. 
63-75.
Bruyneel, K.J.J. (1975) Am. Heart J. 89, 731-741.
Burges, R.A., Butt, W.D. and Baggaley, A . (1968) Biochem J. 1 0 9 ,
38P-39P.
Burns, J.W. and Covell, J.W. (1972) Am. J. Physiol. 2 2 3 , 1491-1497.
Burton, K.P., Templeton, G.H., Hagler, H . K . , Willerson,J.T. and
Buja, L.M., (1980) J. Mol. Cell. Cardiol 109-133.
Bucher, T. (1947) Biochim. Biophys. Acta 1̂, 2^2-31+.
*
BnngolF, M  ,, K). Felber^T.P. (f470) Horm.MehAb. «es. ^  40.
317.
Cahill, G. (1976) Circ. Res. 38, (Supp I), I 109-114.
Campbell, R.C. (1974) Statistics for Biologists, 2nd edn., Cambridge 
Univ. Press.
Carlson, L.A., Boberg, J. and Hogstedt, B. (1965) in Handbook of 
Physiology, Section 5, (Renold, A.E. and Cahill, G.F. eds.)
P. 625, American Physiological Society, Washington DC.
Carlsten, A., Hallgren, B . , Jagenburg, R . , Svanborg, A. and 
Werktt, L. (1963) Metabolism 1063-/O7I,
Case, R.B. (1971/72) Cardiology 56, 245-262.
Ceremuzynski, L . , Staszewska-Barczak, J. and Herbaczynska-Cedro, K.
(1969) Cardiovasc. Res. 190-197.
Challoner, D.R. (1966) Lancet 681-683.
Challoner, D.R. and Steinberg, D. (1965) Nature 2 0 5 , 602-3.
Challoner, D.R. and Steinberg, D. (1966) Am. J. Physiol. 2 1 0 , 280-286
Chan, T.M. and Exton, J.H. (1976) Analyt. Biochem. 7^, 96-105.
Chance, B. (1976a) Circ. Res. 38, (Supp 1 ) 1  31-38.
Chance, B. (1976b) Circ. Res. (Supp I), I 69-74.
Chance, B. and Mela, M. (1966) Proc. Nat. Acad. Sci. 5^, 1243-1251. 
Chance, B. and Williams, G.R. (1956) Adv. Enzymol. 1/7, 65-134. 
Chappell, J.B. (1961) in Biol. Structure and Function Vol. 2, P71 
ed. Goodwin T.W. and Lindberg, 0. Acad. Press London.
Chase, J.F.A. and Tubbs, P.K. (1972) Biochem. J. 1 2 9 , 55-56.
Charlier, R. (1971) Handbook Exptl. Pharmacol. ^  442 pp.
Chen, R.F. (1967) J. Biol. Chem. 2 ^ ,  173-181.
Cheneval, J-P, Hyde, A. and Blondel, B. (1972) J. Physiol. (Paris) 
413-430.
Cheung, W.Y. and Williamson, J.R. (1965) Nature 207, 979-981.
318.
Christian, D.R. Kilsheimer, G.S., Pettet, G. Paradise, R. and 
Ashmore, J. (1969) Adv. Enz. Regn. 1_, 71-83.
Christiansen, R . , Borreback, B. and Bremer, J. (1976) FEBS L e t t .62,
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